[
  {
    "drug": "Acetaminophen (Tylenol)",
    "population": "Pediatric",
    "page": 231,
    "text": "For mild to moderate painscales of 1-5 or in moderate to severe painwhere other medicationsare\ncontraindicated or deferred.\n2 years to 14 years:\nTylenol, 15mg/kg to max of 1000mg or 1 gmIV/IOinfusion overfifteen (15) minutes. Single doseonly",
    "html": "<ul class='proto'><li>For mild to moderate painscales of 1-5 or in moderate to severe painwhere other medicationsare</li><li>contraindicated or deferred.</li><li>2 years to 14 years:</li><li>Tylenol, <b>15mg/kg</b> to <b>max of <b>1000mg</b></b> or <b>1 g</b>mIV/IOinfusion overfifteen (15) minutes.</li><li>Single doseonly</li></ul>"
  },
  {
    "drug": "Atropine (ALS)",
    "population": "Adult",
    "page": 232,
    "text": "Atropine, 1 mgIV/IO. Mayrepeat every five (5) minutesup to a maximum of 3 mg or\n0.04 mg/kg.\nOrganophosphate poisoning:\nAtropine, 2 mgIV/IO, repeat at 2 mgincrements every five (5) minutes if patient remains\nsymptomatic.",
    "html": "<ul class='proto'><li>Atropine, <b>1 mg</b><b>IV/IO</b>.</li><li>Mayrepeat every five (5) minutesup to a <b>maximum of <b>3 mg</b></b> or</li><li><b>0.04 mg/kg</b>.</li><li>Organophosphate poisoning:</li><li>Atropine, <b>2 mg</b><b>IV/IO</b>, repeat at <b>2 mg</b>increments every five (5) minutes if patient remains</li><li>symptomatic.</li></ul>"
  },
  {
    "drug": "Atropine",
    "population": "Pediatric",
    "page": 232,
    "text": "Organophosphate poisoning - Pediatrics lessthan 14 years of age:\nAtropine, 0.05 mg/kgIV/IO not to exceed adult dose of 2 mg, repeat at 0.1 mg/kgincrements\nevery five (5) minutes if patient remains symptomatic.\nBuprenorphine-Naloxone (Suboxone \u00ae)-Adult (ALS):\nOpioid Withdrawal- Clinical Opioid Withdrawal Scale \u2265 8:\nBuprenorphine-Naloxone, 16 mg/4mg sublingual, mayrepeat at 8 mg/2mg sublingual afterten (10)\nminutes if patient remains symptomatic, to a maximum total dose of 24 mg/6mg.",
    "html": "<ul class='proto'><li>Organophosphate poisoning - Pediatrics lessthan 14 years of age:</li><li>Atropine, <b>0.05 mg/kg</b><b>IV/IO</b> <b>not to exceed adult dose of <b>2 mg</b>, repeat at <b>0.1 mg</b></b>/kgincrements</li><li>every five (5) minutes if patient remains symptomatic.</li><li>Buprenorphine-Naloxone (Suboxone \u00ae)-Adult (ALS):</li><li>Opioid Withdrawal- Clinical Opioid Withdrawal Scale \u2265 8:</li><li>Buprenorphine-Naloxone, <b>16 mg</b>/<b>4mg</b> sublingual, mayrepeat at <b>8 mg</b>/<b>2mg</b> sublingual afterten (10)</li><li>minutes if patient remains symptomatic, to a <b>maximum total dose of <b>24 mg</b>/<b>6mg</b></b>.</li></ul>"
  },
  {
    "drug": "Calcium Chloride",
    "population": "Adult",
    "page": 232,
    "text": "Calcium Channel Blocker Poisonings\nCalcium Chloride, 1 gm (10 ml of a 10% solution) IV/IO.\nFor cardiac arrest withsuspected hypocalcemia, hyperkalemia, hypermagnesemia or calcium channel\nblocker poisoning\nCalcium Chloride, 1 gm (10 ml of a 10% solution) IV/IO.\nFor EndStage Renal Disease (ESRD) patients on dialysis withsuspected hyperkalemia and\nhemodynamic instability withdocumented sinus bradycardia,3rd degreeAV Block, 2nd degree TypeIIAV\nBlock, slowjunctional and ventricular escape rhythms, or slowatrial fibrillation. (Basehospital order\nonly).\nCalcium Chloride, 1 gm (10 ml of a 10% solution) IV/IO",
    "html": "<ul class='proto'><li>Calcium Channel Blocker Poisonings</li><li>Calcium Chloride, <b>1 g</b>m (<b>10 ml</b> of a 10% solution) <b>IV/IO</b>.</li><li>For cardiac arrest withsuspected hypocalcemia, hyperkalemia, hypermagnesemia or calcium channel</li><li>blocker poisoning</li><li>Calcium Chloride, <b>1 g</b>m (<b>10 ml</b> of a 10% solution) <b>IV/IO</b>.</li><li>For EndStage Renal Disease (ESRD) patients on dialysis withsuspected hyperkalemia and</li><li>hemodynamic instability withdocumented sinus bradycardia,3rd degreeAV Block, 2nd degree TypeIIAV</li><li>Block, slowjunctional and ventricular escape rhythms, or slowatrial fibrillation.</li><li>(Basehospital order</li><li>only).</li><li>Calcium Chloride, <b>1 g</b>m (<b>10 ml</b> of a 10% solution) <b>IV/IO</b></li></ul>"
  },
  {
    "drug": "Calcium Chloride",
    "population": "Pediatric",
    "page": 233,
    "text": "Calcium Channel Blocker Poisonings\nCalcium Chloride, 20 mg/kgIV/IOover five (5) minutes.",
    "html": "<ul class='proto'><li>Calcium Channel Blocker Poisonings</li><li>Calcium Chloride, <b>20 mg/kg</b><b>IV</b>/IOover five (5) minutes.</li></ul>"
  },
  {
    "drug": "Hypoglycemia",
    "population": "Adult",
    "page": 233,
    "text": "Dextrose 10% /250 ml (D10W 25 gm) IV/IOBolus",
    "html": "<div class='proto'>Dextrose 10% /<b>250 ml</b> (D10W <b>25 g</b>m) <b>IV</b>/IOBolus</div>"
  },
  {
    "drug": "Dextrose",
    "population": "Pediatric",
    "page": 233,
    "text": "Hypoglycemia - Neonates (0 - 4 weeks) withblood glucose lessthan 35 mg/dL or pediatric patients (morethan 4 weeks) withglucose lessthan 60 mg/dL:\nDextrose 10%/250 ml (D10W 25 gm) 0.5 gm/kg (5 ml/kg) IV/IO",
    "html": "<ul class='proto'><li>Hypoglycemia - Neonates (0 - 4 weeks) withblood glucose lessthan <b>35 mg</b>/dL or pediatric patients (morethan 4 weeks) withglucose lessthan <b>60 mg</b>/dL:</li><li>Dextrose 10%/<b>250 ml</b> (D10W <b>25 g</b>m) <b>0.5 g</b>m/kg (<b>5 ml/kg</b>) <b>IV/IO</b></li></ul>"
  },
  {
    "drug": "Diazepam",
    "population": "Adult",
    "page": 233,
    "text": "Seizures:\nDiazepam , 5 mgIV/IO, single doseonly\nDiazepam 10mg IM, single doseonly",
    "html": "<ul class='proto'><li>Seizures:</li><li>Diazepam , <b>5 mg</b><b>IV/IO</b>, single doseonly</li><li>Diazepam <b>10mg</b> <b>IM</b>, single doseonly</li></ul>"
  },
  {
    "drug": "Diazepam",
    "population": "Pediatric",
    "page": 233,
    "text": "Seizures:\nDiazepam 0.1mg/kgIV/IO, single doseonly, not to exceed adult dose of 5mg\nDiazepam 0.2mg/kgIM, single doseonly, not to exceed adult dose of 10mg",
    "html": "<ul class='proto'><li>Seizures:</li><li>Diazepam <b>0.1mg/kg</b><b>IV/IO</b>, single doseonly, <b>not to exceed adult dose of <b>5mg</b></b></li><li>Diazepam <b>0.2mg/kg</b><b>IM</b>, single doseonly, <b>not to exceed adult dose of <b>10mg</b></b></li></ul>"
  },
  {
    "drug": "Diphenhydramine",
    "population": "Pediatric",
    "page": 233,
    "text": "Allergic reaction:\n2 years to 14 years Diphenhydramine, 1 mg/kgslowIV/IO, not to exceed adult dose of 25\nmg, or\nDiphenhydramine, 2 mg/kgIM not to exceed adult dose of 50 mgIM.",
    "html": "<ul class='proto'><li>Allergic reaction:</li><li>2 years to 14 years Diphenhydramine, <b>1 mg/kg</b>slowIV/<b>IO</b>, not to exceed adult dose of 25</li><li>mg, or</li><li>Diphenhydramine, <b>2 mg/kg</b><b>IM</b> not to exceed adult dose of <b>50 mg</b><b>IM</b>.</li></ul>"
  },
  {
    "drug": "Epinephrine (0.1 mg/ml)",
    "population": "Adult",
    "page": 234,
    "text": "For persistent severe anaphylactic reaction:\nEpinephrine (0.1 mg/ml), 0.1 mgslowIVP/IO. Mayrepeat every five (5) minutes as needed to total\ndosage of 0.5 mg.\nCardiac Arrest, Asystole, PEA:\nEpinephrine (0.1 mg/ml), 1 mgIV/IO.",
    "html": "<ul class='proto'><li>For persistent severe anaphylactic reaction:</li><li>Epinephrine (<b>0.1 mg</b>/ml), <b>0.1 mg</b>slowIVP/<b>IO</b>.</li><li>Mayrepeat every five (5) minutes as needed to total</li><li>dosage of <b>0.5 mg</b>.</li><li>Cardiac Arrest, Asystole, PEA:</li><li>Epinephrine (<b>0.1 mg</b>/ml), <b>1 mg</b><b>IV/IO</b>.</li></ul>"
  },
  {
    "drug": "Epinephrine (0.01 mg/ml)",
    "population": "Adult",
    "page": 234,
    "text": "Postresuscitation, persistent profound nontraumatic shock and hypotension, and for persistent shockdue\nto trauma where cardiac arrest is imminent:(PushDose Epinephrine).\nPrepare Epinephrine 0.01 mg/mlsolution by mixing 9 ml of normal saline with 1 ml of\nEpinephrine 0.1 mg/ml in a 10 mlsyringe. Administer 1 mleveryone (1) to five (5) minutes\ntitrated to maintainSBP morethan 90 mmHg.",
    "html": "<ul class='proto'><li>Postresuscitation, persistent profound nontraumatic shock and hypotension, and for persistent shockdue</li><li>to trauma where cardiac arrest is imminent:(PushDose Epinephrine).</li><li>Prepare Epinephrine <b>0.01 mg</b>/mlsolution by mixing <b>9 ml</b> of normal saline with <b>1 ml</b> of</li><li>Epinephrine <b>0.1 mg</b>/ml in a <b>10 ml</b>syringe.</li><li>Administer <b>1 ml</b>everyone (1) to five (5) minutes</li><li>titrated to maintainSBP morethan 90 mmHg.</li></ul>"
  },
  {
    "drug": "Epinephrine (1 mg/ml)",
    "population": "Pediatric",
    "page": 234,
    "text": "Severe Bronchospasm, Asthma Attack, Pending Respiratory Failure, Severe Allergic Reactions:\nEpinephrine, 0.01 mg/kgIM not to exceed adult dosage of 0.3 mg. Mayrepeat after 15 minutesone (1) time if symptoms do not improve.",
    "html": "<ul class='proto'><li>Severe Bronchospasm, Asthma Attack, Pending Respiratory Failure, Severe Allergic Reactions:</li><li>Epinephrine, <b>0.01 mg/kg</b><b>IM</b> <b>not to exceed adult dosage of <b>0.3 mg</b></b>.</li><li>Mayrepeat after 15 minutesone (1) time if symptoms do not improve.</li></ul>"
  },
  {
    "drug": "Epinephrine (0.1 mg/ml)",
    "population": "Pediatric",
    "page": 235,
    "text": "Anaphylactic reaction (no palpable radial pulse and depressed level of consciousness):\nEpinephrine (0.1 mg/ml), 0.01 mg/kgIV/IO, no morethan 0.1 mgper dose. Mayrepeat to a\nmaximum of 0.5 mg.\nCardiac Arrest:\n1 day to 8 years Epinephrine (0.1 mg/ml), 0.01 mg/kgIV/IO (do not exceed adult\ndosage)\n9 to 14 years Epinephrine (0.1 mg/ml), 1.0 mgIV/IONewborn Care:\nEpinephrine (0.1 mg/ml), 0.01 mg/kgIV/IO if heart rate is lessthan 60 afterone (1) minute after\nevaluating airway for hypoxia and assessing bodytemperature for hypothermia.\nEpinephrine (0.1 mg/ml), 0.005 mg/kgIV/IOevery 10 minutes for persistent hypotension as a\nbasehospital order or in radio communication failure.",
    "html": "<ul class='proto'><li>Anaphylactic reaction (no palpable radial pulse and depressed level of consciousness):</li><li>Epinephrine (<b>0.1 mg</b>/ml), <b>0.01 mg/kg</b><b>IV/IO</b>, no morethan <b>0.1 mg</b>per dose.</li><li>Mayrepeat to a</li><li><b>maximum of <b>0.5 mg</b></b>.</li><li>Cardiac Arrest:</li><li>1 day to 8 years Epinephrine (<b>0.1 mg</b>/ml), <b>0.01 mg/kg</b><b>IV/IO</b> (do not exceed adult</li><li>dosage)</li><li>9 to 14 years Epinephrine (<b>0.1 mg</b>/ml), <b>1.0 mg</b><b>IV</b>/IONewborn Care:</li><li>Epinephrine (<b>0.1 mg</b>/ml), <b>0.01 mg/kg</b><b>IV/IO</b> if heart rate is lessthan 60 afterone (1) minute after</li><li>evaluating airway for hypoxia and assessing bodytemperature for hypothermia.</li><li>Epinephrine (<b>0.1 mg</b>/ml), <b>0.005 mg/kg</b><b>IV</b>/IOevery 10 minutes for persistent hypotension as a</li><li>basehospital order or in radio communication failure.</li></ul>"
  },
  {
    "drug": "Epinephrine (0.01 mg/ml)",
    "population": "Pediatric",
    "page": 235,
    "text": "Postresuscitation, profound shock and hypotension, for persistent shockdue to trauma where cardiac\narrest is imminent (PushDose Epinephrine):\nPrepare Epinephrine 0.01 mg/mlsolution by mixing 9 ml of normal saline with 1 ml of Epinephrine\n0.1 mg/ml in a 10 mlsyringe. Administer 0.1 ml/kg (do not exceed adult dosage), everyone (1) to\nfive (5) minutes. Titrate to maintain a SBPmore than 70 mmHg.",
    "html": "<ul class='proto'><li>Postresuscitation, profound shock and hypotension, for persistent shockdue to trauma where cardiac</li><li>arrest is imminent (PushDose Epinephrine):</li><li>Prepare Epinephrine <b>0.01 mg</b>/mlsolution by mixing <b>9 ml</b> of normal saline with <b>1 ml</b> of Epinephrine</li><li><b>0.1 mg</b>/ml in a <b>10 ml</b>syringe.</li><li>Administer <b>0.1 ml/kg</b> (do not exceed adult dosage), everyone (1) to</li><li>five (5) minutes.</li><li>Titrate to maintain a SBPmore than 70 mmHg.</li></ul>"
  },
  {
    "drug": "Fentanyl",
    "population": "Adult",
    "page": 235,
    "text": "Chest Pain (Presumed Ischemic Origin):\nFentanyl, 50 mcgslowIV/IOoverone (1) minute. Mayrepeat every five (5) minutes titrated to pain,\nnot to exceed 200 mcg.\nFentanyl, 100 mcgIM/IN. Mayrepeat 50 mcgevery 10 minutes titrated to pain, not to exceed 200\nmcg.\nAcute traumatic injuries, acute abdominal/flank pain, burninjuries, Cancer pain, Sickle CellCrisis:\nFentanyl, 50 mcgslowIV/IOpush overone (1) minute. Mayrepeat every five (5) minutes\ntitrated to pain, not to exceed 200 mcgIV/IO, or\nFentanyl, 100 mcgIM/IN. Mayrepeat 50 mcgevery 10 minutes titrated to pain, not to exceed 200\nmcg.\nPacing, synchronized cardioversion:\nFentanyl, 50 mcgslowIV/IOoverone (1) minute. Mayrepeat in five (5) minutes titrated to pain,\nnot to exceed 200 mcg.\nFentanyl, 100 mcg IN. Mayrepeat 50 mcgevery 10 minutes titrated to pain, not to exceed 200\nmcg.\nAnycombination of IV/IO/IM/IN may be administered, not to exceed 200 mcg. Contact basehospital for additional orders and to discuss further treatment options.",
    "html": "<ul class='proto'><li>Chest Pain (Presumed Ischemic Origin):</li><li>Fentanyl, <b>50 mcg</b>slowIV/IOoverone (1) minute.</li><li>Mayrepeat every five (5) minutes titrated to pain,</li><li><b>not to exceed <b>200 mcg</b></b>.</li><li>Fentanyl, <b>100 mcg</b><b>IM</b>/<b>IN</b>.</li><li>Mayrepeat <b>50 mcg</b>every 10 minutes titrated to pain, not to exceed 200</li><li>mcg.</li><li>Acute traumatic injuries, acute abdominal/flank pain, burninjuries, Cancer pain, Sickle CellCrisis:</li><li>Fentanyl, <b>50 mcg</b>slowIV/IOpush overone (1) minute.</li><li>Mayrepeat every five (5) minutes</li><li>titrated to pain, not to exceed <b>200 mcg</b><b>IV/IO</b>, or</li><li>Fentanyl, <b>100 mcg</b><b>IM</b>/<b>IN</b>.</li><li>Mayrepeat <b>50 mcg</b>every 10 minutes titrated to pain, not to exceed 200</li><li>mcg.</li><li>Pacing, synchronized cardioversion:</li><li>Fentanyl, <b>50 mcg</b>slowIV/IOoverone (1) minute.</li><li>Mayrepeat in five (5) minutes titrated to pain,</li><li><b>not to exceed <b>200 mcg</b></b>.</li><li>Fentanyl, <b>100 mcg</b> <b>IN</b>.</li><li>Mayrepeat <b>50 mcg</b>every 10 minutes titrated to pain, not to exceed 200</li><li>mcg.</li><li>Anycombination of <b>IV/IO</b>/<b>IM</b>/<b>IN</b> may be administered, <b>not to exceed <b>200 mcg</b></b>.</li><li>Contact basehospital for additional orders and to discuss further treatment options.</li></ul>"
  },
  {
    "drug": "Fentanyl",
    "population": "Pediatric",
    "page": 236,
    "text": "Fentanyl, 0.5 mcg/kgslowIV/IOoverone (1) minute. Mayrepeat in five (5) minutes titrated to pain,\nnot to exceed 50 mcg for a single dose.\nFentanyl, 1 mcg/kgIM/IN, mayrepeat every 10 minutes titrated to pain not to exceed\n100 mcg for a single dose.\nAnycombination of IV/IO/IM/IN may be administered, not to exceed four (4) doses or cumulative\nmaximum of 200 mcg. Contact basehospital for additional orders and to discuss further\ntreatment options.\nGlucose - Oral - Adult (BLS, LALS, ALS)\nAdult withblood glucose lessthan 80 mg/dL:\nGlucose - Oral, one (1) tube for patients with an intactgag reflex and hypoglycemia.\nGlucose - Oral - Pediatric (BLS, LALS, ALS)\nHypoglycemia - Neonates (0 - 4 weeks) withblood glucose lessthan 35 mg/dL or pediatric patients (morethan 4 weeks) withglucose lessthan 60 mg/dL:\nGlucose - Oral, one (1) tube for patients with an intactgag reflex and hypoglycemia.",
    "html": "<ul class='proto'><li>Fentanyl, <b>0.5 mcg/kg</b>slowIV/IOoverone (1) minute.</li><li>Mayrepeat in five (5) minutes titrated to pain,</li><li><b>not to exceed <b>50 mcg</b></b> for a single dose.</li><li>Fentanyl, <b>1 mcg/kg</b><b>IM</b>/<b>IN</b>, mayrepeat every 10 minutes titrated to pain not to exceed</li><li><b>100 mcg</b> for a single dose.</li><li>Anycombination of <b>IV/IO</b>/<b>IM</b>/<b>IN</b> may be administered, not to exceed four (4) doses or cumulative</li><li><b>maximum of <b>200 mcg</b></b>.</li><li>Contact basehospital for additional orders and to discuss further</li><li>treatment options.</li><li>Glucose - Oral - Adult (BLS, LALS, ALS)</li><li>Adult withblood glucose lessthan <b>80 mg</b>/dL:</li><li>Glucose - Oral, one (1) tube for patients with an intactgag reflex and hypoglycemia.</li><li>Glucose - Oral - Pediatric (BLS, LALS, ALS)</li><li>Hypoglycemia - Neonates (0 - 4 weeks) withblood glucose lessthan <b>35 mg</b>/dL or pediatric patients (morethan 4 weeks) withglucose lessthan <b>60 mg</b>/dL:</li><li>Glucose - Oral, one (1) tube for patients with an intactgag reflex and hypoglycemia.</li></ul>"
  },
  {
    "drug": "Glucagon",
    "population": "Pediatric",
    "page": 236,
    "text": "Hypoglycemia, if unable to establishIV:\nGlucagon, 0.03 mg/kgIM/IN, if unable to start an IV. May be repeatedone (1) timeafter\n20 minutes for a combined maximum dose of 1 mg.\nBetablocker poisoning (basehospital order only):\nGlucagon, 0.03 mg/kgIV/IOReference #\u2019s 4060, 4080, 7010, 7020, 13010\nIpratropium Bromide (Atrovent) Inhalation Solutionuse withAlbuterol Adult (ALS)\nAtrovent, 0.5 mgnebulized. Administerone (1) doseonly.\nIpratropium Bromide (Atrovent) Metered-DoseInhaler (MDI) usewith Albuterol Adult (ALS)\nWhenused in combination withAlbuterol MDIuse AlbuterolMDI dosing.\nIpratropium Bromide (Atrovent) Inhalation Solutionuse withAlbuterol - Pediatric (ALS)\n1 day to 12 months Atrovent, 0.25 mgnebulized. Administerone (1) doseonly.\n1 year to 14 years Atrovent, 0.5 mgnebulized. Administerone (1) doseonly.\nIpratropium Bromide (Atrovent) Metered-DoseInhaler (MDI) usewith Albuterol - Pediatric (ALS)\nWhenused in combination withAlbuterol MDIuse AlbuterolMDI dosing.",
    "html": "<ul class='proto'><li>Hypoglycemia, if unable to establishIV:</li><li>Glucagon, <b>0.03 mg/kg</b><b>IM</b>/<b>IN</b>, if unable to start an <b>IV</b>.</li><li>May be repeatedone (1) timeafter</li><li>20 minutes for a combined <b>maximum dose of <b>1 mg</b></b>.</li><li>Betablocker poisoning (basehospital order only):</li><li>Glucagon, <b>0.03 mg/kg</b><b>IV</b>/IOReference #\u2019s 4060, 4080, 7010, 7020, 13010</li><li>Ipratropium Bromide (Atrovent) Inhalation Solutionuse withAlbuterol Adult (ALS)</li><li>Atrovent, <b>0.5 mg</b><b>nebulized</b>.</li><li>Administerone (1) doseonly.</li><li>Ipratropium Bromide (Atrovent) Metered-DoseInhaler (MDI) usewith Albuterol Adult (ALS)</li><li>Whenused in combination withAlbuterol MDIuse AlbuterolMDI dosing.</li><li>Ipratropium Bromide (Atrovent) Inhalation Solutionuse withAlbuterol - Pediatric (ALS)</li><li>1 day to 12 months Atrovent, <b>0.25 mg</b><b>nebulized</b>.</li><li>Administerone (1) doseonly.</li><li>1 year to 14 years Atrovent, <b>0.5 mg</b><b>nebulized</b>.</li><li>Administerone (1) doseonly.</li><li>Ipratropium Bromide (Atrovent) Metered-DoseInhaler (MDI) usewith Albuterol - Pediatric (ALS)</li><li>Whenused in combination withAlbuterol MDIuse AlbuterolMDI dosing.</li></ul>"
  },
  {
    "drug": "Ketamine",
    "population": "Adult",
    "page": 237,
    "text": "Acute traumatic injury, acute abdominal/flank pain, burninjuries, cancer related pain and sickle cellcrisis:\nKetamine, 0.3 mg/kg to a max of 30 mg in a 50 - 100 ml of NSvia IVover five (5) minutes. Mayrepeatone (1) time, after 15 minutes, if painscore remains at five (5) or higher. Do not administerIVP, IO, IM, or IN.",
    "html": "<ul class='proto'><li>Acute traumatic injury, acute abdominal/flank pain, burninjuries, cancer related pain and sickle cellcrisis:</li><li>Ketamine, <b>0.3 mg/kg</b> to a <b>max of <b>30 mg</b> in a 50 - <b>100 ml</b></b> of NSvia IVover five (5) minutes.</li><li>Mayrepeatone (1) time, after 15 minutes, if painscore remains at five (5) or higher.</li><li>Do not administerIVP, <b>IO</b>, <b>IM</b>, or <b>IN</b>.</li></ul>"
  },
  {
    "drug": "Lidocaine",
    "population": "Adult",
    "page": 237,
    "text": "VT (pulseless)/VF:\nInitial Dose: Lidocaine, 1.5 mg/kgIV/IO\nFor refractoryVT (pulseless)/VF, mayadminister an additional 0.75 mg/kgIV/IO, repeatone (1) time in five (5) to 10 minutes; maximum total dose of 3 mg/kg.\nV-Tach, WideComplex Tachycardia - withPulses:\nLidocaine, 1.5 mg/kgslowIV/IOMayadminister an additional 0.75 mg/kgslowIV/IO; maximum total dose of 3 mg/kg.",
    "html": "<ul class='proto'><li>VT (pulseless)/VF:</li><li>Initial Dose: Lidocaine, <b>1.5 mg/kg</b><b>IV/IO</b></li><li>For refractoryVT (pulseless)/VF, mayadminister an additional <b>0.75 mg/kg</b><b>IV/IO</b>, repeatone (1) time in five (5) to 10 minutes; <b>maximum total dose of <b>3 mg</b></b>/kg.</li><li>V-Tach, WideComplex Tachycardia - withPulses:</li><li>Lidocaine, <b>1.5 mg/kg</b>slowIV/IOMayadminister an additional <b>0.75 mg/kg</b>slowIV/<b>IO</b>; <b>maximum total dose of <b>3 mg</b></b>/kg.</li></ul>"
  },
  {
    "drug": "Lidocaine",
    "population": "Pediatric",
    "page": 238,
    "text": "Cardiac Arrest:\n1 day to 8 years Lidocaine, 1.0 mg/kgIV/IO\n9 to 14 years Lidocaine, 1.0 mg/kgIV/IOMayrepeat Lidocaine at 0.5 mg/kgafter five (5) minutes; maximum total dose of 3 mg/kg.\nLidocaine 2% (Intravenous Solution) - Pediatric and Adult (ALS)\nPainassociated withIO infusion:\nLidocaine, 0.5 mg/kgslow IOpush overtwo (2) minutes, not to exceed 40 mgtotal.",
    "html": "<ul class='proto'><li>Cardiac Arrest:</li><li>1 day to 8 years Lidocaine, <b>1.0 mg/kg</b><b>IV/IO</b></li><li>9 to 14 years Lidocaine, <b>1.0 mg/kg</b><b>IV</b>/IOMayrepeat Lidocaine at <b>0.5 mg/kg</b>after five (5) minutes; <b>maximum total dose of <b>3 mg</b></b>/kg.</li><li>Lidocaine 2% (Intravenous Solution) - Pediatric and Adult (ALS)</li><li>Painassociated withIO infusion:</li><li>Lidocaine, <b>0.5 mg/kg</b>slow IOpush overtwo (2) minutes, not to exceed <b>40 mg</b>total.</li></ul>"
  },
  {
    "drug": "Magnesium Sulfate",
    "population": "Adult",
    "page": 238,
    "text": "Polymorphic Ventricular Tachycardia:\nMagnesium Sulfate, 2 gmIV/IObolus overfive (5) minutes for polymorphicVT if prolongedQT is\nobserved during sinus rhythm post-cardioversion.\nEclampsia (Seizure/Tonic/Clonic Activity):\nMagnesium Sulfate, 4 gmIV/IOslow IVpush overthree (3) to four (4) minutes.\nMagnesium Sulfate, 10 mg/minIV/IOdrip to prevent continued seizures.\nSevere Asthma/Respiratory Distress (ALS) (basehospital order only):\nMagnesium Sulfate, 2 gmslow IVdrip over 20 minutes. Do not repeat.",
    "html": "<ul class='proto'><li>Polymorphic Ventricular Tachycardia:</li><li>Magnesium Sulfate, <b>2 g</b>mIV/IObolus overfive (5) minutes for polymorphicVT if prolongedQT is</li><li>observed during sinus rhythm post-cardioversion.</li><li>Eclampsia (Seizure/Tonic/Clonic Activity):</li><li>Magnesium Sulfate, <b>4 g</b>mIV/IOslow IVpush overthree (3) to four (4) minutes.</li><li>Magnesium Sulfate, <b>10 mg</b>/minIV/IOdrip to prevent continued seizures.</li><li>Severe Asthma/Respiratory Distress (ALS) (basehospital order only):</li><li>Magnesium Sulfate, <b>2 g</b>mslow IVdrip over 20 minutes.</li><li>Do not repeat.</li></ul>"
  },
  {
    "drug": "Magnesium Sulfate",
    "population": "Pediatric",
    "page": 238,
    "text": "Severe Asthma/Respiratory Distress (basehospital order only):\nMagnesium Sulfate, 50 mg/kgslow IVdrip over 20 minutes. Do not exceed the adult dosage of\n2 gmtotal. Do not repeat.",
    "html": "<ul class='proto'><li>Severe Asthma/Respiratory Distress (basehospital order only):</li><li>Magnesium Sulfate, <b>50 mg/kg</b>slow IVdrip over 20 minutes.</li><li>Do not exceed the adult dosage of</li><li><b>2 g</b>mtotal.</li><li>Do not repeat.</li></ul>"
  },
  {
    "drug": "Midazolam (Versed)",
    "population": "Pediatric",
    "page": 239,
    "text": "Seizures:\nMidazolam, 0.1 mg/kgIV/IOwith maximum dose 2.5 mg. Mayrepeat Midazolam in five (5)\nminutes, or\nMidazolam, 0.2 mg/kgIM/IN withmaximum dose of 5 mg. Mayrepeat Midazolam in 10 minutes\nfor continued seizure.\nAssess patient for medication related reduced respiratory rate or hypotension.\nMaximum of three (3) doses usingany combination of IV/IO/IM/IN may be administered for\ncontinued seizure activity. Contact basehospital for additional orders and to discuss further\ntreatment options.\nBehavioral Emergencies, if patient meets criteria for potentially fatal and dangerous agitation (basehospital order):\nMidazolam, 0.1 mg/kgIV/IO. Mayrepeat in five (5) minutes, or\nMidazolam, 0.2 mg/kgIM/IN. Mayrepeat in 10 minutes.\nAssess patient for medication related reduced respiratory rate or hypotension.\nMaximum of three (3) doses usingany combination of IV/IO/IM/IN may be administered. Not to\nexceed adult dose. Contact basehospital for additional orders and to discuss further treatment\noptions.",
    "html": "<ul class='proto'><li>Seizures:</li><li>Midazolam, <b>0.1 mg/kg</b><b>IV</b>/IOwith <b>maximum dose <b>2.5 mg</b></b>.</li><li>Mayrepeat Midazolam in five (5)</li><li>minutes, or</li><li>Midazolam, <b>0.2 mg/kg</b><b>IM</b>/<b>IN</b> withmaximum dose of <b>5 mg</b>.</li><li>Mayrepeat Midazolam in 10 minutes</li><li>for continued seizure.</li><li>Assess patient for medication related reduced respiratory rate or hypotension.</li><li>Maximum of three (3) doses usingany combination of <b>IV/IO</b>/<b>IM</b>/<b>IN</b> may be administered for</li><li>continued seizure activity.</li><li>Contact basehospital for additional orders and to discuss further</li><li>treatment options.</li><li>Behavioral Emergencies, if patient meets criteria for potentially fatal and dangerous agitation (basehospital order):</li><li>Midazolam, <b>0.1 mg/kg</b><b>IV/IO</b>.</li><li>Mayrepeat in five (5) minutes, or</li><li>Midazolam, <b>0.2 mg/kg</b><b>IM</b>/<b>IN</b>.</li><li>Mayrepeat in 10 minutes.</li><li>Assess patient for medication related reduced respiratory rate or hypotension.</li><li>Maximum of three (3) doses usingany combination of <b>IV/IO</b>/<b>IM</b>/<b>IN</b> may be administered.</li><li>Not to</li><li>exceed adult dose.</li><li>Contact basehospital for additional orders and to discuss further treatment</li><li>options.</li></ul>"
  },
  {
    "drug": "Naloxone (Narcan)",
    "population": "Adult",
    "page": 240,
    "text": "For resolution of respiratory depression related to suspected opiate overdose:\nNaloxone, 0.5 mgIM/IN, mayrepeat Naloxone 0.5 mgIM/IN everytwo (2) to three (3) minutes if\nneeded to improve respiratory effort.\nFor suspected Fentanyl overdose withrespiratory depression:\nConsider a loading dose of 4 mg IN Naloxone. If no signs of respiratory improvement, consider\nNaloxone 0.5 mgIM/IN everytwo (2) to three (3) minutes if needed.\nDo not exceed 10 mg of Naloxone total regardless of route administered.",
    "html": "<ul class='proto'><li>For resolution of respiratory depression related to suspected opiate overdose:</li><li>Naloxone, <b>0.5 mg</b><b>IM</b>/<b>IN</b>, mayrepeat Naloxone <b>0.5 mg</b><b>IM</b>/<b>IN</b> everytwo (2) to three (3) minutes if</li><li>needed to improve respiratory effort.</li><li>For suspected Fentanyl overdose withrespiratory depression:</li><li>Consider a loading dose of <b>4 mg</b> <b>IN</b> Naloxone.</li><li>If no signs of respiratory improvement, consider</li><li>Naloxone <b>0.5 mg</b><b>IM</b>/<b>IN</b> everytwo (2) to three (3) minutes if needed.</li><li>Do not exceed <b>10 mg</b> of Naloxone total regardless of route administered.</li></ul>"
  },
  {
    "drug": "Naloxone (Narcan)",
    "population": "Adult",
    "page": 240,
    "text": "For resolution of respiratory depression related to suspected opiate overdose:\nNaloxone, 0.5 mgIV/IO/IM/IN, mayrepeat Naloxone 0.5 mgIV/IO/IM/IN everytwo (2) to\nthree (3) minutes if needed to improve respiratory effort.\nFor suspected Fentanyl overdose withrespiratory depression:\nConsider a loading dose of 4 mg IN Naloxone, mayrepeatone (1) time. If no signs of respiratory\nimprovement, consider Naloxone 0.5 mgIV/IO/IM/IN everytwo (2) to three (3) minutes if needed.\nDo not exceed 10 mg of Naloxone total regardless of route administered.",
    "html": "<ul class='proto'><li>For resolution of respiratory depression related to suspected opiate overdose:</li><li>Naloxone, <b>0.5 mg</b><b>IV/IO</b>/<b>IM</b>/<b>IN</b>, mayrepeat Naloxone <b>0.5 mg</b><b>IV/IO</b>/<b>IM</b>/<b>IN</b> everytwo (2) to</li><li>three (3) minutes if needed to improve respiratory effort.</li><li>For suspected Fentanyl overdose withrespiratory depression:</li><li>Consider a loading dose of <b>4 mg</b> <b>IN</b> Naloxone, mayrepeatone (1) time.</li><li>If no signs of respiratory</li><li>improvement, consider Naloxone <b>0.5 mg</b><b>IV/IO</b>/<b>IM</b>/<b>IN</b> everytwo (2) to three (3) minutes if needed.</li><li>Do not exceed <b>10 mg</b> of Naloxone total regardless of route administered.</li></ul>"
  },
  {
    "drug": "Naloxone (Narcan)",
    "population": "Pediatric",
    "page": 240,
    "text": "For resolution of respiratory depression related to suspected opiate overdose:\n1 day to 8 years Naloxone, 0.1 mg/kgIM/IN (do not exceed the adult dose of 0.5 mgper\nadministration)\n9 to 14 years Naloxone, 0.5 mgIM/IN\nMayrepeat everytwo (2) to three (3) minutes if needed. Do not exceed the adult dosage of\n10 mgtotalIM/IN.",
    "html": "<ul class='proto'><li>For resolution of respiratory depression related to suspected opiate overdose:</li><li>1 day to 8 years Naloxone, <b>0.1 mg/kg</b><b>IM</b>/<b>IN</b> (do not exceed the adult dose of <b>0.5 mg</b>per</li><li>administration)</li><li>9 to 14 years Naloxone, <b>0.5 mg</b><b>IM</b>/<b>IN</b></li><li>Mayrepeat everytwo (2) to three (3) minutes if needed.</li><li>Do not exceed the adult dosage of</li><li><b>10 mg</b>totalIM/<b>IN</b>.</li></ul>"
  },
  {
    "drug": "Naloxone (Narcan)",
    "population": "Pediatric",
    "page": 240,
    "text": "For resolution of respiratory depression related to suspected opiate overdose:\n1 day to 8 years Naloxone, 0.1 mg/kgIV/IO/IM/IN (do not exceed the adult dose of\n0.5 mgper administration)\n9 to 14 years Naloxone, 0.5 mgIV/IO/IM/IN\nMayrepeat everytwo (2) to three (3) minutes if needed. Do not exceed the adult dosage of\n10 mgtotalIV/IO/IM/IN.",
    "html": "<ul class='proto'><li>For resolution of respiratory depression related to suspected opiate overdose:</li><li>1 day to 8 years Naloxone, <b>0.1 mg/kg</b><b>IV/IO</b>/<b>IM</b>/<b>IN</b> (do not exceed the adult dose of</li><li><b>0.5 mg</b>per administration)</li><li>9 to 14 years Naloxone, <b>0.5 mg</b><b>IV/IO</b>/<b>IM</b>/<b>IN</b></li><li>Mayrepeat everytwo (2) to three (3) minutes if needed.</li><li>Do not exceed the adult dosage of</li><li><b>10 mg</b>totalIV/<b>IO</b>/<b>IM</b>/<b>IN</b>.</li></ul>"
  },
  {
    "drug": "Nitroglycerin (NTG)",
    "population": "Adult",
    "page": 241,
    "text": "Nitroglycerin, 0.4 mgsublingual/transmucosal.\nOne (1) every three (3) minutes as needed. May be repeated as long as patient continues to\nhavesigns of adequate tissue perfusion. If a Right Ventricular Infarction is suspected, the\nuse of nitrates requires basehospital contact.\nNitroglycerin Paste, 1 inch (1 gm) transdermal, may not repeat.\nNitroglycerin sublingual is the preferred route of administration for ACS. Nitro Paste is a one (1)\ntimedose and intended for whensublingual cannot be easily administered (i.e., CPAP).\nNitroglycerin is contraindicated if thereare signs of inadequate tissue perfusion or if sexual\nenhancement medications havebeen utilized within the past 48 hours.\nOndansetron (Zofran) - Patients four (4) yearsold to Adult (ALS)\nNausea/Vomiting:\nOndansetron, 4 mgslowIV/IO/ODTAllpatients four (4) to eight (8) yearsold: Mayadminister a total of 4 mgs of Ondansetron\nprior to basehospital contact.\nAllpatients nine (9) and older: Mayadminister Ondansetron 4 mg; mayrepeattwo (2) times, at\n10 minute intervals, for a total of 12 mgsprior to basehospital contact.\nMay be used as prophylactic treatment of nausea and vomiting associated withnarcotic\nadministration.",
    "html": "<ul class='proto'><li>Nitroglycerin, <b>0.4 mg</b>sublingual/transmucosal.</li><li>One (1) every three (3) minutes as needed.</li><li>May be repeated as long as patient continues to</li><li>havesigns of adequate tissue perfusion.</li><li>If a Right Ventricular Infarction is suspected, the</li><li>use of nitrates requires basehospital contact.</li><li>Nitroglycerin Paste, 1 inch (<b>1 g</b>m) transdermal, may not repeat.</li><li>Nitroglycerin sublingual is the preferred route of administration for ACS.</li><li>Nitro Paste is a one (1)</li><li>timedose and intended for whensublingual cannot be easily administered (i.e., CPAP).</li><li>Nitroglycerin is contraindicated if thereare signs of inadequate tissue perfusion or if sexual</li><li>enhancement medications havebeen utilized within the past 48 hours.</li><li>Ondansetron (Zofran) - Patients four (4) yearsold to Adult (ALS)</li><li>Nausea/Vomiting:</li><li>Ondansetron, <b>4 mg</b>slowIV/<b>IO</b>/ODTAllpatients four (4) to eight (8) yearsold: Mayadminister a total of <b>4 mg</b>s of Ondansetron</li><li>prior to basehospital contact.</li><li>Allpatients nine (9) and older: Mayadminister Ondansetron <b>4 mg</b>; mayrepeattwo (2) times, at</li><li>10 minute intervals, for a total of <b>12 mg</b>sprior to basehospital contact.</li><li>May be used as prophylactic treatment of nausea and vomiting associated withnarcotic</li><li>administration.</li></ul>"
  },
  {
    "drug": "Sodium Bicarbonate",
    "population": "Adult",
    "page": 242,
    "text": "Tricyclic Poisoning (basehospital order only):\nSodium Bicarbonate, 1 mEq/kgIV/IO\nFor cardiac arrest withsuspected metabolic acidosis, hyperkalemia or tricyclic poisoning (basehospital\norder only):\nSodium Bicarbonate, 50 mEqIV/IO/ 50cc preload or 50cc single-dosevial\nReference #\u2019s 7010, 7020, 14050",
    "html": "<ul class='proto'><li>Tricyclic Poisoning (basehospital order only):</li><li>Sodium Bicarbonate, <b>1 mEq/kg</b><b>IV/IO</b></li><li>For cardiac arrest withsuspected metabolic acidosis, hyperkalemia or tricyclic poisoning (basehospital</li><li>order only):</li><li>Sodium Bicarbonate, <b>50 mEq</b><b>IV/IO</b>/ <b>50cc</b> preload or <b>50cc</b> single-dosevial</li><li>Reference #\u2019s 7010, 7020, 14050</li></ul>"
  },
  {
    "drug": "Sodium Bicarbonate",
    "population": "Pediatric",
    "page": 242,
    "text": "Tricyclic Poisoning (basehospital order only):\nSodium Bicarbonate, 1 mEq/kgIV/IOReference #\u2019s 7010, 7020, 13010\nTranexamic Acid (TXA) - Patients 15 years of age and older (ALS)\nSigns of hemorrhagic shock meeting inclusion criteria:\nAdministerTXA 1 gm in 50 - 100 ml of NSviaIV/IOover 10 minutes. Do not administerIVP as\nthiswill cause hypotension.\nSigns of postpartum hemorrhagic shock (basehospital order only)\nAdministerTXA 1 gm in 50 - 100 ml of NSviaIV/IOover 10 minutes. Do not administerIVP as\nthiswill cause hypotension.\n,\nAPPENDIXI\nMedications for self-administration or withdeployment of the ChemPack.\nMedications listed belowmay be usedonly for the purposes referenced by the associated ICEMA\nTreatment Protocol. Anyotheruse, route or doseother thanthose listed, must be ordered in\nconsultation with the BaseHospital physician.",
    "html": "<ul class='proto'><li>Tricyclic Poisoning (basehospital order only):</li><li>Sodium Bicarbonate, <b>1 mEq/kg</b><b>IV</b>/IOReference #\u2019s 7010, 7020, 13010</li><li>Tranexamic Acid (TXA) - Patients 15 years of age and older (ALS)</li><li>Signs of hemorrhagic shock meeting inclusion criteria:</li><li>AdministerTXA <b>1 g</b>m in 50 - <b>100 ml</b> of NSviaIV/IOover 10 minutes.</li><li>Do not administerIVP as</li><li>thiswill cause hypotension.</li><li>Signs of postpartum hemorrhagic shock (basehospital order only)</li><li>AdministerTXA <b>1 g</b>m in 50 - <b>100 ml</b> of NSviaIV/IOover 10 minutes.</li><li>Do not administerIVP as</li><li>thiswill cause hypotension.</li><li>,</li><li>APPENDIXI</li><li>Medications for self-administration or withdeployment of the ChemPack.</li><li>Medications listed belowmay be usedonly for the purposes referenced by the associated ICEMA</li><li>Treatment Protocol.</li><li>Anyotheruse, route or doseother thanthose listed, must be ordered in</li><li>consultation with the BaseHospital physician.</li></ul>"
  },
  {
    "drug": "Atropine",
    "population": "Pediatric",
    "page": 243,
    "text": "Known nerve agent/organophosphate poisoning withdeployment of the ChemPack using:\nTwo (2) or moremild symptoms: Administer the weight-based doselisted below as soon as an\nexposure is known or strongly suspected. If severe symptoms develop after the first dose, two\n(2) additional doses should be repeated in rapid succession 10 minutes after the first dose; do\nnot administer morethan three (3) doses. If profound anticholinergic effects occur in the absence\nof excessive bronchial secretions, further doses of atropine should be withheld.\nOne (1) or moresevere symptoms: Immediately administer (3) three weight-based doses listed\nbelow in rapid succession.\nWeight-based dosing:\nLessthan 6.8 kg (lessthan 15 lbs): 0.25 mg, IMusing multi-dosevial\n6.8 to 18 kg (15 to 40 lbs): 0.5 mg, IMusing AtroPen auto-injector\n18 to 41 kg (40 to 90 lbs): 1 mg, IMusing AtroPen auto-injector\nMorethan 41 kg (morethan 90 lbs): 2 mg, IMusing multi-dosevial\nSymptoms of insecticide or nerve agent poisoning, as provided by manufacturer in the AtroPen\nproduct labeling, to guide therapy:\nMildsymptoms: Blurred vision, bradycardia, breathing difficulties, chest tightness, coughing,\ndrooling, miosis, muscular twitching, nausea, runny nose, salivation increased, stomach cramps,\ntachycardia, teary eyes, tremor, vomiting, or wheezing.\nSevere symptoms: Breathing difficulties (severe), confused/strange behavior, defecation\n(involuntary), muscular twitching/generalized weakness (severe), respiratory secretions (severe),\nseizure, unconsciousness, urination (involuntary).\nNOTE: Infantsmay become drowsy or unconscious withmuscle floppiness as opposed to\nmuscle twitching.",
    "html": "<ul class='proto'><li>Known nerve agent/organophosphate poisoning withdeployment of the ChemPack using:</li><li>Two (2) or moremild symptoms: Administer the weight-based doselisted below as soon as an</li><li>exposure is known or strongly suspected.</li><li>If severe symptoms develop after the first dose, two</li><li>(2) additional doses should be repeated in rapid succession 10 minutes after the first dose; do</li><li>not administer morethan three (3) doses.</li><li>If profound anticholinergic effects occur in the absence</li><li>of excessive bronchial secretions, further doses of atropine should be withheld.</li><li>One (1) or moresevere symptoms: Immediately administer (3) three weight-based doses listed</li><li>below in rapid succession.</li><li>Weight-based dosing:</li><li>Lessthan 6.8 kg (lessthan 15 lbs): <b>0.25 mg</b>, IMusing multi-dosevial</li><li>6.8 to 18 kg (15 to 40 lbs): <b>0.5 mg</b>, IMusing AtroPen auto-injector</li><li>18 to 41 kg (40 to 90 lbs): <b>1 mg</b>, IMusing AtroPen auto-injector</li><li>Morethan 41 kg (morethan 90 lbs): <b>2 mg</b>, IMusing multi-dosevial</li><li>Symptoms of insecticide or nerve agent poisoning, as provided by manufacturer in the AtroPen</li><li>product labeling, to guide therapy:</li><li>Mildsymptoms: Blurred vision, bradycardia, breathing difficulties, chest tightness, coughing,</li><li>drooling, miosis, muscular twitching, nausea, runny nose, salivation increased, stomach cramps,</li><li>tachycardia, teary eyes, tremor, vomiting, or wheezing.</li><li>Severe symptoms: Breathing difficulties (severe), confused/strange behavior, defecation</li><li>(involuntary), muscular twitching/generalized weakness (severe), respiratory secretions (severe),</li><li>seizure, unconsciousness, urination (involuntary).</li><li>NOTE: Infantsmay become drowsy or unconscious withmuscle floppiness as opposed to</li><li>muscle twitching.</li></ul>"
  },
  {
    "drug": "Diazepam (Valium)",
    "population": "Adult",
    "page": 243,
    "text": "For seizures associated withnerve agent/organophosphate exposure ONLYwith the deployment of the\nChemPack:\nDiazepam 10 mg (5 mg/ml) auto-injectorIM (if IV is unavailable), or\nDiazepam 2.5 mgIV",
    "html": "<ul class='proto'><li>For seizures associated withnerve agent/organophosphate exposure ONLYwith the deployment of the</li><li>ChemPack:</li><li>Diazepam <b>10 mg</b> (<b>5 mg</b>/ml) auto-injectorIM (if <b>IV</b> is unavailable), or</li><li>Diazepam <b>2.5 mg</b><b>IV</b></li></ul>"
  },
  {
    "drug": "Diazepam (Valium)",
    "population": "Pediatric",
    "page": 244,
    "text": "For seizures associated withnerve agent/organophosphate exposure ONLYwith the deployment of the\nChemPack:\nDiazepam 0.05 mg/kgIVNerve Agent AntidoteKit (NAAK)/MarkI or DuoDote (containing Atropine/Pralidoxime Chloride\nfor self-administration or withdeployment of the ChemPack) - Adult\nNerve agent exposure withassociated symptoms:\nOne (1) NAAKauto-injectorIM intoouter thigh. Mayrepeatup to two (2) times every\n10 to 15 minutes if symptoms persist.\nINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nPROCEDURE - STANDARD ORDERS\n12-leadElectrocardiography (EMT-P)\n\u2022 ECGshould be performed prior to medication administration.\n\u2022 ECGshould be performed on anypatient whose medical history and/or presenting\nsymptomsare consistent withacute coronary syndrome including typical or atypical chest\npain, syncopal episode, priorAMI, heart disease, or other associated riskfactors.\nCapnography (EMT-P)\n\u2022 Utilize capnography in patients withrespiratory distress, respiratory failure, cardiac arrest,\nand criticallyill patients\n\u2022 Capnography is required for continuous monitoring of patients given medications thatmaycause respiratory depression.\n\u2022 Perform capnography after administration of Midazolam for behavioral emergencies.\n\u2022 Monitor waveform, numerical value and document in ePCR.",
    "html": "<ul class='proto'><li>For seizures associated withnerve agent/organophosphate exposure ONLYwith the deployment of the</li><li>ChemPack:</li><li>Diazepam <b>0.05 mg/kg</b>IVNerve Agent AntidoteKit (NAAK)/MarkI or DuoDote (containing Atropine/Pralidoxime Chloride</li><li>for self-administration or withdeployment of the ChemPack) - Adult</li><li>Nerve agent exposure withassociated symptoms:</li><li>One (1) NAAKauto-injectorIM intoouter thigh.</li><li>Mayrepeatup to two (2) times every</li><li>10 to 15 minutes if symptoms persist.</li><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>PROCEDURE - STANDARD ORDERS</li><li>12-leadElectrocardiography (EMT-P)</li><li>\u2022 ECGshould be performed prior to medication administration.</li><li>\u2022 ECGshould be performed on anypatient whose medical history and/or presenting</li><li>symptomsare consistent withacute coronary syndrome including typical or atypical chest</li><li>pain, syncopal episode, priorAMI, heart disease, or other associated riskfactors.</li><li>Capnography (EMT-P)</li><li>\u2022 Utilize capnography in patients withrespiratory distress, respiratory failure, cardiac arrest,</li><li>and criticallyill patients</li><li>\u2022 Capnography is required for continuous monitoring of patients given medications thatmaycause respiratory depression.</li><li>\u2022 Perform capnography after administration of Midazolam for behavioral emergencies.</li><li>\u2022 Monitor waveform, numerical value and document in ePCR.</li></ul>"
  },
  {
    "drug": "Tachycardias",
    "population": "Adult",
    "page": 248,
    "text": "INLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nPATIENT CAREGUIDELINESI. PURPOSE\nTo establish guidelines for the minimum standard of care and transport of patients.\nII. BLSINTERVENTIONS\n\u25cf Obtain a thorough assessment of the following:\n\uf0d8 Airway, breathing and circulatory status.\n\uf0d8 Subjective assessment of the patient\u2019sphysical condition and environment.\n\uf0d8 Objective assessment of the patient\u2019sphysical condition and environment.\n\uf0d8 Vital signs (blood pressure, pulse, respiration, GCS, skinsigns, etc.).\n\uf0d8 Prior medical history and current medications.\n\uf0d8 Anyknown medication allergies or adverse reactions to medications, food or\nenvironmental agents.\n\u25cf Initiate careusing the following tools as clinically indicated or available:\n\uf0d8 Spinal motion restriction.\n\uf0d8 Airway control withappropriate BLSairway adjunct.\n\uf0d8 Oxygen as clinically indicated.\n\uf0d8 Assist the patient into a physical position thatachieves the bestmedical benefit\nand maximum comfort.\n\uf0d8 Automated External Defibrillator (AED).\n\uf0d8 Administer Naloxone by intranasal and/or intramuscular routes.\n\uf0d8 Blood glucose monitoring.\n\uf0d8 Consider the benefits of early transport and/or intercept withALS personnel if\nclinically indicated.\n\u25cf Assemble necessary equipment for ALSprocedures or treatment under direction of EMTP.\n\uf0d8 Cardiac monitoring.\n\uf0d8 IV/IO.\n\uf0d8 Endotracheal intubation.\n\u25cf UnderEMT-Psupervision, assemblepre-loadmedications as directed (excluding\ncontrolled substances).\nPATIENT CAREGUIDELINESIII. LIMITEDALS (LALS) INTERVENTIONS\n\u25cf Evaluation and continuation of allinitiated BLScare.\n\u25cf AugmentBLS assessment with an advanced assessment including, but not limited to the\nfollowing:\n\uf0d8 Qualitative lungassessment.\n\uf0d8 Blood glucose monitoring.\n\u25cf AugmentBLS treatment measures withLALS treatments as indicated by LALSprotocols.\n\u25cf Initiate airway control as needed with the appropriate LALSadjunct.\n\u25cf Initiate vascular access as clinically indicated.\nIV. ALSINTERVENTIONS\n\u25cf Evaluation and continuation of allinitiatedBLS and/or LALScare whenindicated by\npatient\u2019scondition.\n\u25cf AugmentBLS and/or LALSassessment withclinically indicated advanced assessments\nincludingbut not limited to the following:\n\uf0d8 Cardiac monitor and/or 12-leadECG.\n\uf0d8 Capnography.\n\uf0d8 Blood glucose monitoring.\n\u25cf AugmentBLS and/or LALStreatment withadvanced treatments as clinically indicated.\n\uf0d8 Initiate airway control whenclinically indicated using an appropriate airway\nadjunct to achieve adequate oxygenation and ventilation.\n\uf0d8 Initiate fluid resuscitation whenclinically indicated..\n\u25cf Review and evaluate treatments initiated by BLS, LALS, or ALSpersonnel.\n\uf0d8 Consider discontinuing treatments not warranted by patient\u2019sclinical condition.\nIntermittent monitoringmay be usedinstead of continuous monitoring whenclinically indicated.\nINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nGLASGOW COMASCALEI. EYEOPENING\n\u2022 Spontaneous: Eyeopening is spontaneous if the patient\u2019seyes arealready open at the\ntime of the assessment with no stimulation other thanthat of the existing ambient\nenvironment. The patientcan closehis eyes to command. Thiseye opening response\nimplies an intact reticular activating mechanism and a functioning arousal mechanism.\n\u2022 To Voice: If the patient\u2019seyesare not open at the time of the assessment, a response to\nvoice is present if the eyesopen when the patient\u2019sname is spoken or shouted.\n\u2022 To Pain: If verbal stimulation is unsuccessful in elicitingeye opening, a response to pain\nis present if the eyesopen when a standard painstimulus is applied.\n\u2022 None: No eyeresponse is present if the above attempts at stimulationare unsuccessful.\nII. BESTVERBAL RESPONSE\n\u2022 Oriented: After being aroused, the patient is asked name, place and date. The patient is\noriented if the answers givenare correct.\n\u2022 Confused: The patient is confused if the individual cannot answer the questions\nregarding, name, place and dateaccurately, but is still capable of producing phrases,\nsentences or conversation exchanges.\n\u2022 Inappropriate: In thisstate, the patient cannot produce phrases, sentences or\nconversational exchanges, butcan produce an intact word or two. These wordsmay be\nelectable only in response to physical stimulation and mayfrequently be obscenities or\nrelative\u2019snames.\n\u2022 Incomprehensible: In thisstate, the patientcan produce groans, moans or unintelligible\nmumblings, butcannot produce an intact word in response to stimulation.\n\u2022 None: In thisstate, the patient does not respond withany phonation to anystimulation no\nmatterhow prolonged or repeated.\nIII. BESTMOTOR RESPONSE\n\u2022 Obedient: In response to instructions, whether verbal or written, or through gestures,\npatient shows ability to comprehend the instruction and to physically execute it. A\ncommon example is the command to holdup twofingers.\n\u2022 Purposeful: When a standard painful stimulus is applied, the patientmay movelimb or\nbodyaway fromstimulus in a purposeful manner or attempt to pushstimulus away.\n\u2022 Withdrawal: If the patient does not obeycommands, the standard painstimulus is\napplied. Withdrawal is present if 1) the elbow flexes, 2) the movement is rapid, 3) there is\nno muscle stiffness and 4) the arm is drawn awayfrom the trunk.\n\u2022 Flexion: Flexion is present if 1) the elbow flexes, 2) the movement is slow, 3) muscle\nstiffness is present, 4) the forearm and handare heldagainst the body and 5) the limbs\nhold a hemiplegic position.\nGLASGOW COMASCALE\n\u2022 Extension: Extension is present if 1) the legs and armsextend, 2) muscle stiffness is\npresent and 3) external rotation of the shoulder and forearm occurs.\n\u2022 None: Maximum standard painstimulation produces no motor response.\nNOTE: Spinal cordinjury mayinvalidate motor assessment in thisform.\nIV. MODIFIED GLASGOW COMASCALE FOR INFANTS AND CHILDREN\nChild Infant Score\nEyeopening Spontaneous Spontaneous 4\nTo speech To speech 3\nTo painonly To painonly 2\nNo response No response 1\nBestverbal Oriented, appropriate Coos and babbles 5\nresponse Confused Irritable cries 4\nInappropriate words Cries to pain 3\nIncomprehensible sounds Moans to pain 2\nNo response No response 1\nBestmotor Obeys commands Moves spontaneously and purposefully 6\nresponse* Localizes painful stimulus Withdraws to touch 5\nWithdraws in response to painWithdraws to response in pain 4\nFlexion in response to painAbnormal flexion posture to pain 3\nExtension in response to painAbnormal extension posture to pain 2\nNo response No response 1\n* If patient is intubated, unconscious, or preverbal, the mostimportant part of thisscale is motor response. Motor\nresponse should be carefully evaluated.\nINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nPOISONINGSI. FIELD ASSESSMENT/TREATMENT INDICATORS\n\u2022 Altered level of consciousness.\n\u2022 Signs and symptoms of substance ingestion, inhalation, injection or surface absorption.\n\u2022 History of substance poisoning.\n\u2022 For nerve agent, organophosphate or carbamate exposure in which the ChemPackhas\nbeendeployed, refer to ICEMA - Nerve Agent AntidoteKit (Training,\nStorage and Administration).\nII. PRIORITIES\n\u2022 Assure the safety of EMSfield personnel, initiate decontamination and isolation\nprocedures as indicated.\n\u2022 Assure and maintain ABCs.\n\u2022 Determine degree of physiological distress.\n\u2022 Obtain vital signs, history and complete physical assessment including the substance\ningested, the amount, the timesubstance wasingested and the route.\n\u2022 If appropriate and can be safely transported, bring ingested substance to the hospital withpatient.\n\u2022 Expeditious transport.\nIII. BLSINTERVENTIONS\n\u2022 Assure and maintain ABCs.\n\u2022 Obtain oxygen saturation on roomair, unless detrimental to patient condition. Administer\n\u2022 Contact poison control (1-800-222-1222).\n\u2022 Obtain accurate history of incident:\n\uf0d8 Name of product or substance.\n\uf0d8 Quantity ingested, and/or duration of exposure.\n\uf0d8 Timeelapsed since exposure.\n\uf0d8 Pertinent medical history, chronic illness, and/or medical problems within the lasttwenty-four (24) hours.\n\uf0d8 Patient medication history.\nPOISONINGS\n\u2022 Obtain and monitor vital signs.\n\u2022 Expeditious transport.\nIV. LIMITEDALS (LALS) INTERVENTIONS PRIOR TO BASEHOSPITAL CONTACT\n\u2022 Perform activities identified in the BLSInterventions.\n\u2022 Obtain vascular access at a TKOrate or if signs of inadequate tissue perfusion,\nadminister 500 ccfluid challenge and repeat until perfusion improves.\n\u2022 For pediatric patients withsigns of inadequate tissue perfusion, administer\n20 ml/kgIV and repeat until perfusion improves.\nV. ALSINTERVENTIONS PRIOR TO BASEHOSPITAL CONTACT\n\u2022 Perform activities identified in the BLS and LALSInterventions.\n\u2022 Monitor cardiac status.\n\u2022 For phenothiazine \u201cpoisoning\u201d withataxia and/or muscle spasms, administer\n\u2022 For known organophosphate poisoning, administer Atropineper ICEMA Reference\n\u2022 For seizures associated withnerve agent or organophosphate poisoning, administer\n\u2022 For seizures associated withnerve agent or organophosphate poisoning, withdeployment\nof the ChemPack, administer Diazepamper ICEMA - Medication -\nStandard Orders.\nVI. BASEHOSPITAL MAYORDER THE FOLLOWING\n\u2022 For tricyclic poisonings, administer Sodium Bicarbonateper ICEMA -\n\u2022 For calcium channel blocker poisonings withpersistent hypotension or bradycardic\narrhythmias, administer Calcium Chlorideper ICEMA - Medication -\nStandard Orders.\n\u2022 For betablocker poisonings, administer Glucagonper ICEMA -\nVII. REFERENCES\nNumber Name\n13040 Nerve Agent AntidoteKit (Training, Storage and Administration)\nINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nHEATRELATED EMERGENCIESI. FIELD ASSESSMENT/TREATMENT INDICATORS\nMINOR HEATILLNESS SYNDROMES\n\u2022 Environmental conditions.\n\u2022 Increased skintemperature.\n\u2022 Increased bodytemperature.\n\u2022 General weakness.\n\u2022 Muscle cramps.\nHEATEXHAUSTION (Compensated)\n\u2022 All or some of the symptoms above.\n\u2022 Elevated temperature.\n\u2022 Vomiting.\n\u2022 Hypotension.\n\u2022 Diaphoresis.\n\u2022 Tachycardia.\n\u2022 Tachypnea.\nHEATSTROKE (Uncompensated)\n\u2022 All or some of the symptoms above.\n\u2022 Hyperthermia.\n\u2022 ALOC or other signs of central nervous system dysfunction.\n\u2022 Absence or decreased sweating.\n\u2022 Tachycardia.\n\u2022 Hypotension.\nHEATEXHAUSTION/ HEATSTROKE\n\u2022 Dehydration.\n\u2022 Elevated temperature, vomiting, hypotension, diaphoresis, tachycardia and tachypnea.\nHEATRELATED EMERGENCIES\n\u2022 No change in LOC.\nHEATRELATED EMERGENCIESII. BLSINTERVENTIONS\n\u2022 Remove patient fromheat source, position withlegs elevated and begin cooling\nmeasures.\n\u2022 Oxygen as clinically indicated.\n\u2022 Rehydrate withsmall amounts of appropriate liquids as tolerated. Do not giveliquids if\naltered level of consciousness.\n\u2022 If patienthas signs of HeatStroke, begin rapid cooling measures including coldpacks\nplaced adjacent to large superficial vessels.\n\u2022 Evaporative cooling measures.\nIII. LIMITEDALS INTERVENTIONS\n\u2022 Obtain vascular access.\n\uf0d8 ADULT\n\uf0a7 Fluid bolus with 500 mlNS. Reassess and repeat fluid bolus if continued\nsigns of inadequate tissue perfusion.\n\uf0d8 PEDIATRIC\n\uf0a7 Patients lessthan nine (9) years of age: Initial 20 ml/kgIVbolus;\nreassess and repeat fluid bolus if continued signs of inadequate tissue\nperfusion.\n\u2022 If clinically indicated, obtain blood glucose. If hypoglycemic administer:\n\uf0d8 ADULT/PEDIATRIC\n\u2022 Seizure precautions, refer to ICEMA - Altered Level of",
    "html": "<ul class='proto'><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>PATIENT CAREGUIDELINESI.</li><li>PURPOSE</li><li>To establish guidelines for the minimum standard of care and transport of patients.</li><li>II.</li><li>BLSINTERVENTIONS</li><li>\u25cf Obtain a thorough assessment of the following:</li><li>\uf0d8 Airway, breathing and circulatory status.</li><li>\uf0d8 Subjective assessment of the patient\u2019sphysical condition and environment.</li><li>\uf0d8 Objective assessment of the patient\u2019sphysical condition and environment.</li><li>\uf0d8 Vital signs (blood pressure, pulse, respiration, GCS, skinsigns, etc.).</li><li>\uf0d8 Prior medical history and current medications.</li><li>\uf0d8 Anyknown medication allergies or adverse reactions to medications, food or</li><li>environmental agents.</li><li>\u25cf Initiate careusing the following tools as clinically indicated or available:</li><li>\uf0d8 Spinal motion restriction.</li><li>\uf0d8 Airway control withappropriate BLSairway adjunct.</li><li>\uf0d8 Oxygen as clinically indicated.</li><li>\uf0d8 Assist the patient into a physical position thatachieves the bestmedical benefit</li><li>and maximum comfort.</li><li>\uf0d8 Automated External Defibrillator (AED).</li><li>\uf0d8 Administer Naloxone by intranasal and/or intramuscular routes.</li><li>\uf0d8 Blood glucose monitoring.</li><li>\uf0d8 Consider the benefits of early transport and/or intercept withALS personnel if</li><li>clinically indicated.</li><li>\u25cf Assemble necessary equipment for ALSprocedures or treatment under direction of EMTP.</li><li>\uf0d8 Cardiac monitoring.</li><li>\uf0d8 <b>IV/IO</b>.</li><li>\uf0d8 Endotracheal intubation.</li><li>\u25cf UnderEMT-Psupervision, assemblepre-loadmedications as directed (excluding</li><li>controlled substances).</li><li>PATIENT CAREGUIDELINESIII.</li><li>LIMITEDALS (LALS) INTERVENTIONS</li><li>\u25cf Evaluation and continuation of allinitiated BLScare.</li><li>\u25cf AugmentBLS assessment with an advanced assessment including, but not limited to the</li><li>following:</li><li>\uf0d8 Qualitative lungassessment.</li><li>\uf0d8 Blood glucose monitoring.</li><li>\u25cf AugmentBLS treatment measures withLALS treatments as indicated by LALSprotocols.</li><li>\u25cf Initiate airway control as needed with the appropriate LALSadjunct.</li><li>\u25cf Initiate vascular access as clinically indicated.</li><li><b>IV</b>.</li><li>ALSINTERVENTIONS</li><li>\u25cf Evaluation and continuation of allinitiatedBLS and/or LALScare whenindicated by</li><li>patient\u2019scondition.</li><li>\u25cf AugmentBLS and/or LALSassessment withclinically indicated advanced assessments</li><li>includingbut not limited to the following:</li><li>\uf0d8 Cardiac monitor and/or 12-leadECG.</li><li>\uf0d8 Capnography.</li><li>\uf0d8 Blood glucose monitoring.</li><li>\u25cf AugmentBLS and/or LALStreatment withadvanced treatments as clinically indicated.</li><li>\uf0d8 Initiate airway control whenclinically indicated using an appropriate airway</li><li>adjunct to achieve adequate oxygenation and ventilation.</li><li>\uf0d8 Initiate fluid resuscitation whenclinically indicated..</li><li>\u25cf Review and evaluate treatments initiated by BLS, LALS, or ALSpersonnel.</li><li>\uf0d8 Consider discontinuing treatments not warranted by patient\u2019sclinical condition.</li><li>Intermittent monitoringmay be usedinstead of continuous monitoring whenclinically indicated.</li><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>GLASGOW COMASCALEI.</li><li>EYEOPENING</li><li>\u2022 Spontaneous: Eyeopening is spontaneous if the patient\u2019seyes arealready open at the</li><li>time of the assessment with no stimulation other thanthat of the existing ambient</li><li>environment.</li><li>The patientcan closehis eyes to command.</li><li>Thiseye opening response</li><li>implies an intact reticular activating mechanism and a functioning arousal mechanism.</li><li>\u2022 To Voice: If the patient\u2019seyesare not open at the time of the assessment, a response to</li><li>voice is present if the eyesopen when the patient\u2019sname is spoken or shouted.</li><li>\u2022 To Pain: If verbal stimulation is unsuccessful in elicitingeye opening, a response to pain</li><li>is present if the eyesopen when a standard painstimulus is applied.</li><li>\u2022 None: No eyeresponse is present if the above attempts at stimulationare unsuccessful.</li><li>II.</li><li>BESTVERBAL RESPONSE</li><li>\u2022 Oriented: After being aroused, the patient is asked name, place and date.</li><li>The patient is</li><li>oriented if the answers givenare correct.</li><li>\u2022 Confused: The patient is confused if the individual cannot answer the questions</li><li>regarding, name, place and dateaccurately, but is still capable of producing phrases,</li><li>sentences or conversation exchanges.</li><li>\u2022 Inappropriate: In thisstate, the patient cannot produce phrases, sentences or</li><li>conversational exchanges, butcan produce an intact word or two.</li><li>These wordsmay be</li><li>electable only in response to physical stimulation and mayfrequently be obscenities or</li><li>relative\u2019snames.</li><li>\u2022 Incomprehensible: In thisstate, the patientcan produce groans, moans or unintelligible</li><li>mumblings, butcannot produce an intact word in response to stimulation.</li><li>\u2022 None: In thisstate, the patient does not respond withany phonation to anystimulation no</li><li>matterhow prolonged or repeated.</li><li>III.</li><li>BESTMOTOR RESPONSE</li><li>\u2022 Obedient: In response to instructions, whether verbal or written, or through gestures,</li><li>patient shows ability to comprehend the instruction and to physically execute it.</li><li>A</li><li>common example is the command to holdup twofingers.</li><li>\u2022 Purposeful: When a standard painful stimulus is applied, the patientmay movelimb or</li><li>bodyaway fromstimulus in a purposeful manner or attempt to pushstimulus away.</li><li>\u2022 Withdrawal: If the patient does not obeycommands, the standard painstimulus is</li><li>applied.</li><li>Withdrawal is present if 1) the elbow flexes, 2) the movement is rapid, 3) there is</li><li>no muscle stiffness and 4) the arm is drawn awayfrom the trunk.</li><li>\u2022 Flexion: Flexion is present if 1) the elbow flexes, 2) the movement is slow, 3) muscle</li><li>stiffness is present, 4) the forearm and handare heldagainst the body and 5) the limbs</li><li>hold a hemiplegic position.</li><li>GLASGOW COMASCALE</li><li>\u2022 Extension: Extension is present if 1) the legs and armsextend, 2) muscle stiffness is</li><li>present and 3) external rotation of the shoulder and forearm occurs.</li><li>\u2022 None: Maximum standard painstimulation produces no motor response.</li><li>NOTE: Spinal cordinjury mayinvalidate motor assessment in thisform.</li><li><b>IV</b>.</li><li>MODIFIED GLASGOW COMASCALE FOR INFANTS AND CHILDREN</li><li>Child Infant Score</li><li>Eyeopening Spontaneous Spontaneous 4</li><li>To speech To speech 3</li><li>To painonly To painonly 2</li><li>No response No response 1</li><li>Bestverbal Oriented, appropriate Coos and babbles 5</li><li>response Confused Irritable cries 4</li><li>Inappropriate words Cries to pain 3</li><li>Incomprehensible sounds Moans to pain 2</li><li>No response No response 1</li><li>Bestmotor Obeys commands Moves spontaneously and purposefully 6</li><li>response* Localizes painful stimulus Withdraws to touch 5</li><li>Withdraws in response to painWithdraws to response in pain 4</li><li>Flexion in response to painAbnormal flexion posture to pain 3</li><li>Extension in response to painAbnormal extension posture to pain 2</li><li>No response No response 1</li><li>* If patient is intubated, unconscious, or preverbal, the mostimportant part of thisscale is motor response.</li><li>Motor</li><li>response should be carefully evaluated.</li><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>POISONINGSI.</li><li>FIELD ASSESSMENT/TREATMENT INDICATORS</li><li>\u2022 Altered level of consciousness.</li><li>\u2022 Signs and symptoms of substance ingestion, inhalation, injection or surface absorption.</li><li>\u2022 History of substance poisoning.</li><li>\u2022 For nerve agent, organophosphate or carbamate exposure in which the ChemPackhas</li><li>beendeployed, refer to ICEMA - Nerve Agent AntidoteKit (Training,</li><li>Storage and Administration).</li><li>II.</li><li>PRIORITIES</li><li>\u2022 Assure the safety of EMSfield personnel, initiate decontamination and isolation</li><li>procedures as indicated.</li><li>\u2022 Assure and maintain ABCs.</li><li>\u2022 Determine degree of physiological distress.</li><li>\u2022 Obtain vital signs, history and complete physical assessment including the substance</li><li>ingested, the amount, the timesubstance wasingested and the route.</li><li>\u2022 If appropriate and can be safely transported, bring ingested substance to the hospital withpatient.</li><li>\u2022 Expeditious transport.</li><li>III.</li><li>BLSINTERVENTIONS</li><li>\u2022 Assure and maintain ABCs.</li><li>\u2022 Obtain oxygen saturation on roomair, unless detrimental to patient condition.</li><li>Administer</li><li>\u2022 Contact poison control (1-800-222-1222).</li><li>\u2022 Obtain accurate history of incident:</li><li>\uf0d8 Name of product or substance.</li><li>\uf0d8 Quantity ingested, and/or duration of exposure.</li><li>\uf0d8 Timeelapsed since exposure.</li><li>\uf0d8 Pertinent medical history, chronic illness, and/or medical problems within the lasttwenty-four (24) hours.</li><li>\uf0d8 Patient medication history.</li><li>POISONINGS</li><li>\u2022 Obtain and monitor vital signs.</li><li>\u2022 Expeditious transport.</li><li><b>IV</b>.</li><li>LIMITEDALS (LALS) INTERVENTIONS PRIOR TO BASEHOSPITAL CONTACT</li><li>\u2022 Perform activities identified in the BLSInterventions.</li><li>\u2022 Obtain vascular access at a TKOrate or if signs of inadequate tissue perfusion,</li><li>administer <b>500 cc</b>fluid challenge and repeat until perfusion improves.</li><li>\u2022 For pediatric patients withsigns of inadequate tissue perfusion, administer</li><li><b>20 ml/kg</b><b>IV</b> and repeat until perfusion improves.</li><li>V.</li><li>ALSINTERVENTIONS PRIOR TO BASEHOSPITAL CONTACT</li><li>\u2022 Perform activities identified in the BLS and LALSInterventions.</li><li>\u2022 Monitor cardiac status.</li><li>\u2022 For phenothiazine \u201cpoisoning\u201d withataxia and/or muscle spasms, administer</li><li>\u2022 For known organophosphate poisoning, administer Atropineper ICEMA Reference</li><li>\u2022 For seizures associated withnerve agent or organophosphate poisoning, administer</li><li>\u2022 For seizures associated withnerve agent or organophosphate poisoning, withdeployment</li><li>of the ChemPack, administer Diazepamper ICEMA - Medication -</li><li>Standard Orders.</li><li>VI.</li><li>BASEHOSPITAL MAYORDER THE FOLLOWING</li><li>\u2022 For tricyclic poisonings, administer Sodium Bicarbonateper ICEMA -</li><li>\u2022 For calcium channel blocker poisonings withpersistent hypotension or bradycardic</li><li>arrhythmias, administer Calcium Chlorideper ICEMA - Medication -</li><li>Standard Orders.</li><li>\u2022 For betablocker poisonings, administer Glucagonper ICEMA -</li><li>VII.</li><li>REFERENCES</li><li>Number Name</li><li>13040 Nerve Agent AntidoteKit (Training, Storage and Administration)</li><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>HEATRELATED EMERGENCIESI.</li><li>FIELD ASSESSMENT/TREATMENT INDICATORS</li><li>MINOR HEATILLNESS SYNDROMES</li><li>\u2022 Environmental conditions.</li><li>\u2022 Increased skintemperature.</li><li>\u2022 Increased bodytemperature.</li><li>\u2022 General weakness.</li><li>\u2022 Muscle cramps.</li><li>HEATEXHAUSTION (Compensated)</li><li>\u2022 All or some of the symptoms above.</li><li>\u2022 Elevated temperature.</li><li>\u2022 Vomiting.</li><li>\u2022 Hypotension.</li><li>\u2022 Diaphoresis.</li><li>\u2022 Tachycardia.</li><li>\u2022 Tachypnea.</li><li>HEATSTROKE (Uncompensated)</li><li>\u2022 All or some of the symptoms above.</li><li>\u2022 Hyperthermia.</li><li>\u2022 ALOC or other signs of central nervous system dysfunction.</li><li>\u2022 Absence or decreased sweating.</li><li>\u2022 Tachycardia.</li><li>\u2022 Hypotension.</li><li>HEATEXHAUSTION/ HEATSTROKE</li><li>\u2022 Dehydration.</li><li>\u2022 Elevated temperature, vomiting, hypotension, diaphoresis, tachycardia and tachypnea.</li><li>HEATRELATED EMERGENCIES</li><li>\u2022 No change in LOC.</li><li>HEATRELATED EMERGENCIESII.</li><li>BLSINTERVENTIONS</li><li>\u2022 Remove patient fromheat source, position withlegs elevated and begin cooling</li><li>measures.</li><li>\u2022 Oxygen as clinically indicated.</li><li>\u2022 Rehydrate withsmall amounts of appropriate liquids as tolerated.</li><li>Do not giveliquids if</li><li>altered level of consciousness.</li><li>\u2022 If patienthas signs of HeatStroke, begin rapid cooling measures including coldpacks</li><li>placed adjacent to large superficial vessels.</li><li>\u2022 Evaporative cooling measures.</li><li>III.</li><li>LIMITEDALS INTERVENTIONS</li><li>\u2022 Obtain vascular access.</li><li>\uf0d8 ADULT</li><li>\uf0a7 Fluid bolus with <b>500 ml</b>NS.</li><li>Reassess and repeat fluid bolus if continued</li><li>signs of inadequate tissue perfusion.</li><li>\uf0d8 PEDIATRIC</li><li>\uf0a7 Patients lessthan nine (9) years of age: Initial <b>20 ml/kg</b>IVbolus;</li><li>reassess and repeat fluid bolus if continued signs of inadequate tissue</li><li>perfusion.</li><li>\u2022 If clinically indicated, obtain blood glucose.</li><li>If hypoglycemic administer:</li><li>\uf0d8 ADULT/PEDIATRIC</li><li>\u2022 Seizure precautions, refer to ICEMA - Altered Level of</li></ul>"
  },
  {
    "drug": "Consciousness/Seizures",
    "population": "Adult",
    "page": 257,
    "text": "\u2022 Contact basehospital for destination and further treatment orders.\nIV. ALSINTERVENTIONS\n\u2022 Obtain vascular access.\n\uf0d8 ADULT\n\uf0a7 Fluid bolus with 500 mlNS. Mayrepeat fluid bolus if continued signs of\ninadequate tissue perfusion.\nHEATRELATED EMERGENCIES\n\uf0d8 PEDIATRIC\n\uf0a7 Patients lessthan nine (9) years of age: Initial 20 ml/kgIV/IObolus;\nreassess and repeat fluid bolus if continued signs of inadequate tissue\nperfusion.\n\u2022 If clinically indicated, obtain blood glucose. If hypoglycemic administer:\n\uf0d8 ADULT/PEDIATRIC\n\u2022 Basehospital mayorder additional medication dosages and additional fluid boluses.\n\u2022 Obtain rhythm strip for documentation withcopy to receiving hospital.\n\u2022 For tonic/clonic typeseizure activity administer:\n\uf0d8 ADULT/PEDIATRICV. REFERENCES\nNumber Name\n14060 Altered Level of Consciousness/Seizures - Adult\nINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nCOLDRELATED EMERGENCIESI. FIELD ASSESSMENT/TREATMENT INDICATORS\nMILDHYPOTHERMIA\n\u2022 Decreased coretemperature.\n\u2022 Cold, paleextremities.\n\u2022 Shivering, reduction in finemotor skills.\n\u2022 Loss of judgment and/or altered level of consciousness or simple problem solving skills.\nSEVERE HYPOTHERMIA\n\u2022 Severe coldexposure or anyprolonged exposure to ambient temperatures below 36\ndegrees with the following indications:\n\uf0d8 AlteredLOC withassociated behavior changes.\n\uf0d8 Unconscious.\n\uf0d8 Lethargic.\n\u2022 Shivering is generally absent.\n\u2022 Blood pressure and heart soundsmay be unobtainable.\nSUSPECTED FROSTBITE\n\u2022 Areas of skinthat is cold, white, and hard to touch.\n\u2022 Capillary refill greater thantwo (2) seconds.\n\u2022 Pain and/or numbness to affected extremity.\nII. BLSINTERVENTIONS\n\u2022 Remove fromcold/wetenvironment; removewet clothing and drypatient.\n\u2022 Begin passive warming.\n\u2022 Insulate and apply wrapped heatpacks, if available, to groin, axilla and neck. Thisprocess should be continuous.\n\u2022 Maintain appropriate airway withoxygen as clinically indicated (warm, humidified if\npossible).\n\u2022 Assess carotid pulse for a minimum of one (1) to two (2) minutes. If no pulse palpable,\nplace patient on AED. If no shock advised, beginCPR.\n\u2022 Insulate to prevent further heatloss.\nCOLDRELATED EMERGENCIES\n\u2022 Elevate extremity if frostbite is suspected.\n\u2022 Do not massage affected extremity.\n\u2022 Wrapaffected bodypart in drysterile gauze to prevent further exposure and handle withextreme care.\nIII. LIMITEDALS INTERVENTIONS\n\u2022 Advanced airway as clinically indicated.\n\u2022 Obtain vascular access.\n\u2022 Obtain blood glucose level, if indicated administer:\n\uf0d8 ADULT/PEDIATRIC\n\uf0a7 Mayrepeat blood glucose level. Repeat Dextroseper ICEMA Reference\nif unable to establishIV.\n\u2022 Obtain vascular access and administer fluid bolus.\n\uf0d8 Nine (9) years and older: 500 mlwarmedNS, mayrepeat.\n\uf0d8 Birth to eight (8) years: 20 ml/kgwarmedNS, mayrepeat.\n\u2022 Contact basehospital.\nIV. ALSINTERVENTIONS\n\u2022 Obtain vascular access.\n\u2022 Cardiac monitor.\n\u2022 If clinically indicated, obtain blood glucose. If hypoglycemic administer:\n\uf0d8 ADULT/PEDIATRIC\nif unable to establishIV.\n\u2022 For complaints of pain in affected bodypart:\n\uf0d8 ADULT/PEDIATRIC\n\u2022 Advanced airway as clinically indicated.\nCOLDRELATED EMERGENCIES\n\u2022 Obtain vascular access and administer fluid bolus.\n\uf0d8 Nine (9) years and older: 500 mlwarmedNS, mayrepeat.\n\uf0d8 Birth to eight (8) years: 20 ml/kgwarmedNS, mayrepeat.\n\u2022 Obtain rhythm strip for documentation.\n\u2022 For documentedVF, PulselessV-Tach:\n\uf0d8 Defibrillateone (1) time at manufacturer recommended dose. Do not defibrillate\nagain until patienthas begun to warm.\n\u2022 For documented asystole:\n\uf0d8 BeginCPR.\n\uf0d8 Maygive additional fluid bolus.\n\u2022 Contact basehospital.\nV. REFERENCE\nNumber NameINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nNERVE AGENT ANTIDOTEKIT (TRAINING, STORAGE AND ADMINISTRATION)\nI. PURPOSE\nTo provide a standard for the training, storage and use of Nerve Agent Antidote Kits (NAAKs) by\nEMSfield personnel.\nII. POLICY\n\u2022 The NAAK (DuoDote or MarkI) is an optional personal protective equipment (PPE) for\nself-administration.\n\u2022 The NAAK is authorized for self-administration by public safety personnel, emergency\nmedical technicians (EMTs), advanced emergency medical technicians (AEMTs) or\nparamedics (EMT-Ps) following exposure to nerve agents, organophosphates, or\ncarbamates.\n\u2022 EMSproviders equipping and employing EMTs or AEMTs withNAAKs for selfadministration mustprovide NAAKtraining as described below. EMT-Ps do not require\nanyadditional training.\n\u2022 Public safety agencies equipping public safety personnel withNAAKs for selfadministration mustprovide trainingper ICEMA - Optional Skills and\nMedications (Authorized Public Safety Personnel).\n\u2022 When the ChemPack is deployed, EMTs, AEMTs or EMT-Psmay administer the NAAK\n\u2022 When the ChemPack is deployed, EMT-Psare authorized by the ICEMA Medical Director\nto administer Diazepam (Valium) perICEMA Reference -#11010 - Medication - Standard\nOrders.\n\u2022 Public safety personnelare not permitted to administer the NAAK to patients without prior\nauthorization (refer to ICEMA - Optional Skills and Medications\n(Authorized Public Safety Personnel). Public safety personnelmay not administer\nAtroPen (Atropine).\nIII. TRAINING REQUIREMENTS\n\u2022 Training willconsist of no lessthantwo (2) hours of ICEMA approved didactic and skills\nlaboratory training thatincludes:\n\uf0d8 Indications\n\uf0d8 Contraindications\n\uf0d8 Side/adverse effects\n\uf0d8 Routes of administration\n\uf0d8 Dose\n\uf0d8 Mechanisms of drugaction\nNERVE AGENT ANTIDOTEKIT\n(TRAINING, STORAGE AND ADMINISTRATION)\n\uf0d8 Disposal of contaminated items and sharps\n\uf0d8 Medication administration and properuse of NAAK\n\u2022 At the completion of the training, the student willcomplete a competency based written\nand skills examination for the administration of Atropine and Pralidoxime Chloride\n(2-Pam) thatincludes:\n\uf0d8 Assessment of when to administer the medication.\n\uf0d8 Managing a patient before, during, and after administering the medication.\n\uf0d8 Using universal precautions and bodysubstance isolation procedures during\nmedication administration.\n\uf0d8 Demonstration of aseptic technique during medication administration.\n\uf0d8 Demonstrate the preparation of the medication.\n\uf0d8 Demonstrate siteselection and administration of medication by the intramuscular\nroute.\n\uf0d8 Proper disposal of contaminated items and sharps.\n\uf0d8 Completion of the notification of usage form.\n\u2022 AllEMS field personnel and public safety personnel willcomplete the competency based\nskills examination everytwo (2) years.\n\u2022 EMSproviders providing NAAKtraining mustretain training records for a minimum of four\n(4) years and makeall records available for review at the request of ICEMA or the\nCaliforniaEMS Authority.\nIV. REFERENCES\nNumber Name\n15050 Optional Skills and Medications (Authorized Public Safety Personnel)\nINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nSMOKE INHALATION/COEXPOSURE/SUSPECTED CYANIDE TOXICITYI. PURPOSE\nTo identify and treat smoke inhalation and suspected cyanide toxicity.\nII. FIELD ASSESSMENT/TREATMENT INDICATORS\n\u2022 Indicators\n\uf0d8 Exposure to fire and smoke particularly in an enclosed-space structure fires.\n\uf0d8 Hydrogen cyanide concentration measured in the airdoes not accurately\ncorrelate to patient\u2019slevel of exposure and toxicity. Consider possibility of\nCarbon Monoxide (CO) and cyanide exposure/toxicity in anypatient (or\nunprotectedEMS field personnel) withsmoke inhalation.\n\u2022 Cyanide Toxicity\n\uf0d8 Initial signs and symptomsarenon-specific and mayinclude; headache,\ndizziness, nausea, vomiting, confusion, and syncope.\n\uf0d8 Worsening signs and symptomsmay include; altered level of consciousness\n(ALOC), hypotension, shortness of breath, seizures, cardiac dysrhythmias, and\ncardiac arrest.\n\uf0d8 The \u201cbitter almond\u201d smell on the breath of a cyanide-poisoned patient is neither\nsensitivenor specific and should not be considered in making the assessment.\n\u2022 COPoisoning\n\uf0d8 Initial signs and symptomsarenon-specific and mayinclude; flulike symptoms,\ndizziness, severe headache, nausea, sleepiness, weakness and disorientation.\n\uf0d8 Worsening signs and symptomsmay include; blurred vision, shortness of breath,\nand altered level of consciousness.\nIII. BLSINTERVENTIONS\n\u2022 Remove patient fromexposure area.\n\u2022 Administer 100% oxygenvia nonrebreather mask.\nIV. ALSINTERVENTIONS\n\u2022 Monitor pulse oximetry (SpO2) though valuesmay be unreliable in patients suffering fromsmoke inhalation.\n\u25cf Place on cardiac monitor and obtain a 12-leadECG.\n\u2022 IVaccess, consider fluid bolus of 300 ccNS.\n\u2022 UseBVM withairway adjuncts as needed. Consider advanced airway if indicated.\nSMOKE INHALATION/COEXPOSURE/SUSPECTED\nCYANIDE TOXICITY (Expanded Scope Specialty\nProgram)\n\u2022 For treatment of bronchospasm as indicated by wheezing, refer to ICEMA  - Respiratory Emergencies - Adult.\n\u2022 Ensure rapid transport to closest receiving emergency department.\nV. REFERENCE\nNumber Name\n14010 Respiratory Emergencies - Adult\nINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nDROWNING/SUBMERSION INJURIES\nCardiac arrest in drowning is caused by hypoxia, airway and ventilationare equally important to\nhigh-qualityCPR.\nI. FIELD ASSESSMENT/TREATMENT INDICATORS\n\u2022 Submersion in water regardless of depth.\n\u2022 ALOCwith submersion\n\u2022 Respiratory distress withfoaming, vomiting, coughing, wheezing, abnormal lungsounds\nand or apnea.\n\u2022 Decreased or absent vital signs.\nII. PRIORITIES\n\u2022 Assure the safety of EMSfield personnel.\n\u2022 Assure and maintain ABCswith an emphasis on reversing hypoxia.\n\u2022 Ventilate through the foam, do not waste timeattempting to suction.\n\u2022 Consider trauma or pre-existing medical problem (hypoglycemia, seizure, dysrhythmia).\n\u2022 Assess for hypothermia.\n\u2022 Encourage transport even if symptomsare mild.\nIII. BLSINTERVENTIONS\n\u2022 Assure and maintain ABCs.\n\u2022 Maintain spinal motion restriction if indicated.\n\u2022 Removewet clothing/ warmpatient.\n\u2022 Obtain and monitor vital signs.\n\u2022 Provide highqualityCPR if indicated with an emphasis on airway.\nIV. LIMITEDALS (LALS) INTERVENTIONS\n\u2022 Perform activities identified in the BLSInterventions.\n\u2022 Obtain vascular access at a TKOrate or if signs of inadequate tissue perfusion,\nadminister 500 ccfluid challenge and repeat until perfusion improves.\nDROWNING/SUBMERSION INJURIES\n\u2022 For pediatric patients withsigns of inadequate tissue perfusion, administer\n20 ml/kgIV and repeat until perfusion improves.\n\u2022 Administer Albuterolper ICEMA -Medication-Standing OrdersV. ALSINTERVENTIONS\n\u2022 Perform activities identified in the BLS and LALSInterventions.\n\u2022 Monitor cardiac status.\n\u2022 Monitorend tidal CO2, pulse oximetry\n\u2022 Obtain glucose level. If indicated administer:\n\uf0d8 Dextroseper ICEMA -Medication-Standing Orders.\n\uf0d8 Mayrepeat blood glucose level. Repeat DextrosePer ICEMA -\nMedication- Standing Orders.\n\u2022 Administer Albuterol/Atroventper ICEMA - Medication - Standard\nOrders.\n\u2022 Consider an advanced airway, refer to ICEMA - Procedure -\nStandard Orders.\nVI. REFERENCES\nNumber Name\n11020 Procedure- Standing Orders\n14050 Cardiac Arrest-Adult\n14150 Cardiac Arrest-Pediatric\nINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY",
    "html": "<ul class='proto'><li>\u2022 Contact basehospital for destination and further treatment orders.</li><li><b>IV</b>.</li><li>ALSINTERVENTIONS</li><li>\u2022 Obtain vascular access.</li><li>\uf0d8 ADULT</li><li>\uf0a7 Fluid bolus with <b>500 ml</b>NS.</li><li>Mayrepeat fluid bolus if continued signs of</li><li>inadequate tissue perfusion.</li><li>HEATRELATED EMERGENCIES</li><li>\uf0d8 PEDIATRIC</li><li>\uf0a7 Patients lessthan nine (9) years of age: Initial <b>20 ml/kg</b><b>IV</b>/IObolus;</li><li>reassess and repeat fluid bolus if continued signs of inadequate tissue</li><li>perfusion.</li><li>\u2022 If clinically indicated, obtain blood glucose.</li><li>If hypoglycemic administer:</li><li>\uf0d8 ADULT/PEDIATRIC</li><li>\u2022 Basehospital mayorder additional medication dosages and additional fluid boluses.</li><li>\u2022 Obtain rhythm strip for documentation withcopy to receiving hospital.</li><li>\u2022 For tonic/clonic typeseizure activity administer:</li><li>\uf0d8 ADULT/PEDIATRICV.</li><li>REFERENCES</li><li>Number Name</li><li>14060 Altered Level of Consciousness/Seizures - Adult</li><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>COLDRELATED EMERGENCIESI.</li><li>FIELD ASSESSMENT/TREATMENT INDICATORS</li><li>MILDHYPOTHERMIA</li><li>\u2022 Decreased coretemperature.</li><li>\u2022 Cold, paleextremities.</li><li>\u2022 Shivering, reduction in finemotor skills.</li><li>\u2022 Loss of judgment and/or altered level of consciousness or simple problem solving skills.</li><li>SEVERE HYPOTHERMIA</li><li>\u2022 Severe coldexposure or anyprolonged exposure to ambient temperatures below 36</li><li>degrees with the following indications:</li><li>\uf0d8 AlteredLOC withassociated behavior changes.</li><li>\uf0d8 Unconscious.</li><li>\uf0d8 Lethargic.</li><li>\u2022 Shivering is generally absent.</li><li>\u2022 Blood pressure and heart soundsmay be unobtainable.</li><li>SUSPECTED FROSTBITE</li><li>\u2022 Areas of skinthat is cold, white, and hard to touch.</li><li>\u2022 Capillary refill greater thantwo (2) seconds.</li><li>\u2022 Pain and/or numbness to affected extremity.</li><li>II.</li><li>BLSINTERVENTIONS</li><li>\u2022 Remove fromcold/wetenvironment; removewet clothing and drypatient.</li><li>\u2022 Begin passive warming.</li><li>\u2022 Insulate and apply wrapped heatpacks, if available, to groin, axilla and neck.</li><li>Thisprocess should be continuous.</li><li>\u2022 Maintain appropriate airway withoxygen as clinically indicated (warm, humidified if</li><li>possible).</li><li>\u2022 Assess carotid pulse for a minimum of one (1) to two (2) minutes.</li><li>If no pulse palpable,</li><li>place patient on AED.</li><li>If no shock advised, beginCPR.</li><li>\u2022 Insulate to prevent further heatloss.</li><li>COLDRELATED EMERGENCIES</li><li>\u2022 Elevate extremity if frostbite is suspected.</li><li>\u2022 Do not massage affected extremity.</li><li>\u2022 Wrapaffected bodypart in drysterile gauze to prevent further exposure and handle withextreme care.</li><li>III.</li><li>LIMITEDALS INTERVENTIONS</li><li>\u2022 Advanced airway as clinically indicated.</li><li>\u2022 Obtain vascular access.</li><li>\u2022 Obtain blood glucose level, if indicated administer:</li><li>\uf0d8 ADULT/PEDIATRIC</li><li>\uf0a7 Mayrepeat blood glucose level.</li><li>Repeat Dextroseper ICEMA Reference</li><li>if unable to establishIV.</li><li>\u2022 Obtain vascular access and administer fluid bolus.</li><li>\uf0d8 Nine (9) years and older: <b>500 ml</b>warmedNS, mayrepeat.</li><li>\uf0d8 Birth to eight (8) years: <b>20 ml/kg</b>warmedNS, mayrepeat.</li><li>\u2022 Contact basehospital.</li><li><b>IV</b>.</li><li>ALSINTERVENTIONS</li><li>\u2022 Obtain vascular access.</li><li>\u2022 Cardiac monitor.</li><li>\u2022 If clinically indicated, obtain blood glucose.</li><li>If hypoglycemic administer:</li><li>\uf0d8 ADULT/PEDIATRIC</li><li>if unable to establishIV.</li><li>\u2022 For complaints of pain in affected bodypart:</li><li>\uf0d8 ADULT/PEDIATRIC</li><li>\u2022 Advanced airway as clinically indicated.</li><li>COLDRELATED EMERGENCIES</li><li>\u2022 Obtain vascular access and administer fluid bolus.</li><li>\uf0d8 Nine (9) years and older: <b>500 ml</b>warmedNS, mayrepeat.</li><li>\uf0d8 Birth to eight (8) years: <b>20 ml/kg</b>warmedNS, mayrepeat.</li><li>\u2022 Obtain rhythm strip for documentation.</li><li>\u2022 For documentedVF, PulselessV-Tach:</li><li>\uf0d8 Defibrillateone (1) time at manufacturer recommended dose.</li><li>Do not defibrillate</li><li>again until patienthas begun to warm.</li><li>\u2022 For documented asystole:</li><li>\uf0d8 BeginCPR.</li><li>\uf0d8 Maygive additional fluid bolus.</li><li>\u2022 Contact basehospital.</li><li>V.</li><li>REFERENCE</li><li>Number NameINLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>NERVE AGENT ANTIDOTEKIT (TRAINING, STORAGE AND ADMINISTRATION)</li><li>I.</li><li>PURPOSE</li><li>To provide a standard for the training, storage and use of Nerve Agent Antidote Kits (NAAKs) by</li><li>EMSfield personnel.</li><li>II.</li><li>POLICY</li><li>\u2022 The NAAK (DuoDote or MarkI) is an optional personal protective equipment (PPE) for</li><li>self-administration.</li><li>\u2022 The NAAK is authorized for self-administration by public safety personnel, emergency</li><li>medical technicians (EMTs), advanced emergency medical technicians (AEMTs) or</li><li>paramedics (EMT-Ps) following exposure to nerve agents, organophosphates, or</li><li>carbamates.</li><li>\u2022 EMSproviders equipping and employing EMTs or AEMTs withNAAKs for selfadministration mustprovide NAAKtraining as described below.</li><li>EMT-Ps do not require</li><li>anyadditional training.</li><li>\u2022 Public safety agencies equipping public safety personnel withNAAKs for selfadministration mustprovide trainingper ICEMA - Optional Skills and</li><li>Medications (Authorized Public Safety Personnel).</li><li>\u2022 When the ChemPack is deployed, EMTs, AEMTs or EMT-Psmay administer the NAAK</li><li>\u2022 When the ChemPack is deployed, EMT-Psare authorized by the ICEMA Medical Director</li><li>to administer Diazepam (Valium) perICEMA Reference -#11010 - Medication - Standard</li><li>Orders.</li><li>\u2022 Public safety personnelare not permitted to administer the NAAK to patients without prior</li><li>authorization (refer to ICEMA - Optional Skills and Medications</li><li>(Authorized Public Safety Personnel).</li><li>Public safety personnelmay not administer</li><li>AtroPen (Atropine).</li><li>III.</li><li>TRAINING REQUIREMENTS</li><li>\u2022 Training willconsist of no lessthantwo (2) hours of ICEMA approved didactic and skills</li><li>laboratory training thatincludes:</li><li>\uf0d8 Indications</li><li>\uf0d8 Contraindications</li><li>\uf0d8 Side/adverse effects</li><li>\uf0d8 Routes of administration</li><li>\uf0d8 Dose</li><li>\uf0d8 Mechanisms of drugaction</li><li>NERVE AGENT ANTIDOTEKIT</li><li>(TRAINING, STORAGE AND ADMINISTRATION)</li><li>\uf0d8 Disposal of contaminated items and sharps</li><li>\uf0d8 Medication administration and properuse of NAAK</li><li>\u2022 At the completion of the training, the student willcomplete a competency based written</li><li>and skills examination for the administration of Atropine and Pralidoxime Chloride</li><li>(2-Pam) thatincludes:</li><li>\uf0d8 Assessment of when to administer the medication.</li><li>\uf0d8 Managing a patient before, during, and after administering the medication.</li><li>\uf0d8 Using universal precautions and bodysubstance isolation procedures during</li><li>medication administration.</li><li>\uf0d8 Demonstration of aseptic technique during medication administration.</li><li>\uf0d8 Demonstrate the preparation of the medication.</li><li>\uf0d8 Demonstrate siteselection and administration of medication by the intramuscular</li><li>route.</li><li>\uf0d8 Proper disposal of contaminated items and sharps.</li><li>\uf0d8 Completion of the notification of usage form.</li><li>\u2022 AllEMS field personnel and public safety personnel willcomplete the competency based</li><li>skills examination everytwo (2) years.</li><li>\u2022 EMSproviders providing NAAKtraining mustretain training records for a minimum of four</li><li>(4) years and makeall records available for review at the request of ICEMA or the</li><li>CaliforniaEMS Authority.</li><li><b>IV</b>.</li><li>REFERENCES</li><li>Number Name</li><li>15050 Optional Skills and Medications (Authorized Public Safety Personnel)</li><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>SMOKE INHALATION/COEXPOSURE/SUSPECTED CYANIDE TOXICITYI.</li><li>PURPOSE</li><li>To identify and treat smoke inhalation and suspected cyanide toxicity.</li><li>II.</li><li>FIELD ASSESSMENT/TREATMENT INDICATORS</li><li>\u2022 Indicators</li><li>\uf0d8 Exposure to fire and smoke particularly in an enclosed-space structure fires.</li><li>\uf0d8 Hydrogen cyanide concentration measured in the airdoes not accurately</li><li>correlate to patient\u2019slevel of exposure and toxicity.</li><li>Consider possibility of</li><li>Carbon Monoxide (CO) and cyanide exposure/toxicity in anypatient (or</li><li>unprotectedEMS field personnel) withsmoke inhalation.</li><li>\u2022 Cyanide Toxicity</li><li>\uf0d8 Initial signs and symptomsarenon-specific and mayinclude; headache,</li><li>dizziness, nausea, vomiting, confusion, and syncope.</li><li>\uf0d8 Worsening signs and symptomsmay include; altered level of consciousness</li><li>(ALOC), hypotension, shortness of breath, seizures, cardiac dysrhythmias, and</li><li>cardiac arrest.</li><li>\uf0d8 The \u201cbitter almond\u201d smell on the breath of a cyanide-poisoned patient is neither</li><li>sensitivenor specific and should not be considered in making the assessment.</li><li>\u2022 COPoisoning</li><li>\uf0d8 Initial signs and symptomsarenon-specific and mayinclude; flulike symptoms,</li><li>dizziness, severe headache, nausea, sleepiness, weakness and disorientation.</li><li>\uf0d8 Worsening signs and symptomsmay include; blurred vision, shortness of breath,</li><li>and altered level of consciousness.</li><li>III.</li><li>BLSINTERVENTIONS</li><li>\u2022 Remove patient fromexposure area.</li><li>\u2022 Administer 100% oxygenvia nonrebreather mask.</li><li><b>IV</b>.</li><li>ALSINTERVENTIONS</li><li>\u2022 Monitor pulse oximetry (SpO2) though valuesmay be unreliable in patients suffering fromsmoke inhalation.</li><li>\u25cf Place on cardiac monitor and obtain a 12-leadECG.</li><li>\u2022 IVaccess, consider fluid bolus of <b>300 cc</b>NS.</li><li>\u2022 UseBVM withairway adjuncts as needed.</li><li>Consider advanced airway if indicated.</li><li>SMOKE INHALATION/COEXPOSURE/SUSPECTED</li><li>CYANIDE TOXICITY (Expanded Scope Specialty</li><li>Program)</li><li>\u2022 For treatment of bronchospasm as indicated by wheezing, refer to ICEMA  - Respiratory Emergencies - Adult.</li><li>\u2022 Ensure rapid transport to closest receiving emergency department.</li><li>V.</li><li>REFERENCE</li><li>Number Name</li><li>14010 Respiratory Emergencies - Adult</li><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>DROWNING/SUBMERSION INJURIES</li><li>Cardiac arrest in drowning is caused by hypoxia, airway and ventilationare equally important to</li><li>high-qualityCPR.</li><li>I.</li><li>FIELD ASSESSMENT/TREATMENT INDICATORS</li><li>\u2022 Submersion in water regardless of depth.</li><li>\u2022 ALOCwith submersion</li><li>\u2022 Respiratory distress withfoaming, vomiting, coughing, wheezing, abnormal lungsounds</li><li>and or apnea.</li><li>\u2022 Decreased or absent vital signs.</li><li>II.</li><li>PRIORITIES</li><li>\u2022 Assure the safety of EMSfield personnel.</li><li>\u2022 Assure and maintain ABCswith an emphasis on reversing hypoxia.</li><li>\u2022 Ventilate through the foam, do not waste timeattempting to suction.</li><li>\u2022 Consider trauma or pre-existing medical problem (hypoglycemia, seizure, dysrhythmia).</li><li>\u2022 Assess for hypothermia.</li><li>\u2022 Encourage transport even if symptomsare mild.</li><li>III.</li><li>BLSINTERVENTIONS</li><li>\u2022 Assure and maintain ABCs.</li><li>\u2022 Maintain spinal motion restriction if indicated.</li><li>\u2022 Removewet clothing/ warmpatient.</li><li>\u2022 Obtain and monitor vital signs.</li><li>\u2022 Provide highqualityCPR if indicated with an emphasis on airway.</li><li><b>IV</b>.</li><li>LIMITEDALS (LALS) INTERVENTIONS</li><li>\u2022 Perform activities identified in the BLSInterventions.</li><li>\u2022 Obtain vascular access at a TKOrate or if signs of inadequate tissue perfusion,</li><li>administer <b>500 cc</b>fluid challenge and repeat until perfusion improves.</li><li>DROWNING/SUBMERSION INJURIES</li><li>\u2022 For pediatric patients withsigns of inadequate tissue perfusion, administer</li><li><b>20 ml/kg</b><b>IV</b> and repeat until perfusion improves.</li><li>\u2022 Administer Albuterolper ICEMA -Medication-Standing OrdersV.</li><li>ALSINTERVENTIONS</li><li>\u2022 Perform activities identified in the BLS and LALSInterventions.</li><li>\u2022 Monitor cardiac status.</li><li>\u2022 Monitorend tidal CO2, pulse oximetry</li><li>\u2022 Obtain glucose level.</li><li>If indicated administer:</li><li>\uf0d8 Dextroseper ICEMA -Medication-Standing Orders.</li><li>\uf0d8 Mayrepeat blood glucose level.</li><li>Repeat DextrosePer ICEMA -</li><li>Medication- Standing Orders.</li><li>\u2022 Administer Albuterol/Atroventper ICEMA - Medication - Standard</li><li>Orders.</li><li>\u2022 Consider an advanced airway, refer to ICEMA - Procedure -</li><li>Standard Orders.</li><li>VI.</li><li>REFERENCES</li><li>Number Name</li><li>11020 Procedure- Standing Orders</li><li>14050 Cardiac Arrest-Adult</li><li>14150 Cardiac Arrest-Pediatric</li><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li></ul>"
  },
  {
    "drug": "RESPIRATORY EMERGENCIES",
    "population": "Adult",
    "page": 269,
    "text": "II. BLSINTERVENTIONS (For severe asthma and/or anaphylaxis only)\n\u2022 Reduce anxiety, allow patient to assume position of comfort.\n\u2022 Administer oxygen as clinically indicated, humidified oxygen preferred.\n\u2022 For anaphylaxis only, administer Epinephrine (0.3 mgauto-injector) perICEMA\n\u2022 Mayrepeat Epinephrine (0.3 mgauto-injector) perICEMA -\nIII. LIMITEDALS (LALS) INTERVENTIONS\n\u2022 Perform activities identified in the BLSInterventions.\n\u2022 Maintain airway withappropriate adjuncts, obtain oxygen saturation on roomair if\npossible.\n\u2022 For signs of inadequate tissue perfusion, initiateIV bolus of 300 mlNS. If signs of\ninadequate tissue perfusion persistmay repeat fluid bolusone (1) time.\n\u2022 If no response to Albuterol, administer Epinephrine (1 mg/ml) perICEMA Reference\n\u2022 Mayrepeat Epinephrine (1 mg/ml), perICEMA - Medication - Standard\nOrders, after 15 minutesone (1) time.\nIV. ALSINTERVENTIONS\n\u2022 Perform activities identified in the BLS and LALSInterventions.\n\u2022 Administer Albuterol, withAtrovent perICEMA - Medication - Standard\nOrders.\n\u2022 For suspected allergic reaction, consider Diphenhydramineper ICEMA\n\u2022 Place patient on Continuous Positive Airway Pressure (CPAP), refer to ICEMA  - Procedure - Standard Orders.\nIf systolicBP remains greater than 90 mmHg, consider Midazolamper ICEMA Reference\n\u2022 If no response to Albuterol, administer Epinephrineper ICEMA -\n\u2022 Mayrepeat Epinephrine (1 mg/ml) perICEMA - Medication - Standard\nOrders after 15 minutesone (1) time.",
    "html": "<ul class='proto'><li>II.</li><li>BLSINTERVENTIONS (For severe asthma and/or anaphylaxis only)</li><li>\u2022 Reduce anxiety, allow patient to assume position of comfort.</li><li>\u2022 Administer oxygen as clinically indicated, humidified oxygen preferred.</li><li>\u2022 For anaphylaxis only, administer Epinephrine (<b>0.3 mg</b>auto-injector) perICEMA</li><li>\u2022 Mayrepeat Epinephrine (<b>0.3 mg</b>auto-injector) perICEMA -</li><li>III.</li><li>LIMITEDALS (LALS) INTERVENTIONS</li><li>\u2022 Perform activities identified in the BLSInterventions.</li><li>\u2022 Maintain airway withappropriate adjuncts, obtain oxygen saturation on roomair if</li><li>possible.</li><li>\u2022 For signs of inadequate tissue perfusion, initiateIV bolus of <b>300 ml</b>NS.</li><li>If signs of</li><li>inadequate tissue perfusion persistmay repeat fluid bolusone (1) time.</li><li>\u2022 If no response to Albuterol, administer Epinephrine (<b>1 mg</b>/ml) perICEMA Reference</li><li>\u2022 Mayrepeat Epinephrine (<b>1 mg</b>/ml), perICEMA - Medication - Standard</li><li>Orders, after 15 minutesone (1) time.</li><li><b>IV</b>.</li><li>ALSINTERVENTIONS</li><li>\u2022 Perform activities identified in the BLS and LALSInterventions.</li><li>\u2022 Administer Albuterol, withAtrovent perICEMA - Medication - Standard</li><li>Orders.</li><li>\u2022 For suspected allergic reaction, consider Diphenhydramineper ICEMA</li><li>\u2022 Place patient on Continuous Positive Airway Pressure (CPAP), refer to ICEMA  - Procedure - Standard Orders.</li><li>If systolicBP remains greater than 90 mmHg, consider Midazolamper ICEMA Reference</li><li>\u2022 If no response to Albuterol, administer Epinephrineper ICEMA -</li><li>\u2022 Mayrepeat Epinephrine (<b>1 mg</b>/ml) perICEMA - Medication - Standard</li><li>Orders after 15 minutesone (1) time.</li></ul>"
  },
  {
    "drug": "RESPIRATORY EMERGENCIES",
    "population": "Adult",
    "page": 270,
    "text": "\u2022 For persistent severe anaphylactic reaction, administer Epinephrine (0.1 mg/ml) per\n\u2022 Consider advanced airway, refer to ICEMA - Procedure - Standard\nOrders.\nV. BASEHOSPITAL MAYORDER THE FOLLOWING\n\u2022 For severe asthma/respiratory distress thathas failed to respond to the other previous\ntreatments, administer Magnesium Sulfateper ICEMA - Medication -\nStandard Orders.\nVI. REFERENCES\nNumber Name\n11020 Procedure - Standard Orders\nACUTE PULMONARY EDEMA/CHFI. FIELD ASSESSMENT/TREATMENT INDICATORS\nHistory of cardiac disease, includingCHF, and maypresent withrales, occasional wheezes,\njugular venous distention and/or peripheral edema.\nII. BLSINTERVENTIONS\n\u2022 Reduce anxiety, allow patient to assume position of comfort.\n\u2022 Administer oxygen as clinically indicated. For pulmonary edema withhigh altitude as a\nsuspected etiology, descend to a lower altitude and administer highflow oxygen with a\nnonre-breather mask.\n\u2022 Be prepared to support ventilations as clinically indicated.\nIII. LIMITEDALS (LALS) INTERVENTIONS\n\u2022 Perform activities identified in the BLSInterventions.\n\u2022 Maintain airway withappropriate adjuncts, obtain oxygen saturation on roomair if\npossible.\n\u2022 Administer Nitroglycerine (NTG) perICEMA - Medication - Standard\nOrders. In the presence of hypotension (SBPless than 100), the use of NTG is\ncontraindicated.\n\u2022 If symptoms do not improve afterNTG administration, consider Albuterolper ICEMAIV. ALSINTERVENTIONS\n\u2022 Perform activities identified in the BLS and LALSInterventions.",
    "html": "<ul class='proto'><li>\u2022 For persistent severe anaphylactic reaction, administer Epinephrine (<b>0.1 mg</b>/ml) per</li><li>\u2022 Consider advanced airway, refer to ICEMA - Procedure - Standard</li><li>Orders.</li><li>V.</li><li>BASEHOSPITAL MAYORDER THE FOLLOWING</li><li>\u2022 For severe asthma/respiratory distress thathas failed to respond to the other previous</li><li>treatments, administer Magnesium Sulfateper ICEMA - Medication -</li><li>Standard Orders.</li><li>VI.</li><li>REFERENCES</li><li>Number Name</li><li>11020 Procedure - Standard Orders</li><li>ACUTE PULMONARY EDEMA/CHFI.</li><li>FIELD ASSESSMENT/TREATMENT INDICATORS</li><li>History of cardiac disease, includingCHF, and maypresent withrales, occasional wheezes,</li><li>jugular venous distention and/or peripheral edema.</li><li>II.</li><li>BLSINTERVENTIONS</li><li>\u2022 Reduce anxiety, allow patient to assume position of comfort.</li><li>\u2022 Administer oxygen as clinically indicated.</li><li>For pulmonary edema withhigh altitude as a</li><li>suspected etiology, descend to a lower altitude and administer highflow oxygen with a</li><li>nonre-breather mask.</li><li>\u2022 Be prepared to support ventilations as clinically indicated.</li><li>III.</li><li>LIMITEDALS (LALS) INTERVENTIONS</li><li>\u2022 Perform activities identified in the BLSInterventions.</li><li>\u2022 Maintain airway withappropriate adjuncts, obtain oxygen saturation on roomair if</li><li>possible.</li><li>\u2022 Administer Nitroglycerine (NTG) perICEMA - Medication - Standard</li><li>Orders.</li><li>In the presence of hypotension (SBPless than 100), the use of NTG is</li><li>contraindicated.</li><li>\u2022 If symptoms do not improve afterNTG administration, consider Albuterolper ICEMAIV.</li><li>ALSINTERVENTIONS</li><li>\u2022 Perform activities identified in the BLS and LALSInterventions.</li></ul>"
  },
  {
    "drug": "BURNS",
    "population": "Adult",
    "page": 285,
    "text": "\uf0d8 Unstable: BPless than 90 mmHG and/or signs of inadequate tissue perfusion,\nstart 2nd IVaccess.\nIVNS 500 mlboluses, mayrepeat to a maximum of 1000 ml.\n\uf0d8 Stable: BPmore than 90 mmHG and/or signs of adequate tissue perfusion.\nIVNS 500 mlper hour.\n\u2022 Transport to appropriate facility.\n\uf0d8 Minor BurnClassification: Transport to the closest mostappropriate receiving\nhospital.\n\uf0d8 Moderate BurnClassification: Transport to the closest mostappropriate receiving\nhospital.\n\uf0d8 Major BurnClassification: Transport to the closest mostappropriate BurnCenter\n(SanBernardino County contact ARMC).\n\uf0d8 Critical Trauma Patient (CTP) withAssociated Burns: Transport to the mostappropriate Trauma Center.\n\u2022 Burnpatients withassociated trauma, should be transported to the closest Trauma\nCenter. Trauma basehospital contacted shall be made.\nA. Manage Special Considerations\n\u2022 Electrical Burns: PlaceAED on patient.\n\uf0d8 Electrical injuries thatresult in cardiac arrest shall be treated as medical\narrests.\n\u2022 Respiratory Distress: UseBVM as needed and transport to the nearest facility\nfor airway control. Contact receiving hospital ASAP. Albuterol withAtroventper\n\u2022 Deteriorating Vital Signs: Transport to the closest mostappropriate receiving\nhospital. Contact basehospital.\n\u2022 Pulseness and Apneic: Transport to the closest mostappropriate receiving\nhospital and treat according to ICEMA policies. Contact basehospital.\n\u2022 Determination of Death on Scene: Refer to ICEMA -\nDetermination of Death on Scene.\n\u2022 Precautions and Comments:\n\uf0d8 Highflow oxygen is essential withknown or potential respiratory injury.\nBeware of possible smoke inhalation.\n\uf0d8 Contact withappropriate advisory agencymay be necessary for\nhazardous materials, before decontamination or patient contact.",
    "html": "<ul class='proto'><li>\uf0d8 Unstable: BPless than 90 mmHG and/or signs of inadequate tissue perfusion,</li><li>start 2nd IVaccess.</li><li>IVNS <b>500 ml</b>boluses, mayrepeat to a <b>maximum of <b>1000 ml</b></b>.</li><li>\uf0d8 Stable: BPmore than 90 mmHG and/or signs of adequate tissue perfusion.</li><li>IVNS <b>500 ml</b>per hour.</li><li>\u2022 Transport to appropriate facility.</li><li>\uf0d8 Minor BurnClassification: Transport to the closest mostappropriate receiving</li><li>hospital.</li><li>\uf0d8 Moderate BurnClassification: Transport to the closest mostappropriate receiving</li><li>hospital.</li><li>\uf0d8 Major BurnClassification: Transport to the closest mostappropriate BurnCenter</li><li>(SanBernardino County contact ARMC).</li><li>\uf0d8 Critical Trauma Patient (CTP) withAssociated Burns: Transport to the mostappropriate Trauma Center.</li><li>\u2022 Burnpatients withassociated trauma, should be transported to the closest Trauma</li><li>Center.</li><li>Trauma basehospital contacted shall be made.</li><li>A.</li><li>Manage Special Considerations</li><li>\u2022 Electrical Burns: PlaceAED on patient.</li><li>\uf0d8 Electrical injuries thatresult in cardiac arrest shall be treated as medical</li><li>arrests.</li><li>\u2022 Respiratory Distress: UseBVM as needed and transport to the nearest facility</li><li>for airway control.</li><li>Contact receiving hospital ASAP.</li><li>Albuterol withAtroventper</li><li>\u2022 Deteriorating Vital Signs: Transport to the closest mostappropriate receiving</li><li>hospital.</li><li>Contact basehospital.</li><li>\u2022 Pulseness and Apneic: Transport to the closest mostappropriate receiving</li><li>hospital and treat according to ICEMA policies.</li><li>Contact basehospital.</li><li>\u2022 Determination of Death on Scene: Refer to ICEMA -</li><li>Determination of Death on Scene.</li><li>\u2022 Precautions and Comments:</li><li>\uf0d8 Highflow oxygen is essential withknown or potential respiratory injury.</li><li>Beware of possible smoke inhalation.</li><li>\uf0d8 Contact withappropriate advisory agencymay be necessary for</li><li>hazardous materials, before decontamination or patient contact.</li></ul>"
  },
  {
    "drug": "BURNS",
    "population": "Adult",
    "page": 286,
    "text": "\uf0d8 Do not applyice or icewater directly to skinsurfaces, as additional injury\nwillresult.\nIV. ALSINTERVENTIONS\n\u2022 Advanced airway (as indicated).\n\u2022 Airway Stabilization:\nBurnpatients withrespiratory compromise or potential for such, will be transported to the\nclosest mostappropriate receiving hospital for airway stabilization.\n\u2022 MonitorECG.\n\u2022 IV/IOAccess (WarmIV fluids whenavailable).\n\uf0d8 Unstable: BPless than 90 mmHG and/or signs of inadequate tissue perfusion,\nstart 2nd IVaccess.\nIV/IONS 500 mlboluses, mayrepeat to a maximum of 1000 ml.\n\uf0d8 Stable: BPmore than 90 mmHG and/or signs of adequate tissue perfusion.\nIV/IONS 500 mlper hour.\n\u2022 Treat pain as indicated.\nPainRelief: Administer an appropriate analgesicper ICEMA - Pain",
    "html": "<ul class='proto'><li>\uf0d8 Do not applyice or icewater directly to skinsurfaces, as additional injury</li><li>willresult.</li><li><b>IV</b>.</li><li>ALSINTERVENTIONS</li><li>\u2022 Advanced airway (as indicated).</li><li>\u2022 Airway Stabilization:</li><li>Burnpatients withrespiratory compromise or potential for such, will be transported to the</li><li>closest mostappropriate receiving hospital for airway stabilization.</li><li>\u2022 MonitorECG.</li><li>\u2022 <b>IV</b>/IOAccess (WarmIV fluids whenavailable).</li><li>\uf0d8 Unstable: BPless than 90 mmHG and/or signs of inadequate tissue perfusion,</li><li>start 2nd IVaccess.</li><li><b>IV</b>/IONS <b>500 ml</b>boluses, mayrepeat to a <b>maximum of <b>1000 ml</b></b>.</li><li>\uf0d8 Stable: BPmore than 90 mmHG and/or signs of adequate tissue perfusion.</li><li><b>IV</b>/IONS <b>500 ml</b>per hour.</li><li>\u2022 Treat pain as indicated.</li><li>PainRelief: Administer an appropriate analgesicper ICEMA - Pain</li></ul>"
  },
  {
    "drug": "TRAUMA",
    "population": "Adult",
    "page": 294,
    "text": "\u2022 Head and NeckTrauma: Place brain injured patients in reverse Trendelenburg\n(elevate the head of the backboard 15 - 20 degrees), if the patient exhibits no\nsigns of shock.\n\uf0d8 Eye: Whenever possible protect an injuredeye with a rigid dressing, cup\nor eyeshield. Do not attempt to replace a partially tornglobe, stabilize it\nin place withsterile saline soaked gauze. Cover uninjuredeye.\n\uf0d8 Avulsed Tooth: Collect teeth, place in moist, sterile saline gauze and\nplace in a plasticbag.\n\u2022 Impaled Object: Immobilize and leave in place. Remove object if it interferes\nwithCPR, or if the object is impaled in the face, cheek or neck and is\ncompromising ventilations.\n\u2022 Determination of Death on Scene: Refer to ICEMA -\nDetermination of Death on Scene.\nIII. LIMITEDALS (LALS) INTERVENTIONS\n\u2022 Perform identifiedBLS interventions and additional LALSinterventions.\n\u2022 Advanced airway (as indicated).\n\uf0d8 Unmanageable Airway: Transport to the closest mostappropriate receiving\nhospital when the patient requires advanced airway and an adequate airway\ncannot be maintained with a BVMdevice.\n\u2022 EstablishIV access.\n\uf0d8 Unstable: If BPless than 90 mmHg and/or signs of inadequate perfusion, start\n2nd IVaccess.\n\uf0d8 Stable: MaintainIV if BPmore than 90 mmHg and/or signs of adequate tissue\nperfusion.\nBlunt Trauma:\n\uf0d8 Unstable: EstablishIV NSadminister 250 mlbolus. Mayrepeatone (1) time to a\nmaximum of 500 ml.\n\uf0d8 Stable: Saline lockonly, do not administerIV fluids.\nPenetrating Trauma:\n\uf0d8 Saline lockonly, do not administerIV fluids.\nIsolated Closed HeadInjury:\n\uf0d8 Unstable: EstablishIVNS, administer 250 mlbolus. Mayrepeatone (1) time to\na maximum of 500 ml.\n\uf0d8 Stable: Saline lockonly, do not administerIV fluids.",
    "html": "<ul class='proto'><li>\u2022 Head and NeckTrauma: Place brain injured patients in reverse Trendelenburg</li><li>(elevate the head of the backboard 15 - 20 degrees), if the patient exhibits no</li><li>signs of shock.</li><li>\uf0d8 Eye: Whenever possible protect an injuredeye with a rigid dressing, cup</li><li>or eyeshield.</li><li>Do not attempt to replace a partially tornglobe, stabilize it</li><li>in place withsterile saline soaked gauze.</li><li>Cover uninjuredeye.</li><li>\uf0d8 Avulsed Tooth: Collect teeth, place in moist, sterile saline gauze and</li><li>place in a plasticbag.</li><li>\u2022 Impaled Object: Immobilize and leave in place.</li><li>Remove object if it interferes</li><li>withCPR, or if the object is impaled in the face, cheek or neck and is</li><li>compromising ventilations.</li><li>\u2022 Determination of Death on Scene: Refer to ICEMA -</li><li>Determination of Death on Scene.</li><li>III.</li><li>LIMITEDALS (LALS) INTERVENTIONS</li><li>\u2022 Perform identifiedBLS interventions and additional LALSinterventions.</li><li>\u2022 Advanced airway (as indicated).</li><li>\uf0d8 Unmanageable Airway: Transport to the closest mostappropriate receiving</li><li>hospital when the patient requires advanced airway and an adequate airway</li><li>cannot be maintained with a BVMdevice.</li><li>\u2022 EstablishIV access.</li><li>\uf0d8 Unstable: If BPless than 90 mmHg and/or signs of inadequate perfusion, start</li><li>2nd IVaccess.</li><li>\uf0d8 Stable: MaintainIV if BPmore than 90 mmHg and/or signs of adequate tissue</li><li>perfusion.</li><li>Blunt Trauma:</li><li>\uf0d8 Unstable: EstablishIV NSadminister <b>250 ml</b>bolus.</li><li>Mayrepeatone (1) time to a</li><li><b>maximum of <b>500 ml</b></b>.</li><li>\uf0d8 Stable: Saline lockonly, do not administerIV fluids.</li><li>Penetrating Trauma:</li><li>\uf0d8 Saline lockonly, do not administerIV fluids.</li><li>Isolated Closed HeadInjury:</li><li>\uf0d8 Unstable: EstablishIVNS, administer <b>250 ml</b>bolus.</li><li>Mayrepeatone (1) time to</li><li>a <b>maximum of <b>500 ml</b></b>.</li><li>\uf0d8 Stable: Saline lockonly, do not administerIV fluids.</li></ul>"
  },
  {
    "drug": "TRAUMA",
    "population": "Adult",
    "page": 295,
    "text": "Isolated Extremity Trauma:\n\uf0d8 Unstable: EstablishIVNS, administer 250 mlbolus. Mayrepeatone (1) time to\na maximum of 500 ml.\n\uf0d8 Stable: Saline lockonly, do not administerIV fluids.\n\u2022 Transport to appropriate hospital.\nA. Manage Special Considerations\n\u2022 Consider PushDoseEpi for persistent shockdue to trauma where cardiac arrest is\n\u2022 Spinal Motion Restriction: LALSpersonnel should removeLBB devices frompatients placed in fullspinal motion restriction precautions by first responders and\nBLSpersonnel if the patient does not meetany of the following indicators using\nthe acronym (NSAID):\nN-euroDeficit(s) present?\nS-pinal Tenderness present?\nA-ltered Mental Status?\nI-ntoxication?\nD-istracting Injury?\n\u2022 Impaled Object: Remove object uponTrauma basehospital physician order, if\nindicated.\nB. Determination of Death on Scene: Refer to ICEMA - Determination\nof Death on Scene.\n\u2022 Severe Blunt Force Trauma Arrest: If indicated, transport to the closest receiving\nhospital.\n\u2022 Penetrating Trauma Arrest: If indicated, transport to the closest receiving\nhospital.\n\u2022 If the patient does not meet the \u201cObvious Death Criteria\u201d perICEMA  - Determination of Death on Scene, contact the Trauma basehospital for\ndetermination of death on scene for those patientswho suffer a traumatic cardiac\narrest in the setting of penetrating trauma and no reported vital signs (palpable\npulse and/or spontaneous respirations) during the EMSencounter with the\npatient.\n\u2022 Resuscitation efforts on a penetrating traumatic arrest victimare not to be\nterminated without Trauma basehospital contact.\n\u2022 Precautions and Comments:\n\uf0d8 Electrical injuries thatresult in cardiac arrest shall be treated as medical\narrests.\n\uf0d8 Consider cardiac etiology in older patients in cardiac arrest withlow\nprobability of mechanism of injury.",
    "html": "<ul class='proto'><li>Isolated Extremity Trauma:</li><li>\uf0d8 Unstable: EstablishIVNS, administer <b>250 ml</b>bolus.</li><li>Mayrepeatone (1) time to</li><li>a <b>maximum of <b>500 ml</b></b>.</li><li>\uf0d8 Stable: Saline lockonly, do not administerIV fluids.</li><li>\u2022 Transport to appropriate hospital.</li><li>A.</li><li>Manage Special Considerations</li><li>\u2022 Consider PushDoseEpi for persistent shockdue to trauma where cardiac arrest is</li><li>\u2022 Spinal Motion Restriction: LALSpersonnel should removeLBB devices frompatients placed in fullspinal motion restriction precautions by first responders and</li><li>BLSpersonnel if the patient does not meetany of the following indicators using</li><li>the acronym (NSAID):</li><li>N-euroDeficit(s) present?</li><li>S-pinal Tenderness present?</li><li>A-ltered Mental Status?</li><li>I-ntoxication?</li><li>D-istracting Injury?</li><li>\u2022 Impaled Object: Remove object uponTrauma basehospital physician order, if</li><li>indicated.</li><li>B.</li><li>Determination of Death on Scene: Refer to ICEMA - Determination</li><li>of Death on Scene.</li><li>\u2022 Severe Blunt Force Trauma Arrest: If indicated, transport to the closest receiving</li><li>hospital.</li><li>\u2022 Penetrating Trauma Arrest: If indicated, transport to the closest receiving</li><li>hospital.</li><li>\u2022 If the patient does not meet the \u201cObvious Death Criteria\u201d perICEMA  - Determination of Death on Scene, contact the Trauma basehospital for</li><li>determination of death on scene for those patientswho suffer a traumatic cardiac</li><li>arrest in the setting of penetrating trauma and no reported vital signs (palpable</li><li>pulse and/or spontaneous respirations) during the EMSencounter with the</li><li>patient.</li><li>\u2022 Resuscitation efforts on a penetrating traumatic arrest victimare not to be</li><li>terminated without Trauma basehospital contact.</li><li>\u2022 Precautions and Comments:</li><li>\uf0d8 Electrical injuries thatresult in cardiac arrest shall be treated as medical</li><li>arrests.</li><li>\uf0d8 Consider cardiac etiology in older patients in cardiac arrest withlow</li><li>probability of mechanism of injury.</li></ul>"
  },
  {
    "drug": "TRAUMA",
    "population": "Adult",
    "page": 296,
    "text": "\uf0d8 If the patient is not responsive to trauma-oriented resuscitation, consider\nmedical etiology and treat accordingly.\n\uf0d8 Unsafe scenemay warrant transport despitelow potential for survival.\nIV. ALSINTERVENTIONS\n\u2022 Perform identifiedBLS and LALSintervention and the additionalALS interventions.\n\u2022 Advanced Airway (as indicated):\n\uf0d8 Unmanageable Airway: If an adequate airway cannot be maintained with a BVMdevice; and the paramedic is unable to intubate or insertSGA or perform a\nsuccessful needle cricothyrotomy (if indicated), then transport to the closest\nreceiving hospital and follow ICEMA - Continuation of Care\n(SanBernardino County Only).\n\u2022 MonitorECG.\n\u2022 EstablishIV/IOaccess.\n\uf0d8 Unstable: If BPless than 90 mmHg and/or signs of inadequate perfusion, start\n2nd IVaccess.\n\uf0d8 Stable: MaintainIV/IO if BPmore than 90 mmHg and/or signs of adequate\ntissue perfusion.\nBlunt Trauma:\n\uf0d8 Unstable: EstablishIV/IONSadminister 250 mlbolus. Mayrepeatone (1) time\nto a maximum of 500 ml.\n\uf0d8 Stable: Saline lockonly, do not administerIV fluids.\nPenetrating Trauma:\n\uf0d8 Saline lockonly, do not administerIV fluids.\nIsolated Closed HeadInjury:\n\uf0d8 Unstable: EstablishIV/IONS, administer 250 mlbolus. Mayrepeatone (1) time\nto a maximum of 500 ml.\n\uf0d8 Stable: Saline lockonly, do not administerIV fluids.\nIsolated Extremity Trauma:\n\uf0d8 Unstable: EstablishIV/IONS, administer 250 mlbolus. Mayrepeatone (1) time\nto a maximum of 500 ml (avoid placement on injured extremity).\n\uf0d8 Stable: Saline lockonly, do not administerIV fluids.\n\u2022 Tranexamic Acid (TXA) administration for blunt or penetrating traumas:",
    "html": "<ul class='proto'><li>\uf0d8 If the patient is not responsive to trauma-oriented resuscitation, consider</li><li>medical etiology and treat accordingly.</li><li>\uf0d8 Unsafe scenemay warrant transport despitelow potential for survival.</li><li><b>IV</b>.</li><li>ALSINTERVENTIONS</li><li>\u2022 Perform identifiedBLS and LALSintervention and the additionalALS interventions.</li><li>\u2022 Advanced Airway (as indicated):</li><li>\uf0d8 Unmanageable Airway: If an adequate airway cannot be maintained with a BVMdevice; and the paramedic is unable to intubate or insertSGA or perform a</li><li>successful needle cricothyrotomy (if indicated), then transport to the closest</li><li>receiving hospital and follow ICEMA - Continuation of Care</li><li>(SanBernardino County Only).</li><li>\u2022 MonitorECG.</li><li>\u2022 EstablishIV/IOaccess.</li><li>\uf0d8 Unstable: If BPless than 90 mmHg and/or signs of inadequate perfusion, start</li><li>2nd IVaccess.</li><li>\uf0d8 Stable: MaintainIV/<b>IO</b> if BPmore than 90 mmHg and/or signs of adequate</li><li>tissue perfusion.</li><li>Blunt Trauma:</li><li>\uf0d8 Unstable: EstablishIV/IONSadminister <b>250 ml</b>bolus.</li><li>Mayrepeatone (1) time</li><li>to a <b>maximum of <b>500 ml</b></b>.</li><li>\uf0d8 Stable: Saline lockonly, do not administerIV fluids.</li><li>Penetrating Trauma:</li><li>\uf0d8 Saline lockonly, do not administerIV fluids.</li><li>Isolated Closed HeadInjury:</li><li>\uf0d8 Unstable: EstablishIV/IONS, administer <b>250 ml</b>bolus.</li><li>Mayrepeatone (1) time</li><li>to a <b>maximum of <b>500 ml</b></b>.</li><li>\uf0d8 Stable: Saline lockonly, do not administerIV fluids.</li><li>Isolated Extremity Trauma:</li><li>\uf0d8 Unstable: EstablishIV/IONS, administer <b>250 ml</b>bolus.</li><li>Mayrepeatone (1) time</li><li>to a <b>maximum of <b>500 ml</b></b> (avoid placement on injured extremity).</li><li>\uf0d8 Stable: Saline lockonly, do not administerIV fluids.</li><li>\u2022 Tranexamic Acid (TXA) administration for blunt or penetrating traumas:</li></ul>"
  },
  {
    "drug": "ALLERGIC REACTIONS",
    "population": "Pediatric",
    "page": 307,
    "text": "I. FIELD ASSESSMENT/TREATMENT INDICATORS\n\u2022 Signs and Symptoms of an acute allergic reaction.\n\u2022 History of Exposure to possible allergen.\nII. BLSINTERVENTIONS\n\u2022 Recognize signs/symptoms of respiratory distress for age.\n\u2022 Reduce anxiety, assist patient to assumePOC.\n\u2022 Oxygen administration as clinically indicated (humidified oxygen preferred).\n\u2022 Assist patient withself-administration of prescribed Epinephrine device if available.\n\u2022 For anaphylaxis only, administer Epinephrine Auto-Injectorper ICEMA\n\u2022 Assist patient withself-administration of prescribed Diphenhydramine.\nIII. LIMITEDALS (LALS) INTERVENTIONS - PEDIATRIC (Lessthan 15 years of age)\n\u2022 Perform activities identified in the BLSInterventions.\n\u2022 Maintain airway withappropriate adjuncts, obtain oxygen saturation on roomair if\npossible.\n\u2022 If no response to Albuterol, consider Epinephrineper ICEMA -\n\u2022 For symptomatic hypotension withpoor perfusion, consider fluid bolus of 20 ml/kg of NS\nnot to exceed 300 mlNS and repeat as indicated.\n\u2022 EstablishIV/IOaccess if indicated.\n\u2022 For anaphylactic shock (e.g., no palpable radial pulse and a depressed level of\nconsciousness), administer Epinephrineper ICEMA - Medication -\nStandard Orders.\nIV. ALSINTERVENTIONS\n\u2022 Perform activities identified in the BLS and LALSInterventions.\n\u2022 If no response to Albuterol and Atrovent, consider Epinephrineper ICEMA Reference",
    "html": "<ul class='proto'><li>I.</li><li>FIELD ASSESSMENT/TREATMENT INDICATORS</li><li>\u2022 Signs and Symptoms of an acute allergic reaction.</li><li>\u2022 History of Exposure to possible allergen.</li><li>II.</li><li>BLSINTERVENTIONS</li><li>\u2022 Recognize signs/symptoms of respiratory distress for age.</li><li>\u2022 Reduce anxiety, assist patient to assumePOC.</li><li>\u2022 Oxygen administration as clinically indicated (humidified oxygen preferred).</li><li>\u2022 Assist patient withself-administration of prescribed Epinephrine device if available.</li><li>\u2022 For anaphylaxis only, administer Epinephrine Auto-Injectorper ICEMA</li><li>\u2022 Assist patient withself-administration of prescribed Diphenhydramine.</li><li>III.</li><li>LIMITEDALS (LALS) INTERVENTIONS - PEDIATRIC (Lessthan 15 years of age)</li><li>\u2022 Perform activities identified in the BLSInterventions.</li><li>\u2022 Maintain airway withappropriate adjuncts, obtain oxygen saturation on roomair if</li><li>possible.</li><li>\u2022 If no response to Albuterol, consider Epinephrineper ICEMA -</li><li>\u2022 For symptomatic hypotension withpoor perfusion, consider fluid bolus of <b>20 ml/kg</b> of NS</li><li>not to exceed <b>300 ml</b>NS and repeat as indicated.</li><li>\u2022 EstablishIV/IOaccess if indicated.</li><li>\u2022 For anaphylactic shock (e.g., no palpable radial pulse and a depressed level of</li><li>consciousness), administer Epinephrineper ICEMA - Medication -</li><li>Standard Orders.</li><li><b>IV</b>.</li><li>ALSINTERVENTIONS</li><li>\u2022 Perform activities identified in the BLS and LALSInterventions.</li><li>\u2022 If no response to Albuterol and Atrovent, consider Epinephrineper ICEMA Reference</li></ul>"
  },
  {
    "drug": "CARDIAC ARREST",
    "population": "Pediatric",
    "page": 310,
    "text": "(Lessthan 15 years of age)\nIII. LIMITEDALS (LALS) INTERVENTIONS\n\u2022 Perform activities identified in the BLSInterventions.\n\u2022 InitiateHP CPRwhile applying the AED.\n\u2022 ObtainIO/IVaccess (IO is preferred for under nine (9) years of age).\n\u2022 For continued signs of inadequate tissue perfusion, administer fluid bolus of NS.\nReassess after eachbolus. Mayrepeattwo (2) times for continued signs of inadequate\ntissue perfusion.\n\uf0d8 1 day to 8 years: 20 ml/kgNS\n\uf0d8 9 to 14 years: 300 mlNSIV. ALSINTERVENTIONS\n\u2022 InitiateHPCPR and continue appropriateBLS Interventions while applying the cardiac\nmonitor without interruption to chest compressions.\n\u2022 Determine the cardiac rhythm and defibrillate at 2 j/kg (or manufacturer\u2019srecommended\nequivalent) if indicated. After defibrillation, immediately resumeHPCPR. Begin a two (2)\nminute cycle of HPCPR.\n\u2022 ObtainIO/IVaccess (IO is preferred).\n\u2022 Utilize continuous quantitative waveform capnography, for monitoring of patient\u2019sairway,\nthe effectiveness of chest compressions and for early identification of ROSC. Document\nthe waveform and the capnography number in mmHg in the ePCR.\n\u2022 Continue withBLS airway management ensuring adequate ventilations. BLSairways\nshould be maintained during activeCPR.\n\u2022 Endotracheal intubation is the advanced airway of choice if BLSairway does not provide\nadequate ventilation. Endotracheal intubationmay only be performed on patientswho\naretaller thanmaximum length of a pediatric emergency measuring tape (Broselow, etc.)\nor equivalent, measuring from the top of the head to the heel of the footper ICEMA\n- Procedure - Standard Orders.\nNOTE: Capnography shall be used for allcardiac arrest patients.\n\u2022 InsertNG/OGtube perICEMA - Procedure - Standard Orders.\nVentricular Fibrillation/Pulseless Ventricular Tachycardia\n\u2022 Initial defibrillation is administered at 2 j/kg (or manufacturer\u2019srecommended equivalent).\nSecond defibrillation is administered at 4 j/kg. Third and subsequent defibrillation\nattempts should be administered at 10 j/kg not to exceed the adult dose.\n\u2022 PerformHP CPRimmediately after eachdefibrillation for two (2) minutes without\nassessing the post-defibrillation rhythm.",
    "html": "<ul class='proto'><li>(Lessthan 15 years of age)</li><li>III.</li><li>LIMITEDALS (LALS) INTERVENTIONS</li><li>\u2022 Perform activities identified in the BLSInterventions.</li><li>\u2022 InitiateHP CPRwhile applying the AED.</li><li>\u2022 ObtainIO/IVaccess (<b>IO</b> is preferred for under nine (9) years of age).</li><li>\u2022 For continued signs of inadequate tissue perfusion, administer fluid bolus of NS.</li><li>Reassess after eachbolus.</li><li>Mayrepeattwo (2) times for continued signs of inadequate</li><li>tissue perfusion.</li><li>\uf0d8</li><li>1 day to 8 years: <b>20 ml/kg</b>NS</li><li>\uf0d8 9 to 14 years: <b>300 ml</b>NSIV.</li><li>ALSINTERVENTIONS</li><li>\u2022 InitiateHPCPR and continue appropriateBLS Interventions while applying the cardiac</li><li>monitor without interruption to chest compressions.</li><li>\u2022 Determine the cardiac rhythm and defibrillate at 2 j/kg (or manufacturer\u2019srecommended</li><li>equivalent) if indicated.</li><li>After defibrillation, immediately resumeHPCPR.</li><li>Begin a two (2)</li><li>minute cycle of HPCPR.</li><li>\u2022 ObtainIO/IVaccess (<b>IO</b> is preferred).</li><li>\u2022 Utilize continuous quantitative waveform capnography, for monitoring of patient\u2019sairway,</li><li>the effectiveness of chest compressions and for early identification of ROSC.</li><li>Document</li><li>the waveform and the capnography number in mmHg in the ePCR.</li><li>\u2022 Continue withBLS airway management ensuring adequate ventilations.</li><li>BLSairways</li><li>should be maintained during activeCPR.</li><li>\u2022 Endotracheal intubation is the advanced airway of choice if BLSairway does not provide</li><li>adequate ventilation.</li><li>Endotracheal intubationmay only be performed on patientswho</li><li>aretaller thanmaximum length of a pediatric emergency measuring tape (Broselow, etc.)</li><li>or equivalent, measuring from the top of the head to the heel of the footper ICEMA</li><li>- Procedure - Standard Orders.</li><li>NOTE: Capnography shall be used for allcardiac arrest patients.</li><li>\u2022 InsertNG/OGtube perICEMA - Procedure - Standard Orders.</li><li>Ventricular Fibrillation/Pulseless Ventricular Tachycardia</li><li>\u2022 Initial defibrillation is administered at 2 j/kg (or manufacturer\u2019srecommended equivalent).</li><li>Second defibrillation is administered at 4 j/kg.</li><li>Third and subsequent defibrillation</li><li>attempts should be administered at 10 j/kg not to exceed the adult dose.</li><li>\u2022 PerformHP CPRimmediately after eachdefibrillation for two (2) minutes without</li><li>assessing the post-defibrillation rhythm.</li></ul>"
  },
  {
    "drug": "CARDIAC ARREST",
    "population": "Pediatric",
    "page": 311,
    "text": "(Lessthan 15 years of age)\nevery five (5) minutes, without interruption of HPCPR, unless capnography indicates\npossible ROSC.\n\u2022 Reassess rhythm for no morethan 10 seconds after eachtwo (2) cycles of HPCPR. If\nVF/VTpersists, defibrillate as indicated above.\n\u2022 Aftertwo (2) cycles of HPCPR, consider administering Lidocaineper ICEMA Reference\n\u2022 If patient remains in pulselessVF/VTafter 20 minutes of HPCPR, consult basehospital.\nPulseless Electrical Activity/Asystole\n\u2022 Assess for reversible causes and initiate treatment.\n\u2022 ContinueHP CPRwith evaluation of rhythm (no morethan 10 seconds) everytwo (2)\nminutes.\n\u2022 Administer initial fluid bolus of 20 ml/kgNS for allages, mayrepeat at:\n\uf0d8 1 day to 8 years: 20 ml/kgNS\n\uf0d8 9 to 14 years: 300 mlNSevery five (5) minutes without interruption of HPCPR.\nStable ROSC\n\u2022 Obtain a 12-leadECG, upload and document then transport to the closest receiving\nhospital.\n\u2022 Utilize continuous waveform capnography, to identify loss of circulation.\n\u2022 Obtain blood glucose level. If indicated administer:\n\uf0d8 Mayrepeat blood glucose level. Repeat Dextroseper ICEMA\n\u2022 For suspected opiate overdose, administer Naloxoneper ICEMA -\n\u2022 For continued signs of shock and hypotension withSBP of lessthan 70 mmHgafter\nsuccessful resuscitation administer PushDose Epinephrineper ICEMA\n\u2022 Basehospital physicianmay order additional medications or interventions as indicated by\npatient condition.",
    "html": "<ul class='proto'><li>(Lessthan 15 years of age)</li><li>every five (5) minutes, without interruption of HPCPR, unless capnography indicates</li><li>possible ROSC.</li><li>\u2022 Reassess rhythm for no morethan 10 seconds after eachtwo (2) cycles of HPCPR.</li><li>If</li><li>VF/VTpersists, defibrillate as indicated above.</li><li>\u2022 Aftertwo (2) cycles of HPCPR, consider administering Lidocaineper ICEMA Reference</li><li>\u2022 If patient remains in pulselessVF/VTafter 20 minutes of HPCPR, consult basehospital.</li><li>Pulseless Electrical Activity/Asystole</li><li>\u2022 Assess for reversible causes and initiate treatment.</li><li>\u2022 ContinueHP CPRwith evaluation of rhythm (no morethan 10 seconds) everytwo (2)</li><li>minutes.</li><li>\u2022 Administer initial fluid bolus of <b>20 ml/kg</b>NS for allages, mayrepeat at:</li><li>\uf0d8</li><li>1 day to 8 years: <b>20 ml/kg</b>NS</li><li>\uf0d8 9 to 14 years: <b>300 ml</b>NSevery five (5) minutes without interruption of HPCPR.</li><li>Stable ROSC</li><li>\u2022 Obtain a 12-leadECG, upload and document then transport to the closest receiving</li><li>hospital.</li><li>\u2022 Utilize continuous waveform capnography, to identify loss of circulation.</li><li>\u2022 Obtain blood glucose level.</li><li>If indicated administer:</li><li>\uf0d8 Mayrepeat blood glucose level.</li><li>Repeat Dextroseper ICEMA</li><li>\u2022 For suspected opiate overdose, administer Naloxoneper ICEMA -</li><li>\u2022 For continued signs of shock and hypotension withSBP of lessthan 70 mmHgafter</li><li>successful resuscitation administer PushDose Epinephrineper ICEMA</li><li>\u2022 Basehospital physicianmay order additional medications or interventions as indicated by</li><li>patient condition.</li></ul>"
  },
  {
    "drug": "ALTERED LEVEL OF CONSCIOUSNESS",
    "population": "Pediatric",
    "page": 313,
    "text": "I. FIELD ASSESSMENT/TREATMENT INDICATORS\n\u2022 Patient exhibits inappropriate behavior for age.\n\u2022 History or observation of an Apparent LifeThreatening Event (ALTE).\nII. BLSINTERVENTIONS\n\u2022 Assess environment and determine possible causes for illness.\n\u2022 Spinal motion restriction, if clinically indicated.\n\u2022 Oxygen therapy, if clinically indicated.\n\u2022 Airway management, as indicated (OPA/NPA, BVMventilation).\n\u2022 Obtain and assess blood glucose level. If indicated, administer Glucose - Oralper\n\u2022 If suspected narcotic overdose withseverely decreased respiratory drive, administer\n\u2022 Obtain patient temperature. Begin cooling measures if temperature is elevated or\nwarming measures if temperature is decreased.\nIII. LIMITEDALS (LALS) INTERVENTIONS\n\u2022 Perform activities identified in the BLSInterventions.\n\u2022 Obtain vascular access.\n\u2022 For symptomatic hypotension withpoor perfusion, consider fluid bolus of 20 ml/kg of NS\nnot to exceed 300 mlNS.\n\u2022 Obtain and assess blood glucose level. If indicated administer:\n\uf0d8 Mayrepeat blood glucose level. Repeat Dextroseper ICEMA\n\uf0d8 If unable to establish an IV, consider Glucagonper ICEMA -\nIV. ALSINTERVENTIONS\n\u2022 Perform activities identified in the BLS and LALSInterventions.\n\u2022 Establish advanced airway as indicatedper ICEMA - Procedure -\nStandard Orders.\n(ALTERED LEVEL OF CONSCIOUSNESS - PEDIATRIC\n(Lessthan 15 years of age)\n\u2022 Place on cardiac monitor.\n\u2022 Basehospital physicianmay order additional medication dosages and additional fluid\nboluses.\nV. REFERENCES\nNumber Name\n11020 Procedure - Standard Orders\nINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY",
    "html": "<ul class='proto'><li>I.</li><li>FIELD ASSESSMENT/TREATMENT INDICATORS</li><li>\u2022 Patient exhibits inappropriate behavior for age.</li><li>\u2022 History or observation of an Apparent LifeThreatening Event (ALTE).</li><li>II.</li><li>BLSINTERVENTIONS</li><li>\u2022 Assess environment and determine possible causes for illness.</li><li>\u2022 Spinal motion restriction, if clinically indicated.</li><li>\u2022 Oxygen therapy, if clinically indicated.</li><li>\u2022 Airway management, as indicated (OPA/NPA, BVMventilation).</li><li>\u2022 Obtain and assess blood glucose level.</li><li>If indicated, administer Glucose - Oralper</li><li>\u2022 If suspected narcotic overdose withseverely decreased respiratory drive, administer</li><li>\u2022 Obtain patient temperature.</li><li>Begin cooling measures if temperature is elevated or</li><li>warming measures if temperature is decreased.</li><li>III.</li><li>LIMITEDALS (LALS) INTERVENTIONS</li><li>\u2022 Perform activities identified in the BLSInterventions.</li><li>\u2022 Obtain vascular access.</li><li>\u2022 For symptomatic hypotension withpoor perfusion, consider fluid bolus of <b>20 ml/kg</b> of NS</li><li>not to exceed <b>300 ml</b>NS.</li><li>\u2022 Obtain and assess blood glucose level.</li><li>If indicated administer:</li><li>\uf0d8 Mayrepeat blood glucose level.</li><li>Repeat Dextroseper ICEMA</li><li>\uf0d8 If unable to establish an <b>IV</b>, consider Glucagonper ICEMA -</li><li><b>IV</b>.</li><li>ALSINTERVENTIONS</li><li>\u2022 Perform activities identified in the BLS and LALSInterventions.</li><li>\u2022 Establish advanced airway as indicatedper ICEMA - Procedure -</li><li>Standard Orders.</li><li>(ALTERED LEVEL OF CONSCIOUSNESS - PEDIATRIC</li><li>(Lessthan 15 years of age)</li><li>\u2022 Place on cardiac monitor.</li><li>\u2022 Basehospital physicianmay order additional medication dosages and additional fluid</li><li>boluses.</li><li>V.</li><li>REFERENCES</li><li>Number Name</li><li>11020 Procedure - Standard Orders</li><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li></ul>"
  },
  {
    "drug": "TRAUMA",
    "population": "Pediatric",
    "page": 319,
    "text": "\u2022 Traumatic Arrest: CPR if indicated. Mayutilize an AED if indicated.\n\u2022 Determination of Death on Scene: Refer to ICEMA -\nDetermination of Death on Scene.\nIII. LIMITEDALS (LALS) INTERVENTIONS\n\u2022 Perform identifiedBLS interventions and additional LALSinterventions.\n\uf0d8 Unmanageable Airway: When an adequate airway cannot be maintained by a\nBVMdevice, transport to the closest mostappropriate receiving hospital.\n\u2022 IVAccess (warmIV fluids whenavailable).\n\uf0d8 Unstable: Vital signs (ageappropriate) and/or signs of inadequate tissue\nperfusion, start 2nd IVaccess.\nAdminister 20 ml/kgNSbolusIV.\n\uf0d8 Stable: Vital signs (ageappropriate) and/or signs of adequate tissue perfusion.\nSaline lockonly, do not administerIV fluids.\n\u2022 Transport to appropriate hospital. Pediatric patients identified as CTPwill be transported\nto a Pediatric Trauma Center whenthere is lessthan a 20 minute difference in transport\ntime to the Pediatric Trauma Center versus the closes Trauma Center.\nA. Manage Special Considerations\n\u2022 Consider PushDoseEpi for persistent shockdue to trauma where cardiac arrest\n\u2022 Spinal Motion Restriction : LALSpersonnel should removeLBB devices frompatients placed in fullspinal motion restriction precautions by first responders and\nBLSpersonnel if the patient does not meetany of the following indicators while\nconsideringage-appropriate assessments whenusing the acronym (NSAID):\nN-euroDeficit(s) present?\nS-pinal Tenderness present?\nA-ltered Mental Status?\nI-ntoxication?\nD-istracting Injury?\n\u2022 Impaled Object: Remove object upontrauma basehospital physician order, if\nindicated.\nB. Determination of Death on Scene: Refer to ICEMA - Determination\nof Death on Scene.\n\u25cf Severe Blunt Force Trauma Arrest: If indicated, transport to the closest receiving\nhospital.\n\u25cf Penetrating Trauma Arrest: If indicated, transport to the closest receiving\nhospital.",
    "html": "<ul class='proto'><li>\u2022 Traumatic Arrest: CPR if indicated.</li><li>Mayutilize an AED if indicated.</li><li>\u2022 Determination of Death on Scene: Refer to ICEMA -</li><li>Determination of Death on Scene.</li><li>III.</li><li>LIMITEDALS (LALS) INTERVENTIONS</li><li>\u2022 Perform identifiedBLS interventions and additional LALSinterventions.</li><li>\uf0d8 Unmanageable Airway: When an adequate airway cannot be maintained by a</li><li>BVMdevice, transport to the closest mostappropriate receiving hospital.</li><li>\u2022 IVAccess (warmIV fluids whenavailable).</li><li>\uf0d8 Unstable: Vital signs (ageappropriate) and/or signs of inadequate tissue</li><li>perfusion, start 2nd IVaccess.</li><li>Administer <b>20 ml/kg</b>NSbolusIV.</li><li>\uf0d8 Stable: Vital signs (ageappropriate) and/or signs of adequate tissue perfusion.</li><li>Saline lockonly, do not administerIV fluids.</li><li>\u2022 Transport to appropriate hospital.</li><li>Pediatric patients identified as CTPwill be transported</li><li>to a Pediatric Trauma Center whenthere is lessthan a 20 minute difference in transport</li><li>time to the Pediatric Trauma Center versus the closes Trauma Center.</li><li>A.</li><li>Manage Special Considerations</li><li>\u2022 Consider PushDoseEpi for persistent shockdue to trauma where cardiac arrest</li><li>\u2022 Spinal Motion Restriction : LALSpersonnel should removeLBB devices frompatients placed in fullspinal motion restriction precautions by first responders and</li><li>BLSpersonnel if the patient does not meetany of the following indicators while</li><li>consideringage-appropriate assessments whenusing the acronym (NSAID):</li><li>N-euroDeficit(s) present?</li><li>S-pinal Tenderness present?</li><li>A-ltered Mental Status?</li><li>I-ntoxication?</li><li>D-istracting Injury?</li><li>\u2022 Impaled Object: Remove object upontrauma basehospital physician order, if</li><li>indicated.</li><li>B.</li><li>Determination of Death on Scene: Refer to ICEMA - Determination</li><li>of Death on Scene.</li><li>\u25cf Severe Blunt Force Trauma Arrest: If indicated, transport to the closest receiving</li><li>hospital.</li><li>\u25cf Penetrating Trauma Arrest: If indicated, transport to the closest receiving</li><li>hospital.</li></ul>"
  },
  {
    "drug": "TRAUMA",
    "population": "Pediatric",
    "page": 320,
    "text": "\u2022 If the patient does not meet the \u201cObvious Death Criteria\u201d in ICEMA  - Determination of Death on Scene, contact the Trauma basehospital for\ndetermination of death on scene for those patientswho suffer a traumatic cardiac\narrest in the setting of penetrating trauma, and no reported vital signs (palpable\npulse and/or spontaneous respirations) during the EMSencounter with the\npatient.\n\u2022 Resuscitation efforts on a penetrating traumatic arrest victimare not to be\nterminated without trauma basehospital contact.\n\u2022 Precautions and Comments:\n\uf0d8 Electrical injuries thatresult in cardiac arrest shall be treated as medical\narrests.\n\uf0d8 Confirmlow blood sugar in children and treat as indicated withaltered\nlevel of consciousness.\n\uf0d8 Suspect child maltreatment whenphysical findingsare inconsistent with\nthe history. Remember reporting requirements for suspected child\nmaltreatment.\n\uf0d8 Unsafe scenemay warrant transport despitelow potential for survival.\nIV. ALSINTERVENTIONS\n\u2022 Perform identifiedBLS and LALSinterventions and the additionalALS interventions.\n\u2022 Establish advanced airway as indicatedper ICEMA -Procedure -\nStandard Orders.\n\uf0d8 Unmanageable Airway: If an adequate airway cannot be maintained with a BVMdevice; and the paramedic is unable to intubate, insertSGA or perform a\nsuccessful needle cricothyrotomy (if indicated), then transport to the closest\nreceiving hospital and follow ICEMA - Continuation of Care.\n\u2022 EstablishIV/IOAccess (warmIV fluids whenavailable).\n\uf0d8 Unstable: Vital signs (ageappropriate) and/or signs of inadequate tissue\nperfusion, start 2nd IVaccess.\nAdminister 20 ml/kgNSbolusIV.\n\uf0d8 Stable: Vital signs (ageappropriate) and/or signs of adequate tissue perfusion.\nSaline lockonly, do not administerIV fluids.\n\u2022 MonitorECG.\n\u2022 Insert nasogastric/orogastric tube as indicated.",
    "html": "<ul class='proto'><li>\u2022 If the patient does not meet the \u201cObvious Death Criteria\u201d in ICEMA  - Determination of Death on Scene, contact the Trauma basehospital for</li><li>determination of death on scene for those patientswho suffer a traumatic cardiac</li><li>arrest in the setting of penetrating trauma, and no reported vital signs (palpable</li><li>pulse and/or spontaneous respirations) during the EMSencounter with the</li><li>patient.</li><li>\u2022 Resuscitation efforts on a penetrating traumatic arrest victimare not to be</li><li>terminated without trauma basehospital contact.</li><li>\u2022 Precautions and Comments:</li><li>\uf0d8 Electrical injuries thatresult in cardiac arrest shall be treated as medical</li><li>arrests.</li><li>\uf0d8 Confirmlow blood sugar in children and treat as indicated withaltered</li><li>level of consciousness.</li><li>\uf0d8 Suspect child maltreatment whenphysical findingsare inconsistent with</li><li>the history.</li><li>Remember reporting requirements for suspected child</li><li>maltreatment.</li><li>\uf0d8 Unsafe scenemay warrant transport despitelow potential for survival.</li><li><b>IV</b>.</li><li>ALSINTERVENTIONS</li><li>\u2022 Perform identifiedBLS and LALSinterventions and the additionalALS interventions.</li><li>\u2022 Establish advanced airway as indicatedper ICEMA -Procedure -</li><li>Standard Orders.</li><li>\uf0d8 Unmanageable Airway: If an adequate airway cannot be maintained with a BVMdevice; and the paramedic is unable to intubate, insertSGA or perform a</li><li>successful needle cricothyrotomy (if indicated), then transport to the closest</li><li>receiving hospital and follow ICEMA - Continuation of Care.</li><li>\u2022 EstablishIV/IOAccess (warmIV fluids whenavailable).</li><li>\uf0d8 Unstable: Vital signs (ageappropriate) and/or signs of inadequate tissue</li><li>perfusion, start 2nd IVaccess.</li><li>Administer <b>20 ml/kg</b>NSbolusIV.</li><li>\uf0d8 Stable: Vital signs (ageappropriate) and/or signs of adequate tissue perfusion.</li><li>Saline lockonly, do not administerIV fluids.</li><li>\u2022 MonitorECG.</li><li>\u2022 Insert nasogastric/orogastric tube as indicated.</li></ul>"
  },
  {
    "drug": "BURNS",
    "population": "Pediatric",
    "page": 324,
    "text": "\u2022 IV/IOAccess (warmIV fluids whenavailable).\n\uf0d8 Unstable: Vital signs (ageappropriate) and/or signs of inadequate tissue\nperfusion consider starting a secondIV or saline lock. Administer 20 ml/kgNSbolusIV/IO, mayrepeatone (1) time.\n\uf0d8 Stable: Vital signs (ageappropriate) and/or signs of adequate tissue perfusion.\n\uf0d8 Lessthan 5 years of age: IVNS 150 mlper hour\n\uf0d8 Morethan 5 years of age - Lessthan 15 years of age: IVNS 250 mlper hour\n\u2022 Transport to appropriate facility:\n\uf0d8 Critical trauma patients withassociated burns or burnpatients sustaining critical\ntrauma, should be transported to the closest Trauma Center. Trauma basehospital contacted shall be made.\n\u2022 Refer to SectionV - BurnClassifications below.\nA. Manage Special Considerations\n\u2022 Respiratory Distress:\n\uf0d8 Administer humidified oxygen, if available.\n\u2022 Deteriorating Vital Signs: Transport to the closest receiving hospital. Contact\nbasehospital.\n\u2022 Pulseness and Apneic: Transport to the closest receiving hospital and treat\naccording to ICEMA protocols. Contact basehospital.\n\u2022 Determination of Death on Scene: Refer to ICEMA -\nDetermination of Death on Scene.\n\u2022 Precautions and Comments:\n\uf0d8 Contact withappropriate advisory agencymay be necessary for\nhazardous materials, before decontamination or patient contact.\n\uf0d8 Do not applyice or icewater directly to skinsurfaces as additional injury\nwillresult.\n\uf0d8 Do not apply cooldressings or allow environmental exposure, since\nhypothermia willresult in a young child.\nIV. ALSINTERVENTIONS\n\u2022 Perform activities identified in the BLS and LALSInterventions.\n\u2022 Establish advanced airway as clinically indicatedper ICEMA -\nProcedure - Standard Orders for patientswho aretaller than the maximum length of a",
    "html": "<ul class='proto'><li>\u2022 <b>IV</b>/IOAccess (warmIV fluids whenavailable).</li><li>\uf0d8 Unstable: Vital signs (ageappropriate) and/or signs of inadequate tissue</li><li>perfusion consider starting a secondIV or saline lock.</li><li>Administer <b>20 ml/kg</b>NSbolusIV/<b>IO</b>, mayrepeatone (1) time.</li><li>\uf0d8 Stable: Vital signs (ageappropriate) and/or signs of adequate tissue perfusion.</li><li>\uf0d8 Lessthan 5 years of age: IVNS <b>150 ml</b>per hour</li><li>\uf0d8 Morethan 5 years of age - Lessthan 15 years of age: IVNS <b>250 ml</b>per hour</li><li>\u2022 Transport to appropriate facility:</li><li>\uf0d8 Critical trauma patients withassociated burns or burnpatients sustaining critical</li><li>trauma, should be transported to the closest Trauma Center.</li><li>Trauma basehospital contacted shall be made.</li><li>\u2022 Refer to SectionV - BurnClassifications below.</li><li>A.</li><li>Manage Special Considerations</li><li>\u2022 Respiratory Distress:</li><li>\uf0d8 Administer humidified oxygen, if available.</li><li>\u2022 Deteriorating Vital Signs: Transport to the closest receiving hospital.</li><li>Contact</li><li>basehospital.</li><li>\u2022 Pulseness and Apneic: Transport to the closest receiving hospital and treat</li><li>according to ICEMA protocols.</li><li>Contact basehospital.</li><li>\u2022 Determination of Death on Scene: Refer to ICEMA -</li><li>Determination of Death on Scene.</li><li>\u2022 Precautions and Comments:</li><li>\uf0d8 Contact withappropriate advisory agencymay be necessary for</li><li>hazardous materials, before decontamination or patient contact.</li><li>\uf0d8 Do not applyice or icewater directly to skinsurfaces as additional injury</li><li>willresult.</li><li>\uf0d8 Do not apply cooldressings or allow environmental exposure, since</li><li>hypothermia willresult in a young child.</li><li><b>IV</b>.</li><li>ALSINTERVENTIONS</li><li>\u2022 Perform activities identified in the BLS and LALSInterventions.</li><li>\u2022 Establish advanced airway as clinically indicatedper ICEMA -</li><li>Procedure - Standard Orders for patientswho aretaller than the maximum length of a</li></ul>"
  },
  {
    "drug": "BURNS",
    "population": "Pediatric",
    "page": 327,
    "text": "\u201cRule of Nines\u201d\nVI. REFERENCES\nNumber Name\n9030 Destination\n10010 Determination of Death on Scene\n11020 Procedure - Standard Orders\nINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nNEWBORN CAREI. FIELD ASSESSMENT/TREATMENT INDICATORS\n\u2022 Field delivery with or without complications.\nII. BLSINTERVENTIONS\n\u2022 Whenhead is delivered, suction mouth then the nose, and check to seethat cord is not\naround baby\u2019sneck.\n\u2022 Dryinfant and provide warmenvironment. Prevent heatloss (removewet towel).\n\u2022 Place baby in supine position at or near the level of the mother\u2019svagina. After pulsation\nof cordhas ceased double clamp cord at approximately seven (7) inches and ten (10)\ninches frombaby and cutbetween clamps.\n\u2022 Maintain airway, suction mouth and nose.\n\u2022 Provide tactile stimulation to facilitate respiratory effort.\n\u2022 Assess breathing if respirations lessthan 20 or gasping, provide tactile stimulation and\nassisted ventilation if indicated.\n\u2022 Circulation:\n\uf0d8 Heart Rateless than 100 ventilateBVM with 100% oxygen for 30 seconds and\nreassess. If heart rate is still lessthan 100 perminute butgreater than 60,\nreevaluateBVM and reposition airway.\n\uf0d8 If heart rate is lessthan 60 bpmafter above interventions, begin compressions\nwithventilations at a 3:1 ratio (approximately 100 compressions and 30\nventilationsper minute).\n\u2022 If central cyanosis is present, utilize supplemental oxygen at 10 to 15 Lperminute using\noxygen tubing close to infant\u2019snose and reassess. If no improvement is noted after 30\nseconds assist ventilation withBVM.\n\u2022 Obtain Apgar scoring at one (1) and five (5) minutes. Do not useApgar to determine\nneed to resuscitate.\nAPGAR SCORE\nSIGN 0 1 2\nHeart RateAbsent Lessthan 100 perminute Morethan 100 perminute\nRespirations Absent Lessthan 20 or irregular Morethan 20 or crying\nMuscle ToneLimp SomeFlexion Active Motion\nReflex Irritability No Response Grimace Cough or Sneeze\nColor Blue or paleBlue Extremities Completely PinkNEWBORN CAREReference No. 14200\nIII. LIMITEDALS (LALS) INTERVENTIONS\n\u2022 Perform activities identified in the BLSInterventions.\n\u2022 Obtain vascular accessviaIV if indicated.\n\u2022 Obtain blood glucose by heelstick.\n\uf0d8 If blood glucose lessthan 35 mg/dL, administer Dextroseper ICEMA ReferenceIV. ALSINTERVENTIONS\n\u2022 Perform activities identified in the BLS and LALSInterventions.\n\u2022 Obtain vascular accessviaIV/IO if indicated.\n\u2022 If BVM is ineffective or tracheal suctioning is required, utilize waveform capnography to\nassess efficacy of compressions and ventilations. Place orogastric tube.\n\u2022 Obtain blood glucose by heelstick.\n\uf0d8 If blood glucose lessthan 35 mg/dL, administer Dextroseper ICEMA Reference\n\u2022 Evaluate airway for hypoxemia and assess bodytemperature for hypothermia then\nheart rateless than 60 afterone (1) minute.\n\u2022 Contact basehospital if hypovolemia is suspected. Basehospital mayorder 10 ml/kgIVNSover five (5) minutes. If unable to contact basehospital and transport time is\nextended, administer 10 ml/kgIVNSover five (5) minutes, mayrepeat.\n\u2022 For persistent hypotension despite adequate ventilation and fluid resuscitation, basehospitalmay order Epinephrineper ICEMA - Medication - Standard\nOrders, everyten (10) minutes. If unable to contact basehospital and transport time is\nextended, giveindicated dosage and contact basehospital as soon as possible.\nV. REFERENCE\nNumber NameINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nOBSTETRICAL EMERGENCIESI. FIELD ASSESSMENT/TREATMENT INDICATORS\n\u2022 Obstetrical emergencies (field delivery) with or without complications.\nII. BLSINTERVENTIONS\nUNCOMPLICATED DELIVERY\n\u2022 Administer oxygen as clinically indicated.\n\u2022 Prepare for delivery.\n\u2022 Massage fundus if placenta delivered.\nCOMPLICATED DELIVERY\n\u2022 Excessive vaginal bleeding prior to delivery:\n\uf0d8 Attempt to control bleeding. Do not place anything intovagina.\n\uf0d8 Place in trendelenburg position.\n\u2022 Prolapsed Cord:\n\uf0d8 Elevate hips.\n\uf0d8 Gently pushpresenting part of headaway fromcord.\n\uf0d8 Consider knee/chest position for mother.\n\u2022 Postpartum Hemorrhage:\n\uf0d8 Massage fundus to control bleeding.\n\uf0d8 Encourage immediate breast feeding.\n\uf0d8 Place in trendelenburg position.\n\u2022 Cordaround infant\u2019sneck:\n\uf0d8 Attempt to slipcord over the head.\n\uf0d8 If unable to slipcord over the head, deliver the babythrough the cord.\n\uf0d8 If unable to deliver the babythrough the cord, double clamp cord, then cutcord\nbetween clamps.\n\u2022 Breech presentation and head not delivered within three (3) to four (4) minutes:\n\uf0d8 Administer oxygen.\nOBSTETRICAL EMERGENCIES\n\uf0d8 Place in trendelenburg position.\n\uf0d8 Transport Code 3 to closest appropriate facility.\n\u2022 Pregnancy Induced Hypertension and/or Eclampsia:\n\uf0d8 Initiate and maintain seizure precautions.\n\uf0d8 Attempt to reduce stimuli.\n\uf0d8 Limit fluid intake.\n\uf0d8 Monitor and document blood pressure.\n\uf0d8 Consider leftlateral position.\nIII. LIMITEDALS (LALS) INTERVENTIONS\nCOMPLICATED DELIVERY\n\u2022 ObtainIV access, and maintainIV rate as appropriate.\n\u2022 Excessive vaginal bleeding or post-partum hemorrhage:\n\uf0d8 Administer fluid challenge of 500 ml, if signs of inadequate tissue perfusion\npersistmay repeat fluid bolus.\n\uf0d8 MaintainIV rate at 150 mlper hour.\nEstablish second large boreIV enroute.\n\u2022 Pregnancy Induced Hypertension and/or Eclampsia:\n\uf0d8 IVTKO, limit fluid intake.\n\uf0d8 Obtain O2 saturation on roomair, if possible.\n\uf0d8 Place in leftlateral position, and obtain blood pressure after five (5) minutes.\n\u2022 Consider immediate notification of basehospital physician.\nIV. ALSINTERVENTIONS\nCOMPLICATED DELIVERY\n\u2022 ObtainIV access, and maintainIV rate as appropriate.\n\u2022 Excessive vaginal bleeding or post-partum hemorrhage:\n\uf0d8 Administer fluid challenge of 500 ml. If signs of inadequate tissue perfusion\npersistmay repeat fluid bolus.\n\uf0d8 MaintainIV rate at 150 mlper hour.\n\uf0d8 Establish second large boreIV enroute.\nOBSTETRICAL EMERGENCIES\n\u2022 Pregnancy induced hypertension:\n\uf0d8 AdministerIVTKO. Limit fluid intake.\n\uf0d8 Obtain O2 saturation on roomair, if possible.\n\uf0d8 Place in leftlateral position, and obtain blood pressure after five (5) minutes.\n\uf0d8 Obtain rhythm strip withcopy to receiving hospital.\n\u2022 Eclampsia (Seizure/Tonic/Clonic Activity):\n\uf0d8 Administer Magnesium Sulfateper ICEMA - Medication -\nStandard Orders.\n\uf0d8 Administer Midazolamper ICEMA - Medication - Standard\nOrders.\n\u2022 Consider immediate notification of basehospital physician.\nPOSTPARTUM HEMMORHAGE (basehospital order only)\n\u2022 Tranexamic Acid (TXA) administration:\n\uf0d8 Must be within three (3) hours of onset and musthave either:\n\uf0d8 Signs and symptoms of hemorrhagic shock withSBP lessthan 90 mm\n\uf0d8 Significant hemorrhage withheart rategreater than or equal to 120.\nV. REFERENCE\nNumber NameINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nNAUSEA AND VOMITINGI. FIELD ASSESSMENT/TREATMENT INDICATORS\n\u2022 Nausea.\n\u2022 Vomiting.\n\u2022 Prophylactic treatment of narcotic induced nausea and/or vomiting.\nII. CONTRAINDICATIONS\nPatients under four (4) years of age.\nKnown sensitivity to Ondansetron or other 5-HT3 antagonists:\n\u2022 Granisetron (Kytril)\n\u2022 Dolasetron (Anzemet)\n\u2022 Palonosetron (Aloxi)\nIII. ALSINTERVENTIONS\n\u2022 Assess patient for need for anti-emetic therapy.\n\u2022 Maintain airway.\n\u2022 Position of comfort.\n\u2022 Oxygen.\n\u2022 Cardiac monitoring in patients withhistory of cardiac problems.\nIV. DOCUMENTATION\nDocument patient response.\nV. REFERENCE\nNumber NameINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nSHOCK (NON-TRAUMATIC)\nI. FIELD ASSESSMENT/TREATMENT INDICATORS\n\u2022 Patient exhibits signs/symptoms of profound shock and hypotension with a SBP of lessthan 90 mmHg for adults and a SBPless than 70 mmHg for pediatrics.\n\u2022 Determine history of illness.\n\u2022 History of GIbleeding, vomiting, diarrhea, fever/sepsis or vaginal bleeding.\n\u2022 PostROSC for Out of Hospital Cardiac Arrest (OHCA).\n\u2022 Consider hypoglycemia or narcotic overdose.\nII. LIMITEDALS (LALS) INTERVENTIONS\n\u2022 Maintain airway withappropriate adjuncts, including perilaryngeal airway adjunct if\nindicated.\n\u2022 Obtain oxygen saturation on roomair or on homeoxygen if possible.\n\u2022 PlaceAED pads on patient as precaution in event patient goesinto sudden cardiac\narrest.\n\u2022 Obtain vascular access.\n\u2022 If hypotensive or havesigns or symptoms of inadequate tissue perfusion, administer fluid\nchallenges:\n\uf0d8 ADULT\n\uf0a7 Administer 500 mlIVbolus, mayrepeatone (1) timeuntil tissue perfusion\nimproves\n\uf0d8 PEDIATRIC\nAdminister 20 ml/kgIVbolus, mayrepeatone (1) time for tachycardia, change in\ncentral/peripheral pulses or altered level of consciousness.\n\u2022 For patients with no respiratory difficulties and adequate signs of tissue perfusion:\n\uf0d8 ADULT/PEDIATRIC\n\uf0a7 MaintainIV at TKO.\nIII. ALSINTERVENTIONS\n\u2022 Perform activities identified in LALSInterventions.\n\u2022 Maintain airway withappropriate adjuncts, including advanced airway if indicated. Obtain\noxygen saturation on roomair or on homeoxygen if possible.\nSHOCK (NON-TRAUMATIC\n\u2022 Place on cardiac monitor.\n\u2022 Obtain vascular access.\n\u2022 If hypotensive or hassigns or symptoms of inadequate tissue perfusion, administer fluid\nchallenges:\n\uf0d8 ADULT\n\uf0a7 Administer 500 mlIVbolus, mayrepeatone (1) time to sustain a SBP of\nmorethan 90 mmHg or until tissue perfusion improves.\nIf no response to fluid administration, stopfluids and administer PushDose Epinephrine\n\uf0d8 PEDIATRIC\n\uf0a7 Administer 20 ml/kgIVbolus, mayrepeatone (1) time for tachycardia,\nchange in central/peripheral pulses or altered level of consciousness.\n\uf0a7 If no response to fluid administration, stopfluids and administer PushDoseEpinephrine perICEMA - Medication - Standard\nOrders.\n\u2022 For postpartum hemorrhage withcontinued signs of inadequate tissue perfusion, not\nresponsive to fluid challenge consider administration of TXA (basehospital order) per\n\uf0d8 Must be within three (3) hours of onset and musthave either:\n\uf0d8 Signs and symptoms of hemorrhagic shock withSBP lessthan 90 mmHg.\n\uf0d8 Significant hemorrhage withheart rategreater than or equal to 120.\n\u2022 For adults withsustainedSBP of morethan 90 mmHg, pediatrics withsustainedSBP\nmorethan 70 mmHg, no respiratory difficulties and adequate signs of tissue perfusion:\n\uf0d8 ADULT\n\uf0a7 MaintainIV at TKO.\n\uf0d8 PEDIATRIC\n\uf0a7 MaintainIV at TKO.\nBaseHospital MayOrder\n\u2022 Establish 2nd large boreIV enroute.\nIV. REFERENCE\nNumber NameINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nSUSPECTED ACUTE MYOCARDIAL INFARCTION (AMI)\nI. FIELD ASSESSMENT/TREATMENT INDICATORS\n\u2022 Chest pain (typical or atypical).\n\u2022 Syncopal episode.\n\u2022 History of previousAMI, Angina, heart disease, or other associated riskfactors.\nII. BLSINTERVENTIONS\n\u2022 Recognition of signs/symptoms of suspectedAMI.\n\u2022 Reduce anxiety, allow patient to assume position of comfort.\n\u2022 Oxygen as clinically indicated.\n\u2022 Obtain oxygen saturation.\n\u2022 Mayassist patient withself-administration of Nitroglycerin and/or Aspirin.\nIII. LIMITEDALS (LALS) INTERVENTIONS\n\u2022 Consider early vascular access.\n\u2022 For patients withchest pain, signs of inadequate tissue perfusion and clear breath\nsounds, administer 300 mlNSbolus, mayrepeat.\n\u2022 Consider establishing a saline lockenroute on sameside as initialIV.\n\u2022 Complete thrombolytic checklist, if timepermits.\n\u2022 Contact basehospital.\nIV. ALSINTERVENTIONS\n\u2022 Consider early vascular access.\n\u2022 For patients withchest pain, signs of inadequate tissue perfusion and clear breath\nsounds, administer 300 mlNSbolus, mayrepeat.\nSUSPECTED ACUTE MYOCARDIAL INFARCTION\n(AMI)\n\u2022 12-LeadTechnology:\n\uf0d8 Obtain 12-leadECG. Do not disconnect 12-leadcables until necessary for\ntransport.\n\uf0d8 If signs of inadequate tissue perfusion or if inferior wallinfarct is suspected,\nobtain a right-sided 12-lead (V4R).\n\uf0d8 If right ventricular infarct (RVI) is suspected withsigns of inadequate tissue\nperfusion, consider 300 mlNSbolus, mayrepeat. Early consultation withbase\nhospital or receiving hospital in rural areas is recommended. (Nitratesare\ncontraindicated in the presence of RVI or hypotension.)\n\uf0d8 Withdocumented STsegment elevation in two (2) or morecontiguous leads\nmakeearly STEMI notification to the STEMI Receiving Center while preparing\npatient for expeditious transport, refer to ICEMA - STElevation\nMyocardial Infarction Critical CareSystem Designation (SanBernardino County\nOnly). In Inyo and MonoCounties, the assigned basehospital should be\ncontacted for STEMI consultation.\n\uf0d8 Repeat 12-leadECG at regular intervals, but do not delay transport of patient. If\npatient is placed on a different cardiac monitor for transport, transporting provider\nshould obtain an initial 12-lead on their cardiac monitor and leave 12-leadcables\nin place throughout transport.\n\uf0d8 EMSfield personnel shall ensure that a copy of the 12-leadECG is uploaded or\nattached as a permanent part of the patient\u2019sePCR.\nFentanyl for cardiac chest paincontrol whenNitroglycerin is contraindicated.\nconcurrent administration of Nitroglycerin withFentanyl if there is no cardiac chest painrelief from the initial Nitroglycerin administration. Contact basehospital for further\nFentanyl orders.\n\u2022 Consider establishing a saline lock as a secondaryIV site.\nV. REFERENCES\nNumber Name\n4040 STElevation Myocardial Infarction Critical CareSystem Designation (SanBernardino County Only)\nINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nDETERMINATION OF DEATH ON SCENEI. PURPOSE\nTo identify situations when an EMT, AEMT or EMT-Pmay be called upon to determine death on\nscene.\nII. POLICY\nAn EMT, AEMT or EMT-Pmaydetermine death on scene if pulselessness and apneaare\npresent withany of the following criteria. The EMT-P is authorized to discontinueBLSCPR\ninitiated at scene if a patient falls into the category of obvious death. In anysituation where theremay be doubt as to the clinical findings of the patient, BLSCPR must be initiated and the basehospital contacted. Whendeath is determined, the County Coroner must be notified along with\nthe appropriatelaw enforcement agency.\nIII. DETERMINATION OF DEATH CRITERIA\n\u2022 Decomposition.\n\u2022 Obvious signs of rigor mortis such as rigidity or stiffening of muscular tissues and joints in\nthe body, which occursany timeafter death and usually appears in the head, face and\nneckmuscles first.\n\u2022 Obvious signs of venous pooling in dependent bodyparts, lividity such as mottled bluishtinged discoloration of the skin, often accompanied by coldextremities.\n\u2022 Decapitation.\n\u2022 Incineration of the torso and/or head.\n\u2022 Massive crush injury.\n\u2022 Penetrating injury withevisceration of the heart, and/or brain.\n\u2022 Gross dismemberment of the trunk.\nIV. SPECIAL CONSIDERATIONS\n\u2022 In the event that a patient progresses to cardio/pulmonary arrest while enroute to\nthe hospital in the setting of a completed and verified limitation of treatment\ndocument (POLST, DNR, Advanced Directive) the field provider should honor the\nwritten limitations and transport the patient to the closest receiving Emergency\nDepartment for a medical evaluation\u201d and \u201cThe BaseStation should advise crew to\nhonor patients wishes as verified in the valid limitations of treatment and transport\nto the closest receiving facility for medical evaluation without callingTOD\u201d.\n\u2022 A copy of the patient carereport must be madeavailable for the Coroner. Thiswill be\ntransmitted to them, whenposted, if the disposition is marked \u201cDead on Scene\u201d and the\nDestination is marked \u201cCoroner, SanBernardino County\u201d on the electronic patient carereport (ePCR).\nDETERMINATION OF DEATH ON SCENE\n\u2022 The completed ePCRmust be posted to the Coroner before the end of the shift.\n\u2022 If unable to post, the use of an approved paper patient carereport as a \u201cdowntime\u201d form is\npermitted by ICEMA - Requirements for Patient CareReports.\nDETERMINATION OF DEATH ON SCENE\nLIMITEDALS (LALS) PROCEDURE\n\u2022 Allterminated LALSresuscitation efforts musthave an AEDevent record attached to the\nePCR.\nALSPROCEDURE\n\u2022 Allpatients in ventricular fibrillation should be resuscitated on scene until ROSC is\nachieved. If patient remains in VF/VTafter 20 minutes of CPR, consult basehospital.\n\u2022 Severe blunt force trauma, pulseless, without signs of life (palpable pulses and/or\nspontaneous respirations) and cardiac electrical activity lessthan 40 bpm or duringEMS\nencounter with the patient meets Determination of Death criteria. AllterminatedALS\nresuscitation efforts musthave an ECGattached to the patient carereport.\n\u2022 Consider termination of resuscitation efforts in the prehospital setting if any of the criteria\naremet in the ICEMA - Cardiac Arrest - Adult.\nV. SUSPECTED SUDDEN INFANT DEATH SYNDROME (SIDS) INCIDENT\nIt is imperative thatall EMSfield personnel be able to assist the caregiver and local police\nagencies during a suspected SIDSincident.\nPROCEDURE\n\u2022 Follow individual department/agency policies at alltimes.\n\u2022 Askopen-ended questions about incident.\n\u2022 Explain whatyou aredoing, the proceduresyou willfollow, and the reasons for them.\n\u2022 If yoususpect a SIDSdeath, explain to the parent/caregiver whatSIDS is and, if this is a\nSIDSrelated death nothing theydid or did not do caused the death.\n\u2022 Provide the parent/caregiver with the number of the California SIDSInformation Line:\n1-800-369-SIDS (7437)\n\u2022 Provide psychosocial support and explain the emergency treatment and transport of their\nchild.\n\u2022 Assure the parent/caregiver thatyour activitiesare standard procedures for the\ninvestigation of alldeath incidents and thatthere is no suspicion of wrongdoing.\n\u2022 Document observations.\nVI. REFERENCES\nNumber Name\n5030 Requirements for Patient CareReports\n14050 Cardiac Arrest - Adult\nINLAND COUNTIES\nEMERGENCY MEDICAL AGENCYEND OF LIFECARE AND DECISIONSI. PURPOSE\nTo establish criteria thatrecognizes and accommodates a patient\u2019sdesignatedend of lifedirectives to limit prehospital treatment by Emergency Medical Service (EMS) field personnel in\nthe prehospital setting, long-termcare facilities, during transport between facilities and/or in the\npatient\u2019shome.\nII. POLICY\nEMSfield personnel shall makeall attempts to honor a patient\u2019send of lifewishes. In doingso,\nallefforts should be made to obtain and verify applicable forms describing the patient\u2019send of lifeinstructions and provideany necessary supportive measures.\nA Do Not Resuscitate (DNR) order onlyapplies to resuscitative measures. An order not to\nresuscitate is not an order to withhold other necessary medical treatments, nutrition or supportive\nmeasures. The treatment given to a patient with a DNRagreement should, in allrespects, be the\nsame as thatprovided to a patient without such an agreement.\nA patient withmedical decision making capacitycan request alternative treatment or revoke a\nDNR or POLST by anymeans thatindicates intent to revoke. A patientmay withdraw or rescind\ntheir request for an aid-in-dying drugregardless of their mental state at anytime.\nForms related to patient\u2019send of lifeinstructions thatEMS field personnelmay encounter include:\n\u2022 Statewide EMSA/California Medical Association (CMA) PrehospitalDNR form.\n\u2022 POLST form.\n\u2022 DNRmedallion, bracelet or necklace.\n\u2022 A Do Not Resuscitate Order in a patient\u2019schart dated and signed by the physician.\n\u2022 End of LifeOptions ActDirective and/or Final Attestation for An Aid-In-Dying Drug to EndMyLife in a Humane and Dignified Manner form.\nIII. VALIDATION CRITERIA\nEMSPrehospitalDNR\n\u2022 The EMSPrehospital DNRform should include the following to be considered valid:\n\uf0d8 Patient\u2019sname.\n\uf0d8 Signature of the patient or a legally recognized decision maker if the patient is\nunable to make or communicate informed healthcare decisions.\n\uf0d8 Signature of patients\u2019 physician, affirming that the patient/legal representativehas\ngiven informed consent to the DNRinstruction.\n\uf0d8 Allsignatures must be dated.\nEND OF LIFECARE AND DECISIONS\n\uf0d8 Correct identification of the patient is crucial. If the patient is unable to be\nidentified after a goodfaith attempt to identify the patient, a reliable witnessmay\nbe used to identify the patient.\n\u2022 In licensed healthcare facilities a DNRorder written by a physician shall be honored.\n\uf0d8 The staff musthave the patient\u2019schart with the DNRorder immediately available\nfor EMSfield personnel upontheir arrival.\n\uf0d8 The ordermay contain the words Do Not Resuscitate, No CPR, or No Code and\ncontain the patient\u2019sname and the date and signature\nof the physician.\nDNRMedallion, Bracelet or Necklace\n\u2022 The DNRmedallion/bracelet/necklace is made of metal with a\npermanently imprinted medical insignia. For the medallion or\nbracelet/necklace to be valid the following applies:\n\uf0d8 Patient must be physically wearing the DNRmedallion/\nbracelet/necklace.\n\uf0d8 Medallion/bracelet/necklace must be engraved with the\nwords \u201cDo Not ResuscitateEMS\u201d or \u201cCalifornia POLSTEMS\u201d, along with a tollfree emergency information\ntelephone number and a patient identification number.\nPhysician Order for LifeSaving Treatment (POLST)\n\u2022 The POLST does not replace the Advanced Directive and should be reviewed along withother documents whenavailable. The POLST:\n\uf0d8 Must be signed and dated by a physician, nurse practitioner or physician\nassistant acting under the supervision of a physician and within the scope of\npractice authorized by law.\n\uf0d8 Must be signed by the patient or decision maker.\n\uf0d8 Is not valid without signatures. Verbal or telephone ordersare acceptable withfollow-upsignature by the physician in accordance withfacility/community policy.\nThere should be a boxchecked indicatingwho the authorized healthcare provider\ndiscussed the POLST orders with. By signing the form, the healthcare provider\nacknowledges thatthese ordersare consistent with the patient\u2019smedical\ncondition and preferences.\nEnd of LifeOptions ActDirective\n\u2022 A terminallyill and competent patientmay elect to obtain medications to hasten their\nimminent death at a time and place of their choosing. Theymust satisfy extensive and\nstringent requirements as required by Californialaw to obtain an Aid-In-Dying Drug and\ncomplete a \u201cFinal Attestation For An Aid-In-Dying Drug to EndMy Life in a Humane and\nDignified Manner\u201d within 48 hours prior self-administration.\nEND OF LIFECARE AND DECISIONS\n\u2022 Thereare no standardized \u201cFinal Attestation For An Aid-In-Dying Drug to EndMy Life in a\nHumane and Dignified Manner\u201d formsbut the lawhas required specific information thatmust be in the final attestation. If available, EMSfield personnel should make a goodfaith effort to review and verify that the final attestation contains the following information:\n\uf0d8 The document is identified as a \u201cFinal Attestation For An Aid-In-Dying Drug to\nEndMy Life in a Humane and Dignified Manner\u201d.\n\uf0d8 Patient\u2019sname, signature and dated.\n\uf0d8 EMSfield personnel should review and verify that the \u201cFinal Attestation for An\nAid-In-Dying Drug to EndMy Life in a Humane and Dignified Manner\u201d is present.\n\uf0d8 Correctly identifies the patient\u2019sname, and is signed and dated by the patient or\ndesignated decision maker.\n\uf0d8 The Final Attestation for An Aid-In-Dying Drugmust be completed within 48 hours\nprior to taking the medications.\n\uf0d8 Obtain a copy of the final attestation and attach it to the electronic patient carerecord (ePCR) whenever possible.\n\uf0d8 There is no mandate for the patient to maintain the final attestation in close\nproximity of the patient.\n\uf0d8 If a copy of the final attestation is available, EMSfield personnel should confirm\nthe patient is the person named in the final attestation. Thiswill normally require\neither the presence of a form of identification or a witnesswho canreliably\nidentify the patient.\nIV. PROCEDUREDNR, Medallion/Bracelet/Neckless or POLST\nIn addition to the validation criteria, the following guidelinesare provided for EMSfield personnel\nwhenresponding to a patient withStandardized Patient-Designated Directives.\n\u2022 EMSfield personnel shall validate the DNRrequest, medallion/bracelet/necklace, or\nPOLST form. Patientmay withdrawany directive at anytime.\n\u2022 The POLSTmay be used for bothadults and pediatric patients.\n\u2022 BLSfield personnel shall continue resuscitative measures if a DNR or POLST cannot be\nvalidated.\n\u2022 LALS and ALSfield personnel shall contact a basehospital for direction if a DNR or\nPOLST cannot be validated or for conflicting requests by family members. WhileALS\nfield personnelare contacting the basehospital for direction, BLStreatment must be\ninitiated and continued. If contact cannot be made, resuscitative efforts shall continue.\n\u2022 If a patient states thatthey wishresuscitative measures, the request shall be honored.\n\u2022 If a family member requests resuscitative measures despite a validDNR or POLST,\ncontinue resuscitative measures until basehospital contact is made.\nEND OF LIFECARE AND DECISIONS\n\u2022 If patient is not in cardiac arrest and has a valid POLST form, EMSfield personnelmay\nprovide comfort measures as described in SectionB of the form.\n\u2022 The patient shall be transported to the hospital if comfort measuresare started by EMSfield personnel.\n\u2022 Directany questions or conflicts in transporting the patient to the basehospital.\n\u2022 EMSfield personnel shall attach a copy of the approvedDNR form or POLST form to the\npatient carereport, along withany other appropriate written documentation. The DNRformshould accompany the patient to the hospitalso that it may be incorporated into the\nmedical record at the receiving facility.\n\u2022 WhenDNR ordersare noted in medical records in licensed facilities, thatfact should be\nrecorded by the EMSprovider, along with the date of the order and the physician\u2019sname.\nIt should be noted on the ePCRthat a writtenDNR orderwas present including the name\nof the physician, datesigned and other appropriate information.\n\u2022 Allcircumstances surrounding the incident must be documented on the EMSpatient carereport. If EMSfield personnelare unable to copy the DNR or POLST form, the following\nshall be documented on the patient carereport:\n\uf0d8 Presence of DNR or POLST form.\n\uf0d8 Date of order.\n\uf0d8 Name of physicianwho signed form.\n\u2022 If a patient dies at home, and the patient is not under the care of Hospice, lawenforcement must be notified. In allcases, the coroner must be notified. Refer to ICEMA\n- Determination of Death On Scene.\n\u2022 If a patient expires in a licensed healthcare facility, the facilityhas the responsibility to\nmake the appropriate notification.\nEnd of LifeOptionsAct\nIn addition to the validation criteria, the following guidelinesare provided for EMSpersonnel whenresponding to a patientwho hasself-administered an aid-in-dying drug.\n\u2022 The lawoffers protections and exemptions for healthcare providersbut is not explicit\naboutEMS response for End of LifeOption Actpatients.\n\u2022 Provide supportive measures whenever possible.\n\u2022 Withhold resuscitative measures if patient is in cardiopulmonary arrest.\n\u2022 The patientmay withdraw or rescind their request for an aid-in-dying drugregardless of\nthe patient\u2019smental state at anytime. EMSfield personnelare encouraged to consult\nwiththeir basehospital whenever necessary.\n\u2022 Family membersmay be at the scene of a patientwho hasself-administered an aid-indying drug. If conflict arises as to resuscitation efforts, inform the family thatonlyEND OF LIFECARE AND DECISIONS\nsupportive measures will be provided according to the patient\u2019swishes and consider basehospital contact to attempt resolution.\n\u2022 Allcircumstances surrounding the incident must be documented on the EMSpatient carereport. If EMSfield personnelare unable to obtain a copy of the End of LifeOptionsAct\nFinal Attestation form, the following shall be documented on the patient carereport:\n\uf0d8 Presence of the End of LifeOptions ActAttestation form.\n\uf0d8 Date of order.\n\uf0d8 Name of physicianwho signed form.\n\u2022 If a patient dies at home and the patient is not under the care of Hospice, lawenforcement must be notified. In allcases, the coroner must be notified. Refer to ICEMA\n- Determination of Death On Scene.\n\u2022 If a patient expires in a licensed healthcare facility, the facilityhas the responsibility to\nmake the appropriate notification.\nV. SUPPORTIVE MEASURES\n\u2022 Medical interventions and/or treatment thatmay provide for the comfort, safety and dignity\nof the patient should be utilized.\n\u2022 The patient should receive palliative treatment for pain, dyspnea, major hemorrhage or\nother medical conditions.\n\u2022 Allowany family members/significant others to express their concerns and begin their\ngrieving process.\n\u2022 Unless a patient is actively dying, medical treatment for other conditions should not be\nwithheld.\nVI. REFERENCE\nNumber Name\n14250 Determination of Death On Scene\nINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY\nVENTRICULAR ASSIST DEVICE (VAD)\nI. PURPOSE\nTo establish guidelines for EMSfield personnel in the prehospital assessment, treatment and\ntransport of patientswho have a Ventricular Assist Device (VAD).\nII. FIELD ASSESSMENT/TREATMENT INDICATORS\n\u2022 The EMSfield personnel shall first assess the patient and not the device. Utilize the\nAmerican Heart Association\u2019sC-A-Brecommendations, withone (1) addition:\n\uf0d8 C-Circulation/Connections (Device)\n\uf0d8 A-Airway\n\uf0d8 B-Breathing\n\u2022 Clinical assessment of the patient is essential and the mostimportant clinical observation\n(i.e., level of consciousness, skinsigns, adequate perfusion).\n\u2022 Follow appropriate ICEMA protocols for the patients\u2019 condition.\n\u2022 Thereare no medication contraindications in relation to the VAD.\n\u2022 If defibrillation or cardioversion is necessary, follow the appropriate ICEMA protocol. The\npump is insulated, soelectrical therapy should not be an issue.\n\u2022 A patient with a VADmight not have a palpable pulse as this is a continuous flowdevice.\nHowever, they do have a heart rate and rhythm. The 12-leadECG or heart monitor willshow the patient\u2019snative heart rhythm and will not necessarily reflect the patient\u2019scirculatory function. Treat arrhythmias according to ICEMA protocols, except for chest\ncompressions.\n\u2022 Waveform capnography monitoring is appropriate as pulse oximetrymay not be\nmeasurable or it may be inaccurate.\n\u2022 VADpatientsmay not have a systolic and diastolic blood pressure obtainable by standard\nmethods using a manual or automatic blood pressure cuff. It may be possible to\nauscultate. The meanarterial blood pressure (MAP) typical range is 70 - 90 mmHg. To\ncalculate the MAP, use the formula below:\nVENTRICULAR ASSIST DEVICE (VAD)\nIII. PROCEDURE\n\u2022 A patient with a VADwill mostlikely have a trained companion withthem. The\ncompanion is familiar with the VAD and emergency troubleshooting. The companion\nshould accompany the patient during transport and be responsible for the VADwhenever\npossible.\n\u2022 VADpatients and their companionsare taught to call 9-1-1 in an emergency, then page\nthe on callVAD Coordinator immediately. The VADCoordinator willtypically be on the\ntelephone to provide additional assistance to the EMSfield personnel whenthey arrive.\n\u2022 Contact information for the VADCoordinator and the VADImplant Center is usually\nattached to or located inside the patients\u2019 VADequipmentbag.\n\u2022 Whentransporting these patients to the appropriate hospital, the VADemergencybag,\npower module, power baseunit, batteries, charger, and backup controller mustall be\nbrought to the hospital.\n\u2022 Transport decision must be made by both the on callVAD Coordinator and the basehospital, typically transported to the nearest appropriateVAD Implant Center (LomaLinda\nUniversity Medical Center in ICEMA region), withpreference given to their implanting\ncenter whenever possible.\nNOTE: If the paramedic on scenehas assessed the patient and observed the following:\n\u2022 The patient is unresponsive and is asystole on the cardiac monitor, and\n\u2022 Allconnections to the device havebeen assessed and not producing a \u201chum\u201d over the\napex of the heart uponauscultation, and\n\u2022 Waveform Capnography is lessthan 10 and MAP is lessthan 50, then chest\ncompressionscan be performed as a lastresort for patient condition.\nINLAND COUNTIES\nEMERGENCY MEDICAL AGENCY Supersedes: N/A",
    "html": "<ul class='proto'><li>\u201cRule of Nines\u201d</li><li>VI.</li><li>REFERENCES</li><li>Number Name</li><li>9030 Destination</li><li>10010 Determination of Death on Scene</li><li>11020 Procedure - Standard Orders</li><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>NEWBORN CAREI.</li><li>FIELD ASSESSMENT/TREATMENT INDICATORS</li><li>\u2022 Field delivery with or without complications.</li><li>II.</li><li>BLSINTERVENTIONS</li><li>\u2022 Whenhead is delivered, suction mouth then the nose, and check to seethat cord is not</li><li>around baby\u2019sneck.</li><li>\u2022 Dryinfant and provide warmenvironment.</li><li>Prevent heatloss (removewet towel).</li><li>\u2022 Place baby in supine position at or near the level of the mother\u2019svagina.</li><li>After pulsation</li><li>of cordhas ceased double clamp cord at approximately seven (7) inches and ten (10)</li><li>inches frombaby and cutbetween clamps.</li><li>\u2022 Maintain airway, suction mouth and nose.</li><li>\u2022 Provide tactile stimulation to facilitate respiratory effort.</li><li>\u2022 Assess breathing if respirations lessthan 20 or gasping, provide tactile stimulation and</li><li>assisted ventilation if indicated.</li><li>\u2022 Circulation:</li><li>\uf0d8 Heart Rateless than 100 ventilateBVM with 100% oxygen for 30 seconds and</li><li>reassess.</li><li>If heart rate is still lessthan 100 perminute butgreater than 60,</li><li>reevaluateBVM and reposition airway.</li><li>\uf0d8 If heart rate is lessthan 60 bpmafter above interventions, begin compressions</li><li>withventilations at a 3:1 ratio (approximately 100 compressions and 30</li><li>ventilationsper minute).</li><li>\u2022 If central cyanosis is present, utilize supplemental oxygen at 10 to 15 Lperminute using</li><li>oxygen tubing close to infant\u2019snose and reassess.</li><li>If no improvement is noted after 30</li><li>seconds assist ventilation withBVM.</li><li>\u2022 Obtain Apgar scoring at one (1) and five (5) minutes.</li><li>Do not useApgar to determine</li><li>need to resuscitate.</li><li>APGAR SCORE</li><li>SIGN 0 1 2</li><li>Heart RateAbsent Lessthan 100 perminute Morethan 100 perminute</li><li>Respirations Absent Lessthan 20 or irregular Morethan 20 or crying</li><li>Muscle ToneLimp SomeFlexion Active Motion</li><li>Reflex Irritability No Response Grimace Cough or Sneeze</li><li>Color Blue or paleBlue Extremities Completely PinkNEWBORN CAREReference No.</li><li>14200</li><li>III.</li><li>LIMITEDALS (LALS) INTERVENTIONS</li><li>\u2022 Perform activities identified in the BLSInterventions.</li><li>\u2022 Obtain vascular accessviaIV if indicated.</li><li>\u2022 Obtain blood glucose by heelstick.</li><li>\uf0d8 If blood glucose lessthan <b>35 mg</b>/dL, administer Dextroseper ICEMA ReferenceIV.</li><li>ALSINTERVENTIONS</li><li>\u2022 Perform activities identified in the BLS and LALSInterventions.</li><li>\u2022 Obtain vascular accessviaIV/<b>IO</b> if indicated.</li><li>\u2022 If BVM is ineffective or tracheal suctioning is required, utilize waveform capnography to</li><li>assess efficacy of compressions and ventilations.</li><li>Place orogastric tube.</li><li>\u2022 Obtain blood glucose by heelstick.</li><li>\uf0d8 If blood glucose lessthan <b>35 mg</b>/dL, administer Dextroseper ICEMA Reference</li><li>\u2022 Evaluate airway for hypoxemia and assess bodytemperature for hypothermia then</li><li>heart rateless than 60 afterone (1) minute.</li><li>\u2022 Contact basehospital if hypovolemia is suspected.</li><li>Basehospital mayorder <b>10 ml/kg</b>IVNSover five (5) minutes.</li><li>If unable to contact basehospital and transport time is</li><li>extended, administer <b>10 ml/kg</b>IVNSover five (5) minutes, mayrepeat.</li><li>\u2022 For persistent hypotension despite adequate ventilation and fluid resuscitation, basehospitalmay order Epinephrineper ICEMA - Medication - Standard</li><li>Orders, everyten (10) minutes.</li><li>If unable to contact basehospital and transport time is</li><li>extended, giveindicated dosage and contact basehospital as soon as possible.</li><li>V.</li><li>REFERENCE</li><li>Number NameINLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>OBSTETRICAL EMERGENCIESI.</li><li>FIELD ASSESSMENT/TREATMENT INDICATORS</li><li>\u2022 Obstetrical emergencies (field delivery) with or without complications.</li><li>II.</li><li>BLSINTERVENTIONS</li><li>UNCOMPLICATED DELIVERY</li><li>\u2022 Administer oxygen as clinically indicated.</li><li>\u2022 Prepare for delivery.</li><li>\u2022 Massage fundus if placenta delivered.</li><li>COMPLICATED DELIVERY</li><li>\u2022 Excessive vaginal bleeding prior to delivery:</li><li>\uf0d8 Attempt to control bleeding.</li><li>Do not place anything intovagina.</li><li>\uf0d8 Place in trendelenburg position.</li><li>\u2022 Prolapsed Cord:</li><li>\uf0d8 Elevate hips.</li><li>\uf0d8 Gently pushpresenting part of headaway fromcord.</li><li>\uf0d8 Consider knee/chest position for mother.</li><li>\u2022 Postpartum Hemorrhage:</li><li>\uf0d8 Massage fundus to control bleeding.</li><li>\uf0d8 Encourage immediate breast feeding.</li><li>\uf0d8 Place in trendelenburg position.</li><li>\u2022 Cordaround infant\u2019sneck:</li><li>\uf0d8 Attempt to slipcord over the head.</li><li>\uf0d8 If unable to slipcord over the head, deliver the babythrough the cord.</li><li>\uf0d8 If unable to deliver the babythrough the cord, double clamp cord, then cutcord</li><li>between clamps.</li><li>\u2022 Breech presentation and head not delivered within three (3) to four (4) minutes:</li><li>\uf0d8 Administer oxygen.</li><li>OBSTETRICAL EMERGENCIES</li><li>\uf0d8 Place in trendelenburg position.</li><li>\uf0d8 Transport Code 3 to closest appropriate facility.</li><li>\u2022 Pregnancy Induced Hypertension and/or Eclampsia:</li><li>\uf0d8 Initiate and maintain seizure precautions.</li><li>\uf0d8 Attempt to reduce stimuli.</li><li>\uf0d8 Limit fluid intake.</li><li>\uf0d8 Monitor and document blood pressure.</li><li>\uf0d8 Consider leftlateral position.</li><li>III.</li><li>LIMITEDALS (LALS) INTERVENTIONS</li><li>COMPLICATED DELIVERY</li><li>\u2022 ObtainIV access, and maintainIV rate as appropriate.</li><li>\u2022 Excessive vaginal bleeding or post-partum hemorrhage:</li><li>\uf0d8 Administer fluid challenge of <b>500 ml</b>, if signs of inadequate tissue perfusion</li><li>persistmay repeat fluid bolus.</li><li>\uf0d8 MaintainIV rate at <b>150 ml</b>per hour.</li><li>Establish second large boreIV enroute.</li><li>\u2022 Pregnancy Induced Hypertension and/or Eclampsia:</li><li>\uf0d8 IVTKO, limit fluid intake.</li><li>\uf0d8 Obtain O2 saturation on roomair, if possible.</li><li>\uf0d8 Place in leftlateral position, and obtain blood pressure after five (5) minutes.</li><li>\u2022 Consider immediate notification of basehospital physician.</li><li><b>IV</b>.</li><li>ALSINTERVENTIONS</li><li>COMPLICATED DELIVERY</li><li>\u2022 ObtainIV access, and maintainIV rate as appropriate.</li><li>\u2022 Excessive vaginal bleeding or post-partum hemorrhage:</li><li>\uf0d8 Administer fluid challenge of <b>500 ml</b>.</li><li>If signs of inadequate tissue perfusion</li><li>persistmay repeat fluid bolus.</li><li>\uf0d8 MaintainIV rate at <b>150 ml</b>per hour.</li><li>\uf0d8 Establish second large boreIV enroute.</li><li>OBSTETRICAL EMERGENCIES</li><li>\u2022 Pregnancy induced hypertension:</li><li>\uf0d8 AdministerIVTKO.</li><li>Limit fluid intake.</li><li>\uf0d8 Obtain O2 saturation on roomair, if possible.</li><li>\uf0d8 Place in leftlateral position, and obtain blood pressure after five (5) minutes.</li><li>\uf0d8 Obtain rhythm strip withcopy to receiving hospital.</li><li>\u2022 Eclampsia (Seizure/Tonic/Clonic Activity):</li><li>\uf0d8 Administer Magnesium Sulfateper ICEMA - Medication -</li><li>Standard Orders.</li><li>\uf0d8 Administer Midazolamper ICEMA - Medication - Standard</li><li>Orders.</li><li>\u2022 Consider immediate notification of basehospital physician.</li><li>POSTPARTUM HEMMORHAGE (basehospital order only)</li><li>\u2022 Tranexamic Acid (TXA) administration:</li><li>\uf0d8 Must be within three (3) hours of onset and musthave either:</li><li>\uf0d8 Signs and symptoms of hemorrhagic shock withSBP lessthan 90 mm</li><li>\uf0d8 Significant hemorrhage withheart rategreater than or equal to 120.</li><li>V.</li><li>REFERENCE</li><li>Number NameINLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>NAUSEA AND VOMITINGI.</li><li>FIELD ASSESSMENT/TREATMENT INDICATORS</li><li>\u2022 Nausea.</li><li>\u2022 Vomiting.</li><li>\u2022 Prophylactic treatment of narcotic induced nausea and/or vomiting.</li><li>II.</li><li>CONTRAINDICATIONS</li><li>Patients under four (4) years of age.</li><li>Known sensitivity to Ondansetron or other 5-HT3 antagonists:</li><li>\u2022 Granisetron (Kytril)</li><li>\u2022 Dolasetron (Anzemet)</li><li>\u2022 Palonosetron (Aloxi)</li><li>III.</li><li>ALSINTERVENTIONS</li><li>\u2022 Assess patient for need for anti-emetic therapy.</li><li>\u2022 Maintain airway.</li><li>\u2022 Position of comfort.</li><li>\u2022 Oxygen.</li><li>\u2022 Cardiac monitoring in patients withhistory of cardiac problems.</li><li><b>IV</b>.</li><li>DOCUMENTATION</li><li>Document patient response.</li><li>V.</li><li>REFERENCE</li><li>Number NameINLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>SHOCK (NON-TRAUMATIC)</li><li>I.</li><li>FIELD ASSESSMENT/TREATMENT INDICATORS</li><li>\u2022 Patient exhibits signs/symptoms of profound shock and hypotension with a SBP of lessthan 90 mmHg for adults and a SBPless than 70 mmHg for pediatrics.</li><li>\u2022 Determine history of illness.</li><li>\u2022 History of GIbleeding, vomiting, diarrhea, fever/sepsis or vaginal bleeding.</li><li>\u2022 PostROSC for Out of Hospital Cardiac Arrest (OHCA).</li><li>\u2022 Consider hypoglycemia or narcotic overdose.</li><li>II.</li><li>LIMITEDALS (LALS) INTERVENTIONS</li><li>\u2022 Maintain airway withappropriate adjuncts, including perilaryngeal airway adjunct if</li><li>indicated.</li><li>\u2022 Obtain oxygen saturation on roomair or on homeoxygen if possible.</li><li>\u2022 PlaceAED pads on patient as precaution in event patient goesinto sudden cardiac</li><li>arrest.</li><li>\u2022 Obtain vascular access.</li><li>\u2022 If hypotensive or havesigns or symptoms of inadequate tissue perfusion, administer fluid</li><li>challenges:</li><li>\uf0d8 ADULT</li><li>\uf0a7 Administer <b>500 ml</b>IVbolus, mayrepeatone (1) timeuntil tissue perfusion</li><li>improves</li><li>\uf0d8 PEDIATRIC</li><li>Administer <b>20 ml/kg</b>IVbolus, mayrepeatone (1) time for tachycardia, change in</li><li>central/peripheral pulses or altered level of consciousness.</li><li>\u2022 For patients with no respiratory difficulties and adequate signs of tissue perfusion:</li><li>\uf0d8 ADULT/PEDIATRIC</li><li>\uf0a7 MaintainIV at TKO.</li><li>III.</li><li>ALSINTERVENTIONS</li><li>\u2022 Perform activities identified in LALSInterventions.</li><li>\u2022 Maintain airway withappropriate adjuncts, including advanced airway if indicated.</li><li>Obtain</li><li>oxygen saturation on roomair or on homeoxygen if possible.</li><li>SHOCK (NON-TRAUMATIC</li><li>\u2022 Place on cardiac monitor.</li><li>\u2022 Obtain vascular access.</li><li>\u2022 If hypotensive or hassigns or symptoms of inadequate tissue perfusion, administer fluid</li><li>challenges:</li><li>\uf0d8 ADULT</li><li>\uf0a7 Administer <b>500 ml</b>IVbolus, mayrepeatone (1) time to sustain a SBP of</li><li>morethan 90 mmHg or until tissue perfusion improves.</li><li>If no response to fluid administration, stopfluids and administer PushDose Epinephrine</li><li>\uf0d8 PEDIATRIC</li><li>\uf0a7 Administer <b>20 ml/kg</b>IVbolus, mayrepeatone (1) time for tachycardia,</li><li>change in central/peripheral pulses or altered level of consciousness.</li><li>\uf0a7 If no response to fluid administration, stopfluids and administer PushDoseEpinephrine perICEMA - Medication - Standard</li><li>Orders.</li><li>\u2022 For postpartum hemorrhage withcontinued signs of inadequate tissue perfusion, not</li><li>responsive to fluid challenge consider administration of TXA (basehospital order) per</li><li>\uf0d8 Must be within three (3) hours of onset and musthave either:</li><li>\uf0d8 Signs and symptoms of hemorrhagic shock withSBP lessthan 90 mmHg.</li><li>\uf0d8 Significant hemorrhage withheart rategreater than or equal to 120.</li><li>\u2022 For adults withsustainedSBP of morethan 90 mmHg, pediatrics withsustainedSBP</li><li>morethan 70 mmHg, no respiratory difficulties and adequate signs of tissue perfusion:</li><li>\uf0d8 ADULT</li><li>\uf0a7 MaintainIV at TKO.</li><li>\uf0d8 PEDIATRIC</li><li>\uf0a7 MaintainIV at TKO.</li><li>BaseHospital MayOrder</li><li>\u2022 Establish 2nd large boreIV enroute.</li><li><b>IV</b>.</li><li>REFERENCE</li><li>Number NameINLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>SUSPECTED ACUTE MYOCARDIAL INFARCTION (AMI)</li><li>I.</li><li>FIELD ASSESSMENT/TREATMENT INDICATORS</li><li>\u2022 Chest pain (typical or atypical).</li><li>\u2022 Syncopal episode.</li><li>\u2022 History of previousAMI, Angina, heart disease, or other associated riskfactors.</li><li>II.</li><li>BLSINTERVENTIONS</li><li>\u2022 Recognition of signs/symptoms of suspectedAMI.</li><li>\u2022 Reduce anxiety, allow patient to assume position of comfort.</li><li>\u2022 Oxygen as clinically indicated.</li><li>\u2022 Obtain oxygen saturation.</li><li>\u2022 Mayassist patient withself-administration of Nitroglycerin and/or Aspirin.</li><li>III.</li><li>LIMITEDALS (LALS) INTERVENTIONS</li><li>\u2022 Consider early vascular access.</li><li>\u2022 For patients withchest pain, signs of inadequate tissue perfusion and clear breath</li><li>sounds, administer <b>300 ml</b>NSbolus, mayrepeat.</li><li>\u2022 Consider establishing a saline lockenroute on sameside as initialIV.</li><li>\u2022 Complete thrombolytic checklist, if timepermits.</li><li>\u2022 Contact basehospital.</li><li><b>IV</b>.</li><li>ALSINTERVENTIONS</li><li>\u2022 Consider early vascular access.</li><li>\u2022 For patients withchest pain, signs of inadequate tissue perfusion and clear breath</li><li>sounds, administer <b>300 ml</b>NSbolus, mayrepeat.</li><li>SUSPECTED ACUTE MYOCARDIAL INFARCTION</li><li>(AMI)</li><li>\u2022 12-LeadTechnology:</li><li>\uf0d8 Obtain 12-leadECG.</li><li>Do not disconnect 12-leadcables until necessary for</li><li>transport.</li><li>\uf0d8 If signs of inadequate tissue perfusion or if inferior wallinfarct is suspected,</li><li>obtain a right-sided 12-lead (V4R).</li><li>\uf0d8 If right ventricular infarct (RVI) is suspected withsigns of inadequate tissue</li><li>perfusion, consider <b>300 ml</b>NSbolus, mayrepeat.</li><li>Early consultation withbase</li><li>hospital or receiving hospital in rural areas is recommended.</li><li>(Nitratesare</li><li>contraindicated in the presence of RVI or hypotension.)</li><li>\uf0d8 Withdocumented STsegment elevation in two (2) or morecontiguous leads</li><li>makeearly STEMI notification to the STEMI Receiving Center while preparing</li><li>patient for expeditious transport, refer to ICEMA - STElevation</li><li>Myocardial Infarction Critical CareSystem Designation (SanBernardino County</li><li>Only).</li><li>In Inyo and MonoCounties, the assigned basehospital should be</li><li>contacted for STEMI consultation.</li><li>\uf0d8 Repeat 12-leadECG at regular intervals, but do not delay transport of patient.</li><li>If</li><li>patient is placed on a different cardiac monitor for transport, transporting provider</li><li>should obtain an initial 12-lead on their cardiac monitor and leave 12-leadcables</li><li>in place throughout transport.</li><li>\uf0d8 EMSfield personnel shall ensure that a copy of the 12-leadECG is uploaded or</li><li>attached as a permanent part of the patient\u2019sePCR.</li><li>Fentanyl for cardiac chest paincontrol whenNitroglycerin is contraindicated.</li><li>concurrent administration of Nitroglycerin withFentanyl if there is no cardiac chest painrelief from the initial Nitroglycerin administration.</li><li>Contact basehospital for further</li><li>Fentanyl orders.</li><li>\u2022 Consider establishing a saline lock as a secondaryIV site.</li><li>V.</li><li>REFERENCES</li><li>Number Name</li><li>4040 STElevation Myocardial Infarction Critical CareSystem Designation (SanBernardino County Only)</li><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>DETERMINATION OF DEATH ON SCENEI.</li><li>PURPOSE</li><li>To identify situations when an EMT, AEMT or EMT-Pmay be called upon to determine death on</li><li>scene.</li><li>II.</li><li>POLICY</li><li>An EMT, AEMT or EMT-Pmaydetermine death on scene if pulselessness and apneaare</li><li>present withany of the following criteria.</li><li>The EMT-P is authorized to discontinueBLSCPR</li><li>initiated at scene if a patient falls into the category of obvious death.</li><li>In anysituation where theremay be doubt as to the clinical findings of the patient, BLSCPR must be initiated and the basehospital contacted.</li><li>Whendeath is determined, the County Coroner must be notified along with</li><li>the appropriatelaw enforcement agency.</li><li>III.</li><li>DETERMINATION OF DEATH CRITERIA</li><li>\u2022 Decomposition.</li><li>\u2022 Obvious signs of rigor mortis such as rigidity or stiffening of muscular tissues and joints in</li><li>the body, which occursany timeafter death and usually appears in the head, face and</li><li>neckmuscles first.</li><li>\u2022 Obvious signs of venous pooling in dependent bodyparts, lividity such as mottled bluishtinged discoloration of the skin, often accompanied by coldextremities.</li><li>\u2022 Decapitation.</li><li>\u2022 Incineration of the torso and/or head.</li><li>\u2022 Massive crush injury.</li><li>\u2022 Penetrating injury withevisceration of the heart, and/or brain.</li><li>\u2022 Gross dismemberment of the trunk.</li><li><b>IV</b>.</li><li>SPECIAL CONSIDERATIONS</li><li>\u2022 In the event that a patient progresses to cardio/pulmonary arrest while enroute to</li><li>the hospital in the setting of a completed and verified limitation of treatment</li><li>document (POLST, DNR, Advanced Directive) the field provider should honor the</li><li>written limitations and transport the patient to the closest receiving Emergency</li><li>Department for a medical evaluation\u201d and \u201cThe BaseStation should advise crew to</li><li>honor patients wishes as verified in the valid limitations of treatment and transport</li><li>to the closest receiving facility for medical evaluation without callingTOD\u201d.</li><li>\u2022 A copy of the patient carereport must be madeavailable for the Coroner.</li><li>Thiswill be</li><li>transmitted to them, whenposted, if the disposition is marked \u201cDead on Scene\u201d and the</li><li>Destination is marked \u201cCoroner, SanBernardino County\u201d on the electronic patient carereport (ePCR).</li><li>DETERMINATION OF DEATH ON SCENE</li><li>\u2022 The completed ePCRmust be posted to the Coroner before the end of the shift.</li><li>\u2022 If unable to post, the use of an approved paper patient carereport as a \u201cdowntime\u201d form is</li><li>permitted by ICEMA - Requirements for Patient CareReports.</li><li>DETERMINATION OF DEATH ON SCENE</li><li>LIMITEDALS (LALS) PROCEDURE</li><li>\u2022 Allterminated LALSresuscitation efforts musthave an AEDevent record attached to the</li><li>ePCR.</li><li>ALSPROCEDURE</li><li>\u2022 Allpatients in ventricular fibrillation should be resuscitated on scene until ROSC is</li><li>achieved.</li><li>If patient remains in VF/VTafter 20 minutes of CPR, consult basehospital.</li><li>\u2022 Severe blunt force trauma, pulseless, without signs of life (palpable pulses and/or</li><li>spontaneous respirations) and cardiac electrical activity lessthan 40 bpm or duringEMS</li><li>encounter with the patient meets Determination of Death criteria.</li><li>AllterminatedALS</li><li>resuscitation efforts musthave an ECGattached to the patient carereport.</li><li>\u2022 Consider termination of resuscitation efforts in the prehospital setting if any of the criteria</li><li>aremet in the ICEMA - Cardiac Arrest - Adult.</li><li>V.</li><li>SUSPECTED SUDDEN INFANT DEATH SYNDROME (SIDS) INCIDENT</li><li>It is imperative thatall EMSfield personnel be able to assist the caregiver and local police</li><li>agencies during a suspected SIDSincident.</li><li>PROCEDURE</li><li>\u2022 Follow individual department/agency policies at alltimes.</li><li>\u2022 Askopen-ended questions about incident.</li><li>\u2022 Explain whatyou aredoing, the proceduresyou willfollow, and the reasons for them.</li><li>\u2022 If yoususpect a SIDSdeath, explain to the parent/caregiver whatSIDS is and, if this is a</li><li>SIDSrelated death nothing theydid or did not do caused the death.</li><li>\u2022 Provide the parent/caregiver with the number of the California SIDSInformation Line:</li><li>1-800-369-SIDS (7437)</li><li>\u2022 Provide psychosocial support and explain the emergency treatment and transport of their</li><li>child.</li><li>\u2022 Assure the parent/caregiver thatyour activitiesare standard procedures for the</li><li>investigation of alldeath incidents and thatthere is no suspicion of wrongdoing.</li><li>\u2022 Document observations.</li><li>VI.</li><li>REFERENCES</li><li>Number Name</li><li>5030 Requirements for Patient CareReports</li><li>14050 Cardiac Arrest - Adult</li><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCYEND OF LIFECARE AND DECISIONSI.</li><li>PURPOSE</li><li>To establish criteria thatrecognizes and accommodates a patient\u2019sdesignatedend of lifedirectives to limit prehospital treatment by Emergency Medical Service (EMS) field personnel in</li><li>the prehospital setting, long-termcare facilities, during transport between facilities and/or in the</li><li>patient\u2019shome.</li><li>II.</li><li>POLICY</li><li>EMSfield personnel shall makeall attempts to honor a patient\u2019send of lifewishes.</li><li>In doingso,</li><li>allefforts should be made to obtain and verify applicable forms describing the patient\u2019send of lifeinstructions and provideany necessary supportive measures.</li><li>A Do Not Resuscitate (DNR) order onlyapplies to resuscitative measures.</li><li>An order not to</li><li>resuscitate is not an order to withhold other necessary medical treatments, nutrition or supportive</li><li>measures.</li><li>The treatment given to a patient with a DNRagreement should, in allrespects, be the</li><li>same as thatprovided to a patient without such an agreement.</li><li>A patient withmedical decision making capacitycan request alternative treatment or revoke a</li><li>DNR or POLST by anymeans thatindicates intent to revoke.</li><li>A patientmay withdraw or rescind</li><li>their request for an aid-in-dying drugregardless of their mental state at anytime.</li><li>Forms related to patient\u2019send of lifeinstructions thatEMS field personnelmay encounter include:</li><li>\u2022 Statewide EMSA/California Medical Association (CMA) PrehospitalDNR form.</li><li>\u2022 POLST form.</li><li>\u2022 DNRmedallion, bracelet or necklace.</li><li>\u2022 A Do Not Resuscitate Order in a patient\u2019schart dated and signed by the physician.</li><li>\u2022 End of LifeOptions ActDirective and/or Final Attestation for An Aid-In-Dying Drug to EndMyLife in a Humane and Dignified Manner form.</li><li>III.</li><li>VALIDATION CRITERIA</li><li>EMSPrehospitalDNR</li><li>\u2022 The EMSPrehospital DNRform should include the following to be considered valid:</li><li>\uf0d8 Patient\u2019sname.</li><li>\uf0d8 Signature of the patient or a legally recognized decision maker if the patient is</li><li>unable to make or communicate informed healthcare decisions.</li><li>\uf0d8 Signature of patients\u2019 physician, affirming that the patient/legal representativehas</li><li>given informed consent to the DNRinstruction.</li><li>\uf0d8 Allsignatures must be dated.</li><li>END OF LIFECARE AND DECISIONS</li><li>\uf0d8 Correct identification of the patient is crucial.</li><li>If the patient is unable to be</li><li>identified after a goodfaith attempt to identify the patient, a reliable witnessmay</li><li>be used to identify the patient.</li><li>\u2022 In licensed healthcare facilities a DNRorder written by a physician shall be honored.</li><li>\uf0d8 The staff musthave the patient\u2019schart with the DNRorder immediately available</li><li>for EMSfield personnel upontheir arrival.</li><li>\uf0d8 The ordermay contain the words Do Not Resuscitate, No CPR, or No Code and</li><li>contain the patient\u2019sname and the date and signature</li><li>of the physician.</li><li>DNRMedallion, Bracelet or Necklace</li><li>\u2022 The DNRmedallion/bracelet/necklace is made of metal with a</li><li>permanently imprinted medical insignia.</li><li>For the medallion or</li><li>bracelet/necklace to be valid the following applies:</li><li>\uf0d8 Patient must be physically wearing the DNRmedallion/</li><li>bracelet/necklace.</li><li>\uf0d8 Medallion/bracelet/necklace must be engraved with the</li><li>words \u201cDo Not ResuscitateEMS\u201d or \u201cCalifornia POLSTEMS\u201d, along with a tollfree emergency information</li><li>telephone number and a patient identification number.</li><li>Physician Order for LifeSaving Treatment (POLST)</li><li>\u2022 The POLST does not replace the Advanced Directive and should be reviewed along withother documents whenavailable.</li><li>The POLST:</li><li>\uf0d8 Must be signed and dated by a physician, nurse practitioner or physician</li><li>assistant acting under the supervision of a physician and within the scope of</li><li>practice authorized by law.</li><li>\uf0d8 Must be signed by the patient or decision maker.</li><li>\uf0d8 Is not valid without signatures.</li><li>Verbal or telephone ordersare acceptable withfollow-upsignature by the physician in accordance withfacility/community policy.</li><li>There should be a boxchecked indicatingwho the authorized healthcare provider</li><li>discussed the POLST orders with.</li><li>By signing the form, the healthcare provider</li><li>acknowledges thatthese ordersare consistent with the patient\u2019smedical</li><li>condition and preferences.</li><li>End of LifeOptions ActDirective</li><li>\u2022 A terminallyill and competent patientmay elect to obtain medications to hasten their</li><li>imminent death at a time and place of their choosing.</li><li>Theymust satisfy extensive and</li><li>stringent requirements as required by Californialaw to obtain an Aid-In-Dying Drug and</li><li>complete a \u201cFinal Attestation For An Aid-In-Dying Drug to EndMy Life in a Humane and</li><li>Dignified Manner\u201d within 48 hours prior self-administration.</li><li>END OF LIFECARE AND DECISIONS</li><li>\u2022 Thereare no standardized \u201cFinal Attestation For An Aid-In-Dying Drug to EndMy Life in a</li><li>Humane and Dignified Manner\u201d formsbut the lawhas required specific information thatmust be in the final attestation.</li><li>If available, EMSfield personnel should make a goodfaith effort to review and verify that the final attestation contains the following information:</li><li>\uf0d8 The document is identified as a \u201cFinal Attestation For An Aid-In-Dying Drug to</li><li>EndMy Life in a Humane and Dignified Manner\u201d.</li><li>\uf0d8 Patient\u2019sname, signature and dated.</li><li>\uf0d8 EMSfield personnel should review and verify that the \u201cFinal Attestation for An</li><li>Aid-In-Dying Drug to EndMy Life in a Humane and Dignified Manner\u201d is present.</li><li>\uf0d8 Correctly identifies the patient\u2019sname, and is signed and dated by the patient or</li><li>designated decision maker.</li><li>\uf0d8 The Final Attestation for An Aid-In-Dying Drugmust be completed within 48 hours</li><li>prior to taking the medications.</li><li>\uf0d8 Obtain a copy of the final attestation and attach it to the electronic patient carerecord (ePCR) whenever possible.</li><li>\uf0d8 There is no mandate for the patient to maintain the final attestation in close</li><li>proximity of the patient.</li><li>\uf0d8 If a copy of the final attestation is available, EMSfield personnel should confirm</li><li>the patient is the person named in the final attestation.</li><li>Thiswill normally require</li><li>either the presence of a form of identification or a witnesswho canreliably</li><li>identify the patient.</li><li><b>IV</b>.</li><li>PROCEDUREDNR, Medallion/Bracelet/Neckless or POLST</li><li>In addition to the validation criteria, the following guidelinesare provided for EMSfield personnel</li><li>whenresponding to a patient withStandardized Patient-Designated Directives.</li><li>\u2022 EMSfield personnel shall validate the DNRrequest, medallion/bracelet/necklace, or</li><li>POLST form.</li><li>Patientmay withdrawany directive at anytime.</li><li>\u2022 The POLSTmay be used for bothadults and pediatric patients.</li><li>\u2022 BLSfield personnel shall continue resuscitative measures if a DNR or POLST cannot be</li><li>validated.</li><li>\u2022 LALS and ALSfield personnel shall contact a basehospital for direction if a DNR or</li><li>POLST cannot be validated or for conflicting requests by family members.</li><li>WhileALS</li><li>field personnelare contacting the basehospital for direction, BLStreatment must be</li><li>initiated and continued.</li><li>If contact cannot be made, resuscitative efforts shall continue.</li><li>\u2022 If a patient states thatthey wishresuscitative measures, the request shall be honored.</li><li>\u2022 If a family member requests resuscitative measures despite a validDNR or POLST,</li><li>continue resuscitative measures until basehospital contact is made.</li><li>END OF LIFECARE AND DECISIONS</li><li>\u2022 If patient is not in cardiac arrest and has a valid POLST form, EMSfield personnelmay</li><li>provide comfort measures as described in SectionB of the form.</li><li>\u2022 The patient shall be transported to the hospital if comfort measuresare started by EMSfield personnel.</li><li>\u2022 Directany questions or conflicts in transporting the patient to the basehospital.</li><li>\u2022 EMSfield personnel shall attach a copy of the approvedDNR form or POLST form to the</li><li>patient carereport, along withany other appropriate written documentation.</li><li>The DNRformshould accompany the patient to the hospitalso that it may be incorporated into the</li><li>medical record at the receiving facility.</li><li>\u2022 WhenDNR ordersare noted in medical records in licensed facilities, thatfact should be</li><li>recorded by the EMSprovider, along with the date of the order and the physician\u2019sname.</li><li>It should be noted on the ePCRthat a writtenDNR orderwas present including the name</li><li>of the physician, datesigned and other appropriate information.</li><li>\u2022 Allcircumstances surrounding the incident must be documented on the EMSpatient carereport.</li><li>If EMSfield personnelare unable to copy the DNR or POLST form, the following</li><li>shall be documented on the patient carereport:</li><li>\uf0d8 Presence of DNR or POLST form.</li><li>\uf0d8 Date of order.</li><li>\uf0d8 Name of physicianwho signed form.</li><li>\u2022 If a patient dies at home, and the patient is not under the care of Hospice, lawenforcement must be notified.</li><li>In allcases, the coroner must be notified.</li><li>Refer to ICEMA</li><li>- Determination of Death On Scene.</li><li>\u2022 If a patient expires in a licensed healthcare facility, the facilityhas the responsibility to</li><li>make the appropriate notification.</li><li>End of LifeOptionsAct</li><li>In addition to the validation criteria, the following guidelinesare provided for EMSpersonnel whenresponding to a patientwho hasself-administered an aid-in-dying drug.</li><li>\u2022 The lawoffers protections and exemptions for healthcare providersbut is not explicit</li><li>aboutEMS response for End of LifeOption Actpatients.</li><li>\u2022 Provide supportive measures whenever possible.</li><li>\u2022 Withhold resuscitative measures if patient is in cardiopulmonary arrest.</li><li>\u2022 The patientmay withdraw or rescind their request for an aid-in-dying drugregardless of</li><li>the patient\u2019smental state at anytime.</li><li>EMSfield personnelare encouraged to consult</li><li>withtheir basehospital whenever necessary.</li><li>\u2022 Family membersmay be at the scene of a patientwho hasself-administered an aid-indying drug.</li><li>If conflict arises as to resuscitation efforts, inform the family thatonlyEND OF LIFECARE AND DECISIONS</li><li>supportive measures will be provided according to the patient\u2019swishes and consider basehospital contact to attempt resolution.</li><li>\u2022 Allcircumstances surrounding the incident must be documented on the EMSpatient carereport.</li><li>If EMSfield personnelare unable to obtain a copy of the End of LifeOptionsAct</li><li>Final Attestation form, the following shall be documented on the patient carereport:</li><li>\uf0d8 Presence of the End of LifeOptions ActAttestation form.</li><li>\uf0d8 Date of order.</li><li>\uf0d8 Name of physicianwho signed form.</li><li>\u2022 If a patient dies at home and the patient is not under the care of Hospice, lawenforcement must be notified.</li><li>In allcases, the coroner must be notified.</li><li>Refer to ICEMA</li><li>- Determination of Death On Scene.</li><li>\u2022 If a patient expires in a licensed healthcare facility, the facilityhas the responsibility to</li><li>make the appropriate notification.</li><li>V.</li><li>SUPPORTIVE MEASURES</li><li>\u2022 Medical interventions and/or treatment thatmay provide for the comfort, safety and dignity</li><li>of the patient should be utilized.</li><li>\u2022 The patient should receive palliative treatment for pain, dyspnea, major hemorrhage or</li><li>other medical conditions.</li><li>\u2022 Allowany family members/significant others to express their concerns and begin their</li><li>grieving process.</li><li>\u2022 Unless a patient is actively dying, medical treatment for other conditions should not be</li><li>withheld.</li><li>VI.</li><li>REFERENCE</li><li>Number Name</li><li>14250 Determination of Death On Scene</li><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY</li><li>VENTRICULAR ASSIST DEVICE (VAD)</li><li>I.</li><li>PURPOSE</li><li>To establish guidelines for EMSfield personnel in the prehospital assessment, treatment and</li><li>transport of patientswho have a Ventricular Assist Device (VAD).</li><li>II.</li><li>FIELD ASSESSMENT/TREATMENT INDICATORS</li><li>\u2022 The EMSfield personnel shall first assess the patient and not the device.</li><li>Utilize the</li><li>American Heart Association\u2019sC-A-Brecommendations, withone (1) addition:</li><li>\uf0d8 C-Circulation/Connections (Device)</li><li>\uf0d8 A-Airway</li><li>\uf0d8 B-Breathing</li><li>\u2022 Clinical assessment of the patient is essential and the mostimportant clinical observation</li><li>(i.e., level of consciousness, skinsigns, adequate perfusion).</li><li>\u2022 Follow appropriate ICEMA protocols for the patients\u2019 condition.</li><li>\u2022 Thereare no medication contraindications in relation to the VAD.</li><li>\u2022 If defibrillation or cardioversion is necessary, follow the appropriate ICEMA protocol.</li><li>The</li><li>pump is insulated, soelectrical therapy should not be an issue.</li><li>\u2022 A patient with a VADmight not have a palpable pulse as this is a continuous flowdevice.</li><li>However, they do have a heart rate and rhythm.</li><li>The 12-leadECG or heart monitor willshow the patient\u2019snative heart rhythm and will not necessarily reflect the patient\u2019scirculatory function.</li><li>Treat arrhythmias according to ICEMA protocols, except for chest</li><li>compressions.</li><li>\u2022 Waveform capnography monitoring is appropriate as pulse oximetrymay not be</li><li>measurable or it may be inaccurate.</li><li>\u2022 VADpatientsmay not have a systolic and diastolic blood pressure obtainable by standard</li><li>methods using a manual or automatic blood pressure cuff.</li><li>It may be possible to</li><li>auscultate.</li><li>The meanarterial blood pressure (MAP) typical range is 70 - 90 mmHg.</li><li>To</li><li>calculate the MAP, use the formula below:</li><li>VENTRICULAR ASSIST DEVICE (VAD)</li><li>III.</li><li>PROCEDURE</li><li>\u2022 A patient with a VADwill mostlikely have a trained companion withthem.</li><li>The</li><li>companion is familiar with the VAD and emergency troubleshooting.</li><li>The companion</li><li>should accompany the patient during transport and be responsible for the VADwhenever</li><li>possible.</li><li>\u2022 VADpatients and their companionsare taught to call 9-1-1 in an emergency, then page</li><li>the on callVAD Coordinator immediately.</li><li>The VADCoordinator willtypically be on the</li><li>telephone to provide additional assistance to the EMSfield personnel whenthey arrive.</li><li>\u2022 Contact information for the VADCoordinator and the VADImplant Center is usually</li><li>attached to or located inside the patients\u2019 VADequipmentbag.</li><li>\u2022 Whentransporting these patients to the appropriate hospital, the VADemergencybag,</li><li>power module, power baseunit, batteries, charger, and backup controller mustall be</li><li>brought to the hospital.</li><li>\u2022 Transport decision must be made by both the on callVAD Coordinator and the basehospital, typically transported to the nearest appropriateVAD Implant Center (LomaLinda</li><li>University Medical Center in ICEMA region), withpreference given to their implanting</li><li>center whenever possible.</li><li>NOTE: If the paramedic on scenehas assessed the patient and observed the following:</li><li>\u2022 The patient is unresponsive and is asystole on the cardiac monitor, and</li><li>\u2022 Allconnections to the device havebeen assessed and not producing a \u201chum\u201d over the</li><li>apex of the heart uponauscultation, and</li><li>\u2022 Waveform Capnography is lessthan 10 and MAP is lessthan 50, then chest</li><li>compressionscan be performed as a lastresort for patient condition.</li><li>INLAND COUNTIES</li><li>EMERGENCY MEDICAL AGENCY Supersedes: N/A</li></ul>"
  }
]